UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT
OF 1934
Date of Report (Date of earliest event reported):
October 18, 2023
RF Acquisition Corp.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-41332 |
|
61-1991323 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
16400 Dallas Parkway
Dallas, Texas 75248
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: +65 6904 0766
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each
exchange on
which registered |
Units, each consisting of one share of Class A Common Stock, one redeemable warrant, and one right to receive one-tenth of one share of Class A Common Stock |
|
RFACU |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Share of Class A Common Stock, par value $0.0001 per share |
|
RFAC |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share |
|
RFACW |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Rights, each right receives one-tenth of one share of Class A Common Stock |
|
RFACR |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01. Entry into a Material Definitive Agreement
Merger Agreement
On October 18, 2023, RF Acquisition Corp.,
a Delaware corporation (“SPAC”) entered into an agreement and plan of merger (as it may be amended, supplemented or
otherwise modified from time to time, the “Merger Agreement”) with GCL Global Holdings Ltd, a Cayman Islands exempted
company limited by shares (“PubCo”), Grand Centrex Limited, a British Virgin Islands business company (“GCL
BVI”), GCL Global Limited, a Cayman Islands exempted company limited by shares (“GCL Global”), and, for the
limited purposes set forth therein, RF Dynamic LLC, a Delaware limited liability company (the “Sponsor”). Pursuant
to the terms of the Merger Agreement, PubCo will form a Cayman Islands exempted company limited by shares, to be a wholly owned direct
subsidiary of PubCo (“Merger Sub 1”), and a Delaware limited liability company, to be a wholly owned direct subsidiary
of PubCo (“Merger Sub 2”), for the purpose of participating in the transactions contemplated by the Merger Agreement,
including, without limitation, the merger of Merger Sub 1 with and into GCL Global, with GCL Global surviving such merger as a wholly
owned subsidiary of PubCo (the “Initial Merger”), and the merger of Merger Sub 2 with and into SPAC, with SPAC surviving
such merger as a wholly owned subsidiary of PubCo (the “SPAC Merger” and together with the Initial Merger, the “Mergers”,
and together with the other transactions contemplated by the Merger Agreement and the other agreements contemplated thereby, the “Transactions”).
The requisite members of the board of directors of SPAC (the “Board”) have (i) approved and declared advisable
the Merger Agreement and the Transactions and (ii) resolved to recommend the approval and adoption of the Merger Agreement and the
Transactions by the stockholders of SPAC.
Restructuring
On or before December 17, 2023, GCL BVI and
GCL Global shall cause, and shall cause the GCL Companies (as defined in the Merger Agreement) to, complete the Restructuring (as defined
in the Merger Agreement).
Treatment of Securities
Merger Sub 1 Shares. At the effective
time of the Initial Merger (the “Initial Merger Effective Time”), by virtue of the Initial Merger and without any action
on the part of any party to the Merger Agreement or the holders of shares of Merger Sub 1, each share of Merger Sub 1 that is issued and
outstanding immediately prior to the Initial Merger Effective Time shall automatically be converted into an equal number and class of
shares of GCL Global, which shares shall constitute the only outstanding shares of GCL Global.
Ordinary Shares of GCL Global. At
the Initial Merger Effective Time, by virtue of the Initial Merger and without any action on the part of any party to the Merger Agreement
or the holders of ordinary shares of GCL Global (“Company Shares”), each Company Share that is issued and outstanding
immediately prior to the Initial Merger Effective Time (other than any treasury shares or Dissenting Shares (as defined in the Merger
Agreement)), shall automatically be cancelled and cease to exist in exchange for the right to receive, such number of newly issued ordinary
shares of PubCo (“PubCo Shares”) equal to the Company Exchange Ratio (as defined in the Merger Agreement), rounded
up to the nearest whole share, as such calculations are set forth in the Payment Spreadsheet (as defined in the Merger Agreement) as to
each holder set forth therein (the “Merger Consideration Shares”). As of the Initial Merger Effective Time, each Company
Shareholder (as defined in the Merger Agreement) shall cease to have any other rights in and to the Company (as defined in the Merger
Agreement) or GCL Global (other than appraisal and dissenter’s rights). Prior to the payment of the Merger Consideration Shares
to any Company Shareholder, such Company Shareholder shall deliver to SPAC a duly completed and executed letter of transmittal in such
form as is typical for transactions of this type together with the certificate (if the Company Shares are certificated) representing the
Company Shares owned by such Company Shareholder. Such letter of transmittal will include, without limitation: a release in favor of PubCo,
the GCL Companies and SPAC in such holder’s capacity as a Company Shareholder, from any Action (as defined in the Merger Agreement)
or liability whatsoever, based upon, relating to or arising out of such Company Shareholder’s ownership of share capital of the
Company and/or the Transactions.
Treasury Shares of GCL Global. At
the Initial Merger Effective Time, if there are any Company Shares that are owned by the Company as treasury shares or any Company Shares
owned by any direct or indirect subsidiary of the Company immediately prior to the Initial Merger Effective Time, such Company Shares
shall be canceled and shall cease to exist without any conversion thereof or payment therefor.
Dissenting Shares of GCL Global.
Each of the Dissenting Shares issued and outstanding immediately prior to the Initial Merger Effective Time shall be canceled and cease
to exist in accordance with Section 2.7(a) of the Merger Agreement and shall thereafter represent only the right to receive
the applicable payments set forth in Section 2.7(a) of the Merger Agreement.
SPAC Units. At the effective time
of the SPAC Merger (the “SPAC Merger Effective Time”), each unit of SPAC, each unit comprising one share of SPAC Class A
Common Stock (as defined in the Merger Agreement), one SPAC Right (as defined in the Merger Agreement) and one SPAC Warrant (as defined
in the Merger Agreement) (each, a “SPAC Unit”), that is outstanding immediately prior to the SPAC Merger Effective
Time shall be automatically separated and the holder thereof shall be deemed to hold one share of SPAC Class A Common Stock, one
SPAC Warrant, and one SPAC Right in accordance with the terms of the applicable SPAC Unit, which underlying securities of SPAC shall be
adjusted in accordance with the applicable terms of Section 2.3(g) of the Merger Agreement.
SPAC Rights. At the SPAC Merger Effective
Time, and immediately following the separation of each SPAC Unit in accordance with Section 2.3(g)(i) of the Merger Agreement,
by virtue of the SPAC Merger and conditioned on the consummation of the Mergers and without any action on the part of any party to the
Merger Agreement or the holders of SPAC Capital Stock (as defined in the Merger Agreement), each holder of 10 or more SPAC Rights shall
be deemed to hold one share of SPAC Class A Common Stock for each 10 such SPAC Rights (including all SPAC Rights that were included
in the SPAC Units).
SPAC Common Stock. At the SPAC Merger
Effective Time, and immediately following the separation of each SPAC Unit in accordance with Section 2.3(g)(i) of the Merger
Agreement and the exchange of each SPAC Right in accordance with Section 2.3(g)(ii) of the Merger Agreement, by virtue of the
SPAC Merger and conditioned on the consummation of the Mergers and without any action on the part of any party to the Merger Agreement
or the holders of SPAC Capital Stock each share of SPAC Class A Common Stock that is issued and outstanding immediately prior to
the SPAC Merger Effective Time, shall automatically be cancelled and cease to exist in exchange for the right to receive a newly issued
PubCo Share. As of the SPAC Merger Effective Time, each SPAC Stockholder shall cease to have any other rights in and to SPAC.
SPAC Treasury Stock. At the SPAC
Merger Effective Time, if there are any shares of SPAC Capital Stock that are owned by SPAC as treasury shares or any shares of SPAC Capital
Stock owned by any direct or indirect Subsidiary of SPAC immediately prior to the SPAC Merger Effective Time, such shares of SPAC Capital
Stock shall be canceled and shall cease to exist without any conversion thereof or payment or other consideration therefor.
SPAC Warrants. At the SPAC Merger
Effective Time, without any action on the part of any holder of a SPAC Warrant, each SPAC Warrant that is issued and outstanding immediately
prior to the SPAC Merger Effective Time (but after giving effect to the separation of each SPAC Unit in accordance with Section 2.3(g)(i) of
the Merger Agreement) shall, pursuant to and in accordance with Section 4.5 of the SPAC Warrant Agreement (as defined in the Merger
Agreement) and the Assignment and Assumption Agreement (as defined in the Merger Agreement), automatically and irrevocably be modified
to provide that such SPAC Warrant shall no longer entitle the holder thereof to purchase the number of shares of SPAC Class A Common
Stock set forth therein and in substitution thereof such SPAC Warrant shall entitle the holder thereof to acquire such equal number of
PubCo Shares (each, an “Assumed Warrant”). Each Assumed Warrant shall continue to have and be subject to substantially
the same terms and conditions as were applicable to such SPAC Warrant as of immediately prior to the SPAC Merger Effective Time, except
that each Assumed Warrant shall be exercisable for shares of PubCo Shares rather than SPAC Class A Common Stock.
Representations and Warranties
The Merger Agreement contains customary representations
and warranties of the parties thereto with respect to, among other things, (a) with respect to the Company and the Acquisition Entities
(as defined in the Merger Agreement): (i) entity organization, good standing and qualification, (ii) subsidiaries and capitalization,
(iii) authorization to enter into the Merger Agreement and to consummate the Transactions, (iv) financial statements, (v) material
contracts, (vi) intellectual property, (vii) title to properties and assets and outstanding liens, (viii) real property,
(ix) environmental matters, (x) non-conflict with governing documents, laws and governmental orders, and certain contracts,
(xi) absence of material changes, (xii) litigation, (xiii) insurance, (xiv) governmental consents, (xv) material
permits, (xvi) registration and voting rights, (xvii) brokers, finders and transaction expenses, (xviii) related-party
transactions, (xix) labor agreements, actions and employee compensation, (xx) employee benefit plans, (xxi) taxes, (xxii) books
and records, (xxiii) anti-money laundering, (xxiv) takeover statutes and charter provisions, (xxv) registration statement,
(xxvi) approval of the board of directors of the Company, (xxvii) PubCo incentive equity plan, and (xxviii) foreign private
issuer, and, (b) with respect to SPAC: (i) entity organization, good standing and qualification, (ii) capitalization, (iii) authorization
to enter into the Merger Agreement and to consummate the Transactions, (iv) financial statements, (v) compliance with other
instruments, (vi) absence of material changes, (vii) litigation, (viii) governmental consents, (ix) brokers, finders
and transaction expenses, (x) taxes, (xi) registration statement, (xii) SEC filings, (xiii) trust account, (xiv) the
Investment Company Act of 1940, (xv) the JOBS Act (as defined in the Merger Agreement), (xvi) NASDAQ quotation, and (xvii) approval
of the board of directors of SPAC.
Covenants
The Merger Agreement includes customary covenants
of the parties with respect to the operation of their respective businesses prior to the consummation of the Mergers and efforts to satisfy
conditions to the consummation of the Merger. The Merger Agreement also contains additional covenants of the parties, including, among
others, covenants providing for (i) PubCo and GCL Global maintaining a directors’ and officers’ liability insurance policy,
(ii) delivery by the Company of the Audited Company Financials (as defined in the Merger Agreement) on or before December 11,
2023, (iii) if it is determined by the parties to the Merger Agreement that it is probable the Transaction will not be consummated
on or prior to December 28, 2023, the filing and mailing of proxy materials to be sent to the stockholders, of SPAC seeking approval
to extend the duration of the SPAC through September 30, 2024, (iv) the Company and SPAC to cause a registration statement to
be filed to register the shares of PubCo Shares to be issued in the Transactions (the “Registration Statement”) to
comply with the rules and regulations promulgated by the Securities and Exchange Commission (the “SEC”), to have
the Registration Statement declared effective under the Securities Act (as defined in the Merger Agreement) as promptly as practicable
after such filing and to keep the Registration Statement effective as long as is necessary to consummate the Mergers. The Company and
SPAC have also agreed to obtain all requisite approvals of their respective stockholders including, without limitation, (a) approval
of the Transactions, (b) approval of the PubCo Incentive Equity Plan (as defined in the Merger Agreement), (c) any other proposals
as the SEC may indicate are necessary in its comments to the Registration Statement or correspondence related thereto, (d) to remove
the requirement from SPAC’s Governing Documents (as defined in the Merger Agreement) limiting redemptions and consummation of a
business combination if the surviving company would not have net tangible assets of at least $5,000,001 and any other proposals as determined
by SPAC and PubCo to be necessary or appropriate in connection with the Transactions, and (e) adjournment of the SPAC Stockholder
Meeting (as defined in the Merger Agreement), if necessary, to permit further solicitation of proxies because there are insufficient votes
to approve and adopt any of the foregoing or for such other reasons as the chairman of the SPAC Stockholder Meeting may deem necessary.
Transaction Financing; Incentive Shares
The Merger Agreement includes a covenant for SPAC,
the Company, and Sponsor to use reasonable best efforts to obtain transaction financing, in the form of signed agreements for a private
placement of equity or other alternative financing in an aggregate amount of not less than $20,000,000 (“Transaction Financing”).
In connection with non-redemption or similar agreements
or sources of Transaction financing, PubCo has agreed to reserve 2,000,000 PubCo Shares (such shares, the “Incentive Shares”),
to be allocated as determined by the Sponsor, in its sole discretion, none of which shall be subject to any lock-up period. Sponsor may
direct PubCo to issue all such Incentive Shares to Sponsor.
PubCo Incentive Equity Plan
PubCo has agreed to adopt, subject to stockholder
approval, a stock incentive plan (the “PubCo Incentive Equity Plan”) to be effective as of the Closing. The PubCo Equity
Incentive Plan shall provide for the reservation of an aggregate number of shares of PubCo Shares equal to up to 15% of the fully diluted
outstanding shares of PubCo Shares immediately after the Closing, for issuance pursuant to the Incentive Plan.
Non-Solicitation Restrictions; Exclusivity
Except in connection with Transaction Financing,
each of the Company and SPAC has agreed not to, and to cause its Representatives (as defined in the Merger Agreement) not to, until the
earlier of Closing (as defined in the Merger Agreement) or the valid termination of the Merger Agreement, (i) initiate any negotiations
with any Person (as defined in the Merger Agreement) with respect to, or provide any non-public information or data concerning the Company
and SPAC or their respective subsidiaries, to any Person relating to an Acquisition Proposal (as defined in the Merger Agreement) or Alternative
Transaction (as defined in the Merger Agreement) or afford to any Person access to the business, properties, assets or personnel of any
GCL Company or SPAC or any of their respective subsidiaries in connection with an Acquisition Proposal or Alternative Transaction, (ii) enter
into any acquisition agreement, merger agreement or similar definitive agreement, or any letter of intent, memorandum of understanding
or agreement in principle, or any other agreement relating to an Acquisition Proposal or Alternative Transaction, (iii) grant any
waiver, amendment or release under any confidentiality agreement or the anti-takeover laws of any state relating to an Acquisition Proposal
or Alternative Transaction, or (iv) otherwise knowingly facilitate any such inquiries, proposals, discussions, or negotiations or
any effort or attempt by any Person to make an Acquisition Proposal or Alternative Transaction. Each of the Company and SPAC shall, and
shall cause its Representatives to, immediately cease any and all existing discussions or negotiations with any person conducted heretofore
with respect to any Alternative Transaction or Acquisition Proposal.
Conditions to Closing
The consummation of the Mergers is conditioned
upon, among other things, (i) receipt of the SPAC Stockholders’ Approval (as defined in the Merger Agreement) and the Company
Written Consent (as defined in the Merger Agreement), (ii) obtaining all Regulatory Approvals (as defined in the Merger Agreement),
(iii) the Registration Statement being declared effective under the Securities Act and no stop order suspending the effectiveness
thereof being issued and no proceedings for that purpose having been initiated or threatened by the SEC and not withdrawn, (iv) the
approval for listing of the PubCo Shares to be issued in connection with the Transaction, subject only to official notice of issuance
thereof, (v) solely with respect to SPAC, (A) each of the representations and warranties of the Company and each Acquisition
Entity being true and correct to applicable standards and each of the covenants of the Company and each Acquisition Entity having been
performed or complied with in all material respects, (B) SPAC’s receipt of evidence of the completion by the GCL Companies
of the Restructuring, (C) the joinder of each Acquisition Entity to the Merger Agreement, (D) the absence of any event that
has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (as defined in the Merger
Agreement), and (E) obtaining all approvals, waivers or consents from the third parties listed on Section 9.2 of the Company
Disclosure Schedules (as defined in the merger agreement), and (vi) solely with respect to the Company, (A) the Sponsor making
arrangements to pay any SPAC Transaction Expenses (as defined in the Merger Agreement) in excess of the Maximum Allowable SPAC Transaction
Expenses (as defined in the Merger Agreement), (B) the availability at the Closing from the Trust Account (as defined in the Merger
Agreement) and any Transaction Financing (after giving effect to any redemptions but prior to paying any SPAC Transaction Expenses or
Company Transaction Expenses (as defined in the Merger Agreement)) of $25,000,000 (“Minimum Cash”); provided, that
any cash obtained as Transaction Financing and subsequently used by the Company or any of its Affiliates (as defined in the Merger Agreement)
during the period between execution of the Merger Agreement and the Closing shall be applied toward the calculation of Minimum Cash, (C) each
of the representations and warranties of SPAC being true and correct to applicable standards and each of the covenants of SPAC having
been performed or complied with in all material respects, and (D) the absence of any event that has had or would reasonably be expected
to have, individually or in the aggregate, a material adverse effect.
Termination
Prior to the Closing, the Merger Agreement may
be terminated and the Transactions abandoned:
(i) by mutual written consent of the Company
and SPAC if the Transactions have not been completed by September 30, 2024 (in the event the SPAC Extension Proposal (as defined
in the Meger Agreement) is approved), or December 28, 2023 (if the SPAC Extension Proposal is not approved);
(ii) by written notice from the Company or
SPAC to the other if any Governmental Authority (as defined in the Merger Agreement) shall have enacted, issued, promulgated, enforced
or entered any Governmental Order (as defined in the Merger Agreement) which has become final and nonappealable and has the effect of
making consummation of the Transactions illegal or otherwise preventing or prohibiting consummation of the Transactions;
(iii) by written notice from the Company or
SPAC to the other if the SPAC Stockholders’ Approval shall not have been obtained by reason of the failure to obtain the required
vote at the SPAC Stockholder Meeting duly convened therefor or at any adjournment or postponement thereof;
(iv) by written notice from SPAC to the Company
if the Company Written Consent shall not have been obtained within five business days after the Registration Statement becomes effective;
(v) by written notice to the Company from
SPAC if (i) there is any breach of any representation, warranty, covenant or agreement on the part of the Company or any Acquisition
Entity set forth in the Merger Agreement, such that the conditions specified in Sections 9.2(a) or (b) would not be satisfied
at the Closing (a “Terminating Company Breach”), except that, if such Terminating Company Breach is curable by the
Company or such Acquisition Entity through the exercise of its reasonable best efforts, then, for a period of up to 30 days (or any shorter
period of the time that remains between the date SPAC provides written notice of such violation or breach and the Termination Date (as
defined in the Merger Agreement)) after receipt by the Company of notice from SPAC of such breach (the “Company Cure Period”),
such termination shall not be effective, and such termination shall become effective only if the Terminating Company Breach is not cured
within the Company Cure Period, or (ii) the Closing has not occurred on or before the Termination Date, unless SPAC is in material
breach of any of its representations, warranties, covenants or agreements under the Merger Agreement; or
(vi) prior to the Closing, by written notice
to SPAC from the Company if (i) there is any breach of any representation, warranty, covenant or agreement on the part of SPAC set
forth in the Merger Agreement, such that the conditions specified in Section 9.3(a) and (b) would not be satisfied at the
Closing (a “Terminating SPAC Breach”), except that, if any such Terminating SPAC Breach is curable by SPAC through
the exercise of its reasonable best efforts, then, for a period of up to 30 days (or any shorter period of the time that remains between
the date the Company provides written notice of such violation or breach and the Termination Date) after receipt by SPAC of notice from
the Company of such breach (the “SPAC Cure Period”), such termination shall not be effective, and such termination
shall become effective only if the Terminating SPAC Breach is not cured within the SPAC Cure Period or (ii) the Closing has not occurred
on or before the Termination Date, unless the Company is in material breach of any of its representations, warranties, covenants or agreements
under the Merger Agreement.
The Merger Agreement and other agreements described
below have been included to provide investors with information regarding their respective terms. They are not intended to provide any
other factual information about SPAC, the Company or the other parties thereto. In particular, the assertions embodied in the representations
and warranties in the Merger Agreement were made as of a specified date, are modified or qualified by information in one or more confidential
disclosure letters prepared in connection with the execution and delivery of the Merger Agreement, may be subject to a contractual standard
of materiality different from what might be viewed as material to investors, or may have been used for the purpose of allocating risk
between the parties. Accordingly, the representations and warranties in the Merger Agreement are not necessarily characterizations of
the actual state of facts about SPAC, the Company or the other parties thereto at the time they were made or otherwise and should only
be read in conjunction with the other information that SPAC and PubCo make publicly available in reports, statements and other documents
filed with the SEC. SPAC and the Company investors and securityholders are not third-party beneficiaries under the Merger Agreement.
Certain Related Agreements
Support Agreements. In connection
with the execution of the Merger Agreement, the Sponsor, entered into a support agreement with SPAC, GCL BVI and PubCo (the “Sponsor
Support Agreement”) pursuant to which the Sponsor has agreed to vote all Covered Shares (as therein defined) beneficially owned
by it in favor of each Transaction Proposal (as defined in the Merger Agreement).
In addition, in connection with the execution of
the Merger Agreement, PubCo, SPAC, GCL BVI and Epicsoft Ventures Pte Ltd (the “Shareholder”) entered into a support
agreement (the “Shareholder Support Agreement”), pursuant to which the Shareholder agreed to vote all Covered Shares
(as therein defined) beneficially owned by it in favor of the Mergers and the consummation of the Transactions.
Registration Rights Agreement.
At the Closing, PubCo, certain Company Shareholders (as defined in the Merger Agreement) and the Sponsor will enter into a registration
rights agreement in customary form and substance, pursuant to which, among other things, PubCo will agree to provide certain Company Shareholders
with certain rights relating to the registration for resale of the PubCo Shares that they will receive in the Initial Merger.
Lock-up Agreements. At the Closing,
PubCo, certain holders of Company Shares, and the Sponsor will enter into lock-up agreements (each, a “Lock-Up Agreement”)
substantially in the form attached as Exhibit A to the Merger Agreement, pursuant to which, such parties will agree, subject to certain
customary exceptions, not to Transfer (as defined therein) any PubCo Shares until the earlier of (i) the date that is 12 months following
the Closing Date, and (ii) subsequent to the Mergers, (a) the date on which the last sale price of the PubCo Shares equals or
exceeds $12.00 per PubCo Shares (as adjusted for share splits, share consolidations, share capitalizations, rights issuances, subdivisions,
reorganizations, recapitalization and the like) for any 20 trading days within any 30-day trading period commencing at least 150 days
after the consummation of the Mergers, or (b) the date on which PubCo completes a liquidation, merger, share exchange, reorganization
or other similar transaction that results in all of PubCo’s shareholders having the right to exchange their PubCo Shares for cash,
securities or other property.
The foregoing descriptions of agreements and the
transactions and documents contemplated thereby are not complete and are subject to and qualified in their entirety by reference to the
Merger Agreement, Sponsor Support Agreement, Shareholder Support Agreement, and form of Lock-Up Agreement, copies of which are filed with
this Current Report on Form 8-K as Exhibits 2.1, 10.1, 10.2, and 10.3, respectively, and the terms of which are incorporated by reference
herein.
Important Information for Investors and Stockholders
This document relates to the proposed Transactions
among SPAC and PubCo. This document does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange,
any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful
prior to registration or qualification under the securities laws of any such jurisdiction. PubCo intends to file a registration statement
on Form F-4 with the SEC, which will include a document that serves as a prospectus and proxy statement, referred to as a proxy statement/prospectus.
A proxy statement/prospectus will be sent to all SPAC shareholders. SPAC and PubCo also will file other documents regarding the proposed
Transactions with the SEC. Before making any voting decision, investors and security holders of SPAC are urged to read the registration
statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with
the proposed Transactions as they become available because they will contain important information about the proposed Transactions.
Investors and security holders will be able to
obtain free copies of the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be
filed with the SEC by PubCo through the website maintained by the SEC at www.sec.gov.
Participants in the Solicitation
SPAC, PubCo, and their respective directors and
executive officers may be deemed to be participants in the solicitation of proxies from SPAC’s stockholders in connection with the
proposed Transactions. A list of the names of the respective directors and executive officers of SPAC and PubCo, and information regarding
their interests in the business combination, will be contained in the proxy statement/prospectus when available. You may obtain free copies
of these documents as described in the preceding paragraph.
This communication does not constitute an offer
to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of
any securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification
under the securities laws of such other jurisdiction.
Forward-Looking Statements
All statements contained
in this Current Report on Form 8-K other than statements of historical facts, contain certain statements that are forward-looking
statements. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,”
“forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,”
“seek,” “target,” “continue,” “may” or other similar expressions that predict or indicate
future events or trends or that are not statements of historical matters, but the absence of these words does not mean a statement is
not forward looking. Indications of, and guidance or outlook on, future earnings, dividends or financial position or performance are also
forward-looking statements.
These forward-looking statements involve significant
risks and uncertainties that could cause the actual results to differ materially, and potentially adversely, from those expressed or implied
in the forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that
are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Most of these factors are
outside SPAC’s and PubCo’s control and are difficult to predict. Factors that may cause such differences include, but are
not limited to: (i) the occurrence of any event, change, or other circumstances that could give rise to the termination of the Merger
Agreement; (ii) the outcome of any legal proceedings that may be instituted against SPAC and/or PubCo following the announcement
of the Merger Agreement and the Transactions; (iii) the inability to complete the proposed Transactions, including due to failure
to obtain approval of the stockholders of SPAC, certain regulatory approvals, or the satisfaction of other conditions to Closing in the
Merger Agreement; (iv) the occurrence of any event, change, or other circumstance that could give rise to the termination of the
Merger Agreement or could otherwise cause the transaction to fail to close; (v) the impact of the COVID-19 pandemic on PubCo’s
business and/or the ability of the parties to complete the proposed Transactions; (vi) the inability to maintain the listing of SPAC
shares on the Nasdaq Stock Market following the proposed Transactions; (vii) the risk that the proposed Transactions disrupt current
plans and operations as a result of the announcement and consummation of the proposed Transactions; (viii) the ability to recognize
the anticipated benefits of the proposed Transactions, which may be affected by, among other things, competition, the ability of PubCo
to grow and manage growth profitably, and the ability of PubCo to retain its key employees; (ix) costs related to the proposed Transactions;
(x) changes in applicable laws or regulations; and (xi) the possibility that PubCo or SPAC may be adversely affected by other
economic, business, and/or competitive factors. The foregoing list of factors is not exclusive. Additional information concerning certain
of these and other risk factors is included under the heading “Risk Factors” in the
Registration Statement to be filed by GCL with the SEC and those included under the heading “Risk Factors” in SPAC’s
Annual Report on Form 10-K filed with the SEC on April 26, 2023, and the Quarterly Reports on Form 10-Q filed with the
SEC on May 26, 2023 and August 23, 2023, respectively. These filings identify and address other important risks and uncertainties
that could cause actual events and results to differ materially from those contained herein. All subsequent written and oral forward-looking
statements concerning SPAC and PubCo, the Transactions or other matters attributable to SPAC, PubCo or any person acting on their behalf
are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any
forward-looking statements, which speak only as of the date made. Each of SPAC and PubCo expressly disclaims any obligations or undertaking
to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations
with respect thereto or any change in events, conditions, or circumstances on which any statement is based, except as required by law.
Item 9.01 Financial Statements and Exhibits.
Exhibit |
|
Description |
2.1* |
|
Agreement and Plan of Merger dated as of October 18, 2023, by and among RF Acquisition Corp., GCL Global Holdings Ltd, Grand Centrex Limited, GCL Global Limited and, for the limited purposes set forth therein, the Sponsor |
|
|
|
10.1 |
|
Sponsor Support Agreement dated as of October 18, 2023, by and among RF Acquisition Corp., RF Dynamic, LLC, GCL Global Holdings Ltd and Grand Centrex Limited |
|
|
|
10.2 |
|
Shareholder Support Agreement dated as of October 18, 2023, by and among RF Acquisition Corp., GCL Global Holdings Ltd., Grand Centrex Limited, and Epicsoft Ventures Pte Ltd |
|
|
|
10.3 |
|
Form of Lock-Up Agreement (included in Exhibit A of Exhibit 2.1 hereto) |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
* |
Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). SPAC agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request. |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: October 23, 2023 |
RF Acquisition Corp. |
|
|
|
|
By: |
/s/ Tse Meng Ng |
|
|
Name: |
Tse Meng Ng |
|
|
Title: |
Chief Executive Officer |
Exhibit 2.1
Execution Version
AGREEMENT AND PLAN OF MERGER
by and among
RF ACQUISITION CORP.,
GCL GLOBAL HOLDINGS LTD,
GRAND CENTREX LIMITED,
GCL GLOBAL LIMITED,
and
RF DYNAMIC LLC
dated as of October 18, 2023
table
of contents
|
|
Page |
|
|
|
Article I DEFINITIONS |
7 |
|
|
Section 1.1 |
Definitions |
7 |
Section 1.2 |
Construction |
25 |
Section 1.3 |
Knowledge |
26 |
|
|
|
Article II TRANSACTIONS; CLOSING |
27 |
|
|
Section 2.1 |
Pre-Closing Actions |
27 |
Section 2.2 |
The Initial Merger |
28 |
Section 2.3 |
The SPAC Merger |
30 |
Section 2.4 |
EQUITABLE ADJUSTMENTS |
33 |
Section 2.5 |
Closing |
33 |
Section 2.6 |
Closing Deliverables |
33 |
Section 2.7 |
Appraisal and Dissenter’s Rights |
35 |
Section 2.8 |
Withholding |
36 |
Section 2.9 |
TAX CONSEQUENCES |
36 |
|
|
|
Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
36 |
|
|
Section 3.1 |
Organization, Good Standing, Corporate Power and Qualification |
37 |
Section 3.2 |
Subsidiaries; Capitalization |
37 |
Section 3.3 |
Due Authorization |
38 |
Section 3.4 |
Financial Statements |
38 |
Section 3.5 |
Material Contracts |
40 |
Section 3.6 |
Intellectual Property |
42 |
Section 3.7 |
Title to Properties and Assets; Liens |
45 |
Section 3.8 |
Real Property |
45 |
Section 3.9 |
Environmental Matters |
46 |
Section 3.10 |
Compliance with Other Instruments |
46 |
Section 3.11 |
Compliance with Laws |
47 |
Section 3.12 |
Absence of Changes |
47 |
Section 3.13 |
Litigation |
48 |
Section 3.14 |
Insurance |
48 |
Section 3.15 |
Governmental Consents |
49 |
Section 3.16 |
Permits |
49 |
Section 3.17 |
Registration and Voting Rights |
49 |
Section 3.18 |
Brokers or Finders; Transaction Expenses |
49 |
Section 3.19 |
Related-Party Transactions |
49 |
Section 3.20 |
Labor Agreements and Actions; Employee Compensation |
50 |
Section 3.21 |
Employee Benefit Plans |
52 |
Section 3.22 |
TaXES AND RETURNS |
55 |
Section 3.23 |
Books and Records |
57 |
Section 3.24 |
ANTI-Money Laundering |
57 |
Section 3.25 |
Takeover Statutes and Charter Provisions |
57 |
Section 3.26 |
Registration Statement |
57 |
Section 3.27 |
Board Approval |
58 |
Section 3.28 |
No Additional Representations or Warranties |
58 |
|
|
|
Article IV REPRESENTATIONS AND WARRANTIES OF SPAC |
58 |
|
|
Section 4.1 |
Organization, Good Standing, Corporate Power and Qualification |
59 |
Section 4.2 |
Capitalization |
59 |
Section 4.3 |
Due Authorization |
60 |
Section 4.4 |
Financial Statements |
60 |
Section 4.5 |
Compliance with Other Instruments |
61 |
Section 4.6 |
Absence of Changes |
62 |
Section 4.7 |
Litigation |
62 |
Section 4.8 |
Governmental Consents |
62 |
Section 4.9 |
Brokers or Finders; Transaction Expenses |
62 |
Section 4.10 |
TaxES AND RETURNS |
62 |
Section 4.11 |
Registration Statement |
64 |
Section 4.12 |
SEC Filings |
64 |
Section 4.13 |
Trust Account |
64 |
Section 4.14 |
Investment Company Act; JOBS Act |
65 |
Section 4.15 |
Business Activities |
65 |
Section 4.16 |
Nasdaq Quotation |
66 |
Section 4.17 |
Board Approval |
66 |
|
|
|
Article V REPRESENTATIONS AND WARRANTIES OF PUBCO AND THE ACQUISITION ENTITIES |
66 |
|
|
Section 5.1 |
Organization, Good Standing, Corporate Power and Qualification |
66 |
Section 5.2 |
Capitalization and Voting Rights |
67 |
Section 5.3 |
Due Authorization |
67 |
Section 5.4 |
Compliance with Other Instruments |
67 |
Section 5.5 |
Absence of Changes |
68 |
Section 5.6 |
Actions |
68 |
Section 5.7 |
Brokers or Finders; Transaction Expenses |
68 |
Section 5.8 |
Registration Statement |
68 |
Section 5.9 |
Investment Company Act; JOBS Act |
69 |
Section 5.10 |
Business Activities |
69 |
Section 5.11 |
PubCo Incentive Equity Plan |
69 |
Section 5.12 |
TaxES |
69 |
Section 5.13 |
Foreign Private Issuer |
69 |
|
|
|
Article VI COVENANTS OF THE COMPANY AND THE ACQUISITION ENTITIES |
70 |
|
|
Section 6.1 |
Company Conduct of Business |
70 |
Section 6.2 |
Post-Closing Directors and Officers of PubCo |
73 |
Section 6.3 |
D&O Indemnification and Insurance |
73 |
Section 6.4 |
No Trading in SPAC Stock |
75 |
Section 6.5 |
PCAOB AUDITED FINANCIALS |
75 |
Section 6.6 |
INCENTIVE SHARES |
75 |
|
|
|
Article VII COVENANTS OF SPAC |
75 |
|
|
Section 7.1 |
Trust Account Payments |
75 |
Section 7.2 |
SPAC Nasdaq Listing |
76 |
Section 7.3 |
SPAC Conduct of Business |
76 |
Section 7.4 |
SPAC Public Filings |
78 |
Section 7.5 |
ASSIGNMENT AND ASSUMPTION OF the SPAC Warrant Agreement |
78 |
Section 7.6 |
SPAC Extension Proposal |
79 |
|
|
|
Article VIII JOINT COVENANTS |
79 |
|
Section 8.1 |
PubCo Listing |
79 |
Section 8.2 |
Regulatory Approvals; Other Filings |
79 |
Section 8.3 |
Preparation of Registration Statement; SPAC Stockholder Meeting and Approvals; Company Written Consent and Approvals |
80 |
Section 8.4 |
Support of Transaction |
84 |
Section 8.5 |
Tax Matters |
84 |
Section 8.6 |
Stockholder Litigation |
86 |
Section 8.7 |
Acquisition Proposals and Alternative Transactions |
86 |
Section 8.8 |
Access to Information; Inspection |
87 |
Section 8.9 |
OBLIGATIONS OF GCL COMPANIES AND ACQUISITION ENTITIES |
87 |
Section 8.10 |
TRANSACTION FINANCING |
87 |
|
|
|
Article IX CONDITIONS TO OBLIGATIONS |
88 |
|
|
Section 9.1 |
Conditions to Obligations of SPAC, the Acquisition Entities and the Company |
88 |
Section 9.2 |
Conditions to Obligations of SPAC |
88 |
Section 9.3 |
Conditions to the Obligations of the Company |
89 |
|
|
|
Article X TERMINATION/EFFECTIVENESS |
89 |
|
|
|
Section 10.1 |
Termination |
89 |
Section 10.2 |
Effect of Termination |
90 |
|
|
|
Article XI MISCELLANEOUS |
91 |
|
|
Section 11.1 |
Trust Account Waiver |
91 |
Section 11.2 |
Waiver |
91 |
Section 11.3 |
Notices |
91 |
Section 11.4 |
Assignment |
93 |
Section 11.5 |
Rights of Third Parties |
93 |
Section 11.6 |
Expenses |
93 |
Section 11.7 |
Governing Law |
93 |
Section 11.8 |
Headings; Counterparts |
93 |
Section 11.9 |
Disclosure Schedules |
94 |
Section 11.10 |
Entire Agreement |
94 |
Section 11.11 |
Amendments |
94 |
Section 11.12 |
Publicity |
94 |
Section 11.13 |
Severability |
95 |
Section 11.14 |
Jurisdiction; Waiver of Jury Trial |
95 |
Section 11.15 |
Enforcement |
95 |
Section 11.16 |
Non-Recourse |
96 |
Section 11.17 |
Non-Survival of Representations, Warranties and Covenants |
96 |
|
|
|
Annex I – Restructuring Diagram |
|
|
|
Exhibits |
|
|
|
Exhibit A |
Form of Lock-Up Agreement |
A-1 |
AGREEMENT
AND PLAN OF MERGER
This Agreement and Plan of
Merger, dated as of October 18, 2023 (this “Agreement”), is made and entered into by and among (i) RF Acquisition
Corp., a Delaware corporation (“SPAC”), (ii) GCL Global Holdings LTD, a Cayman Islands exempted company limited
by shares (“PubCo”), (iii) Grand Centrex Limited, a British Virgin Islands business company (“GCL BVI”),
(iv) GCL Global Limited, a Cayman Islands exempted company limited by shares (“GCL Global”) and (v) for the
limited purposes set forth herein, RF Dynamic LLC, a Delaware limited liability company (the “Sponsor”).
RECITALS
WHEREAS, SPAC is a
blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or
similar business combination with one or more businesses;
WHEREAS, GCL Global
is a newly formed entity, formed for the purpose of effecting the Restructuring (as defined herein) and participating in the transactions
contemplated herein;
WHEREAS, PubCo is a
newly formed exempted company, formed for the purpose of becoming the publicly traded holding company for the Surviving Corporation (as
defined herein) and SPAC upon the Closing;
WHEREAS, following
the date hereof, and prior to the Closing, PubCo will form (i) a Cayman Islands exempted company limited by shares, to be a direct
wholly owned subsidiary of PubCo (“Merger Sub 1”) and (ii) a Delaware corporation, to be a direct wholly owned
subsidiary of PubCo (“Merger Sub 2” and, together with PubCo and Merger Sub 1, each, individually, an “Acquisition
Entity” and, collectively, the “Acquisition Entities” ), for the purpose of participating in the transactions
contemplated herein. Following the formation of each Acquisition Entity, PubCo shall cause Merger Sub 1 and Merger Sub 2 to enter into
a joinder to this Agreement, in form and substance satisfactory to SPAC (each, a “Joinder”);
WHEREAS, upon the terms
and subject to the conditions of this Agreement, and in accordance with the Delaware General Corporation Law (“DGCL”)
and the Cayman Islands Companies Act (As Revised) (the “Cayman Companies Act” ), as applicable, (a) Merger Sub
1 will merge with and into GCL Global (the “Initial Merger”), the separate existence of Merger Sub 1 will cease and
GCL Global will be the surviving corporation of the Initial Merger and a direct wholly owned subsidiary of PubCo (GCL Global is hereinafter
referred to for the periods from and after the Initial Merger Effective Time (as defined below) as the “Surviving Corporation”),
and (b) immediately following confirmation of the effective filing of the Initial Merger, Merger Sub 2 will merge with and into SPAC
(the “SPAC Merger” and together with the Initial Merger, the “Mergers” ), the separate existence
of Merger Sub 2 will cease and SPAC will be the surviving corporation of the SPAC Merger and a direct wholly owned subsidiary of PubCo;
WHEREAS, (a) upon
the Initial Merger Effective Time, the holders of GCL Global Shares will receive ordinary shares of PubCo, par value $0.0001 per share
(“PubCo Shares”) in accordance with this Agreement and the PubCo Governing Documents, and (b) upon the SPAC Merger
Effective Time the holders of SPAC Common Stock will receive PubCo Shares;
WHEREAS, concurrently
with the execution and delivery of this Agreement, SPAC, the Company and Epicsoft Ventures Pte Ltd have entered into a support agreement
(the “Shareholder Support Agreement”);
WHEREAS, concurrently
with the execution and delivery of this Agreement, the Company, SPAC and RF Dynamic LLC, a Delaware limited liability company (the “Sponsor”)
have entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”);
WHEREAS, at Closing,
PubCo, certain holders of Company Shares and the Sponsor will enter into lock-up agreements substantially in the form attached hereto
as Exhibit A (collectively, the “Lock-Up Agreements”);
WHEREAS, at Closing,
PubCo, certain Company Shareholders and the Sponsor will enter into a registration rights agreement in customary form and substance (the
“Registration Rights Agreement”) pursuant to which, among other things, PubCo agrees to provide certain Company Shareholders
with certain rights relating to the registration for resale of the PubCo Shares that they will receive in the Initial Merger;
WHEREAS, the board
of directors of SPAC (the “SPAC Board”) has (i) determined that it is fair to, advisable for and in the best interests
of SPAC and its stockholders to enter into this Agreement and to consummate the Mergers and the other Transactions, (ii) approved
the execution and delivery of this Agreement and the documents contemplated hereby and the consummation of the Mergers and the other Transactions,
and (iii) determined to recommend to its stockholders the approval and adoption of this Agreement, the Mergers and the other Transactions;
and
WHEREAS, each of the
board of directors of GCL Global and the board of directors of GCL BVI has (i) determined that it is fair to, advisable for and in
the best interests of the Company and its shareholders, as applicable, to enter into this Agreement and to consummate the Restructuring,
the Mergers and the other Transactions, (ii) approved the execution and delivery of this Agreement and the documents contemplated
hereby, any definitive documents executed as of the date hereof or to be executed in connection with the Restructuring and any other documents
contemplated thereby (the “Restructuring Agreements”), the consummation of the Restructuring, and the consummation
of the Mergers and the other Transactions, and (iii) determined to recommend to its shareholders the approval and adoption of this
Agreement, the Restructuring Agreements, the Restructuring, the Mergers and the other Transactions.
NOW, THEREFORE,
in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth in this Agreement
and intending to be legally bound hereby, SPAC, PubCo, Merger Sub 1, Merger Sub 2 and the Company agree as follows:
Article I
DEFINITIONS
Section 1.1 Definitions.
As used herein, the following terms shall have the following meanings:
“Acquisition Entity”
has the meaning set forth in the Recitals hereto.
“Acquisition Proposal”
means, as to the Company or SPAC, other than the Transactions and the Reorganization, any offer or proposal relating to: (a) any
acquisition or purchase, direct or indirect, of (i) 20% or more of the consolidated assets of such Person and its Subsidiaries or
(ii) 20% or more of any class of equity or voting securities of (x) such Person or (y) one or more Subsidiaries of such
Person holding assets constituting, individually or in the aggregate, 20% or more of the consolidated assets of such Person and its Subsidiaries;
(b) any tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in any Person beneficially
owning 20% or more of any class of equity or voting securities of (i) such Person or (ii) one or more Subsidiaries of such Person
holding assets constituting, individually or in the aggregate, 20% or more of the consolidated assets of such Person and its Subsidiaries;
or (c) a merger, consolidation, share exchange, business combination, sale of substantially all the assets, reorganization, recapitalization,
liquidation, dissolution or other similar transaction involving (i) such Person or (ii) one or more Subsidiaries of such Person
holding assets constituting, individually or in the aggregate, 20% or more of the consolidated assets of such Person and its Subsidiaries.
Notwithstanding anything to the contrary, any transaction in which the Company or one of its Subsidiaries or Affiliates acquires another
entity for strategic purposes, as reasonably determined by the Company, shall not be deemed an “Acquisition Proposal.”
“Action”
means any action, lawsuit, complaint, claim, petition, suit, audit, examination, assessment, arbitration, mediation or inquiry, or any
proceeding or investigation, by or before any Governmental Authority.
“Additional SEC Reports”
has the meaning set forth in Section 7.4.
“Affiliate”
means, with respect to any specified Person, any Person that, directly or indirectly, controls, is controlled by, or is under common control
with, such specified Person, whether through one or more intermediaries or otherwise. The term “control” (including the terms
“controlling”, “controlled by” and “under common control with”) means the possession, directly or
indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of
voting securities, by Contract or otherwise.
“Agreement”
has the meaning set forth in the preamble.
“Alternative Transaction”
means, (i) as to any GCL Company, a transaction (other than any Transaction, the Restructuring or any transaction in which the GCL
Company or its respective Subsidiaries or Affiliates is the surviving entity) concerning the sale or transfer of (a) all or any material
part of the business or assets of the GCL Companies, taken as a whole, or (b) any of the Company Shares or other equity interests
or profit interests (including any phantom or synthetic equity) of any GCL Company, whether newly issued or already outstanding, in any
case, whether such transaction takes the form of a sale or issuance of shares or other equity interests, assets, merger, consolidation,
issuance of debt securities or convertible securities, warrants, management Contract, joint venture or partnership, or otherwise, and
(ii) as to SPAC, a transaction involving the sale or transfer of SPAC Common Stock, in any case, whether such transaction takes the
form of a sale of shares or other equity interests, assets, merger, consolidation, business combination, issuance of debt securities or
convertible securities, warrants, management Contract, joint venture or partnership, or otherwise.
“Ancillary Agreements”
means, collectively, the Shareholder Support Agreement, the Sponsor Support Agreement, the Lock-Up Agreements, the Registration Rights
Agreement, the PubCo Governing Documents, the Assignment and Assumption Agreement, and the Joinders.
“Anti-Bribery Laws”
means the anti-bribery provisions of the Foreign Corrupt Practices Act of 1977 and all other applicable anti-corruption and bribery Laws
(including the U.K. Bribery Act 2010 or other Laws of other countries implementing the OECD Convention on Combating Bribery of Foreign
Officials).
“Anti-Money Laundering
Laws” means the financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, anti-money laundering provisions of the USA PATRIOT Act of 2001, as amended, all other applicable anti-money laundering
Laws of any jurisdiction, and similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority.
“Assignment and Assumption
Agreement” has the meaning set forth in Section 7.5.
“Assumed Warrant”
has the meaning set forth in Section 2.3(g)(v).
“Audited Company
Financials” means the audited consolidated financial statements of the GCL Companies (including, in each case, any related notes
thereto), consisting of the consolidated statements of financial position of the GCL Companies as of March 31, 2023 and March 31,
2022, and the related audited consolidated statements of profit or loss and other comprehensive income, changes in equity and cash flows
for the fiscal years then ended, each audited by a PCAOB qualified auditor in accordance with PCAOB standards.
“Business Combination”
has the meaning set forth in Article II of the SPAC Charter.
“Business Combination
Proposal” means any offer, inquiry, proposal or indication of interest (whether written or oral, binding or non-binding, and
other than an offer, inquiry, proposal or indication of interest with respect to the Transactions), relating to a Business Combination.
“Business Day”
means a day other than a Saturday, Sunday or other day on which commercial banks in New York, New York and the Cayman Islands are authorized
or required by Law to close.
“Cayman Companies
Act” has the meaning set forth in the Recitals hereto.
“Cayman Registrar”
means the Registrar of Companies of the Cayman Islands.
“Closing”
has the meaning set forth in Section 2.5.
“Closing Date”
has the meaning set forth in Section 2.5.
“Code”
means the United States Internal Revenue Code of 1986.
“Company”
means (a) prior to the completion of the Restructuring, GCL BVI, and (b) from and after the completion of the Restructuring,
GCL Global.
“GCL Global Memorandum
and Articles” means the Memorandum and Articles of Association of GCL Global dated September 8, 2023 (as amended from time
to time).
“Company Audited
Financial Statements” has the meaning set forth in Section 3.4(a).
“Company Benefit
Plan” has the meaning set forth in Section 3.21(a).
“Company Board”
has the meaning, as the case may be, (a) prior to the completion of the Restructuring, the Board of Directors of GCL BVI, and (b) from
and after the completion of the Restructuring, the Board of Directors of GCL Global.
“Company Board Recommendation”
has the meaning set forth in Section 8.3(c)(ii).
“Company Cure Period”
has the meaning set forth in Section 10.1(e).
“Company Disclosure
Schedules” has the meaning set forth in Article III.
“Company Exchange
Ratio” means the quotient obtained by dividing the Price per Company Share by $10.00 (ten dollars). For illustrative purposes
only, assuming the sum of the Fully-Diluted Company Shares is 26,085,179, the Company Exchange Ratio would be 4.600313 (rounded to the
sixth decimal place).
“Company Financial
Statements” has the meaning set forth in Section 3.4(a).
“Company Health Plan”
has the meaning set forth in Section 3.21(l).
“Company Intellectual
Property” means, collectively, any and all (i) Owned Intellectual Property and (ii) Licensed Intellectual Property.
“Company Products”
means each product, service, solution or offering (together with all Intellectual Property, deliverables, technology and materials utilized
as part thereof) developed by or on behalf of any of the GCL Companies that (i) has been sold, distributed or made available to third
parties by any of the GCL Companies, or manufactured by any of the GCL Companies, or ordered or purchased by third parties from the Company
or its Subsidiaries, in each case at any time during the three-year period preceding the date of this Agreement or (ii) that, as
of the date hereof have, in whole or in part, entered any prototype or similar development stage, process or status.
“Company Shareholder”
means any holder of any Company Shares.
“Company Shares”
means the ordinary shares of the Company.
“Company Transaction
Expenses” means fees and disbursements incurred by the Company or the Company Shareholders in connection with the Transactions
for the categories listed on Schedule 2.1(b)(i) hereto.
“Company Transaction
Expenses Certificate” has the meaning set forth in Section 2.1(b)(i).
“Company Unaudited
Financial Statements” has the meaning set forth in Section 3.4(a).
“Company Written
Consent” has the meaning set forth in Section 8.3(c)(i).
“Computer Security
Incident” means any data or security breaches or unauthorized access, modification, disclosure, misuse, loss, or unavailability
of Protected Data or IT Systems or violation or suspected (after investigation that did not eliminate such suspicion) violation of Privacy
and Security Requirements. Examples of such incidents include: (i) an attacker commands a botnet to send high volumes of connection
requests to a web server, causing it to crash; (ii) users are tricked into opening a “quarterly report” sent via
email that is actually malware; running the tool has infected their computers and established connections with an external host;
(iii) an attacker obtains sensitive data and threatens that the details will be released publicly if the organization does not pay
a designated sum of money; or (iv) a user provides or exposes sensitive information to others through peer-to-peer file sharing
services.
“Confidential Information”
means any non-public information of or concerning the GCL Companies or any of their respective businesses, including business plans, financial
data, customer and client lists, customer and client information (including names, addresses and contact information and including prospective
customers and prospective clients), marketing plans, technology, products, services, solutions, offerings, platforms, Proprietary Information
and Intellectual Property, whether existing or being developed.
“Continental”
means Continental Stock Transfer & Trust Company.
“Contract Workers”
means independent contractors, consultants, temporary employees, leased employees or other agents employed or used with respect to the
operation of the business of the GCL Companies and classified by the Company as other than employees or compensated other than through
wages paid by the Company through its payroll department.
“Contracts”
means any contracts, subcontracts, agreements, arrangements, understandings, commitments, instruments, undertakings, indentures, leases,
mortgages and purchase orders, whether written or oral.
“Copyrights”
means all rights in copyrights, and other rights in any works of authorship of any type, in all forms, media or medium, now known or hereinafter
developed, and whether or not completed, published, or used, including all drafts, plans, sketches, artwork, layouts, copy, designs, photographs,
illustrations, collections, serials, printed or graphic matter, slides, compilations, serials, promotions, audio or visual recordings,
transcriptions, Software, and all derivative works, translations, adaptations and combinations of any of the foregoing, all registrations
and applications therefor and all extensions, restorations, and renewals of any of the foregoing, all worldwide rights and priorities
afforded under any Law with respect to any of the foregoing, and all termination rights, moral rights, author rights and all other rights
associated therewith.
“COVID-19”
means SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof.
“D&O Indemnified
Parties” has the meaning set forth in Section 6.3(a).
“Databases”
means all compilations of data, the selection and arrangement of that data, and all related documentation, including documentation regarding
the procedures used in connection with the selection, collection, arrangement, processing and distribution of data contained therein to
the extent they exist, together with documentation regarding the attributes of the data contained therein or the relationships among such
data and documentation regarding data structures and formats, and file structures and formats, whether registered or unregistered, and
any registrations or applications for registration therefor.
“Deadline Extension
Loans” means any loans provided by the Sponsor or its Affiliates to SPAC for the purpose of extending the date by which SPAC
must consummate a business combination.
“Develop”
or “Development” means any conception, reduction to practice, invention, creation, formulation, design, enhancement,
testing, discovery, editing, commercialization, modification, improvement, or development (and any contribution to the foregoing), whether
independently or jointly.
“Disclosure Schedules”
means, as applicable, the Company Disclosure Schedules or the SPAC Disclosure Schedules.
“Dissenting Shares”
has the meaning set forth in Section 2.7(a).
“DGCL”
has the meaning set forth in the Recitals hereto.
“DTC” means
the Depository Trust Company.
“Environmental Laws”
means any and all applicable Laws relating to pollution, protection, preservation or remediation of the environment (including natural
resources) and human health and safety, including but not limited to the use, storage, emission, disposal or release of or exposure to
Hazardous Materials.
“Environmental Permits”
means the Permits required under Environmental Laws.
“ERISA”
means the United States Employee Retirement Income Security Act of 1974, as amended.
“ERISA Affiliate”
means any trade or business, whether or not incorporated, that together with a company would be deemed to be a “single employer”
within the meaning of Section 414(b), (c), (m) or (o) of the Code.
“Exchange Act”
means the United States Securities Exchange Act of 1934, as amended.
“Export Laws”
means (i) all Laws imposing trade sanctions on any Person, including, all Laws administered by OFAC, all sanctions, Laws or embargos
imposed or administered by the U.S. Department of State, the United Nations Security Council, His Majesty’s Treasury or the European
Union, and all anti-boycott Laws administered by the U.S. Department of State or the Department of Treasury, and (ii) all Laws relating
to the import, export, re- export, or transfer of information, data, goods, and technology, including the Export Administration Regulations
administered by the U.S. Department of Commerce, the International Traffic in Arms Regulations administered by the U.S. Department of
State, and the export control Laws of the United Kingdom or the European Union.
“FCPA”
means the United States Foreign Corrupt Practices Act of 1977, as amended.
“Financial Derivative/Hedging
Arrangement” means any transaction (including an agreement with respect thereto) which is a rate swap transaction, basis swap,
forward rate transaction, commodity swap, commodity option, equity or equity index swap, equity or equity index option, bond option, interest
rate option, foreign exchange transaction, cap transaction, floor transaction, collar transaction, currency swap transaction, cross-currency
rate swap transaction, currency option or any combination of these transactions.
“Fully-Diluted Company
Shares” means the total number of issued and outstanding Company Shares as of immediately prior to the Initial Merger Effective
Time, on an as-converted basis and assuming the exercise of any options, warrants, or other similar securities of the Company as of immediately
prior to the Initial Merger Effective Time, if applicable.
“GAAP”
means generally accepted accounting principles in the United States as in effect from time to time.
“GCL BVI Memorandum
and Articles” means the Memorandum and Articles of Association of GCL BVI dated November 16, 2018.
“GCL Companies”
means, collectively, GCL Global and its Subsidiaries (but not, for the avoidance of doubt, the Acquisition Entities), GCL BVI, GCL Global
Pte Ltd, a Singapore company (“GCL Global SG”) and the Group Subsidiaries.
“GCL Company Interests”
means all of the issued and outstanding equity interests of the GCL Companies.
“Governing Documents”
means the legal document(s) by which any Person (other than an individual) establishes its legal existence or which govern its internal
affairs. For example, the “Governing Documents” of a Delaware corporation are its certificate of incorporation and bylaws,
the “Governing Documents” of a Delaware limited liability company are its limited liability company agreement and certificate
of formation under the Delaware Limited Liability Act and the “Governing Documents” of a Cayman Islands exempted company are
its memorandum of association and articles of association under the Cayman Companies Act, in each case, as amended and/or restated from
time to time.
“Governmental Authority”
means any federal, state, provincial, municipal, local, international, supranational or foreign government, governmental authority, regulatory
or administrative agency (which for the purposes of this Agreement shall include the SEC), governmental commission, department, board,
bureau, agency, court, arbitral tribunal, securities exchange or similar body or instrumentality thereof.
“Governmental Order”
means any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case, entered by or with any Governmental
Authority.
“GRA” has
the meaning set forth in Section 2.9.
“Group Subsidiaries”
means, collectively, (a) Titan Digital Media Pte. Ltd., a Singapore company (“Titan SG”), (b) Epicsoft Hong
Kong Limited, a Hong Kong company (“Epic HK”), (c) Epicsoft Malaysia Sdn. Bhd., a Malaysia company (“Epic
MY”), (d) Epicsoft Asia Pte. Ltd., a Singapore company (“Epic SG”), (e) 4Divinity Pte. Ltd. (“4Divinity
SG”), a Singapore company, (f) 2Game Digital Limited, a Hong Kong company (“2Game HK”), (g) Starry
Jewelry Pte Ltd., a Singapore company (“Starry Jewelry”) and (h) Martiangear Pte Ltd., a Singapore company (“Martiangear”).
“Hazardous Materials”
means any material, substance or waste that is listed, regulated, or defined as “hazardous,” “toxic,” or “radioactive”
(or words of similar intent or meaning) under Environmental Laws, including but not limited to petroleum, petroleum by-products, asbestos
or asbestos-containing material, polychlorinated biphenyls, flammable or explosive substances, per- and polyfluoroalkyl substances or
pesticides.
“Healthcare Reform
Laws” has the meaning set forth in Section 3.21(l).
“HSR Act”
means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
“IFRS”
shall mean the International Financial Reporting Standards issued by the International Accounting Standards Board, as in effect from time
to time.
“Incentive Shares”
has the meaning set forth in Section 6.6.
“Indebtedness”
means, with respect to any Person, without duplication, any obligations (whether or not contingent) consisting of (a) the outstanding
principal amount of and accrued and unpaid interest on, and other payment obligations for, borrowed money, or payment obligations issued
or incurred in substitution or exchange for payment obligations for borrowed money, (b) amounts owing as deferred purchase price
for property or services, including “earnout” payments, (c) payment obligations evidenced by any promissory note, bond,
debenture, mortgage or other debt instrument or debt security, (d) contingent reimbursement obligations with respect to letters of
credit, bankers’ acceptance or similar facilities (in each case to the extent drawn), (e) payment obligations of a third party
secured by (or for which the holder of such payment obligations has an existing right, contingent or otherwise, to be secured by) any
Lien, other than a Permitted Lien, on assets or properties of such Person, whether or not the obligations secured thereby have been assumed,
(f) obligations under capitalized leases, (g) obligations under any Financial Derivative/Hedging Arrangement, (h) guarantees,
make-whole agreements, hold harmless agreements or other similar arrangements with respect to any amounts of a type described in clauses (a) through
(g) above, and (i) with respect to each of the foregoing, any unpaid interest, breakage costs, prepayment or redemption penalties
or premiums, or other unpaid fees or obligations; provided, however, that Indebtedness shall not include accounts payable
to trade creditors and accrued expenses arising in the Ordinary Course.
“Initial Merger”
has the meaning set forth in the Recitals hereto.
“Initial Merger Constituent
Corporations” has the meaning set forth in Section 2.2(b).
“Initial Merger Effective
Time” has the meaning set forth in Section 2.2(c).
“Initial Merger Filing
Documents” has the meaning set forth in Section 2.2(c).
“Intellectual Property”
means all of the following: (a) Copyrights; (b) Trademarks; (c) Patents; (d) Proprietary Information
(including knowledge databases, customer lists and customer databases); (e) all domain names, uniform resource locators and
other names and locators associated with the internet, including applications and registrations thereof; (f) all rights (as
such may exist or be created in any jurisdiction), whether statutory, common law or otherwise, in, arising out of, or associated with
the foregoing; (g) all other intellectual property or proprietary rights now known or hereafter recognized in any jurisdiction
worldwide; (h) all rights equivalent or similar or pertaining to the foregoing, including those arising under international
treaties and convention rights; (i) all rights and powers to assert, defend and recover title to any of the foregoing;
(j) all rights to assert, defend, sue, and recover damages for any past, present and future infringement, misuse, misappropriation,
impairment, unauthorized use or other violation of any rights in or to any of the foregoing; and (k) all administrative rights
arising from the foregoing, including the right to prosecute applications and oppose, interfere with or challenge the applications of
others, the rights to obtain renewals, continuations, divisions and extensions of legal protection pertaining to any of the foregoing.
“Intended Tax Treatment”
has the meaning set forth in Section 2.9.
“Interim Period”
has the meaning set forth in Section 6.1.
“Investment Company
Act” means the United States Investment Company Act of 1940.
“IRS” means
the United States Internal Revenue Service.
“IT Systems”
means, collectively, the hardware, Software, data, Databases, data communication lines, network and telecommunications equipment, platforms,
servers, peripherals, computer systems, and other information technology equipment, facilities, infrastructure and documentation used,
owned, leased or licensed by any of the GCL Companies and used in their business as currently conducted.
“Joinders”
means joinders to this Agreement, in form and substance satisfactory to SPAC, to be executed and delivered by each Acquisition Entity
following its formation.
“Key Shareholder”
means any holder of 5% or more of the Fully-Diluted Company Shares.
“Law” means
any statute, law, ordinance, rule, regulation or Governmental Order, in each case, of any Governmental Authority, or any provisions or
interpretations of the foregoing.
“Leased Real Property”
means all real property leased, licensed, subleased, sublicensed or otherwise used or occupied by any of the GCL Companies or to which
the GCL Companies otherwise has a right to use.
“Licensed Intellectual
Property” means Intellectual Property licensed or made available by another Person to any of the GCL Companies.
“Lien”
means all liens, mortgages, deeds of trust, pledges, hypothecations, charges, security interests, options, leases, subleases, restrictions,
title retention devices (including the interest of a seller or lessor under any conditional sale agreement or capital lease, or any financing
lease having substantially the same economic effect as any of the foregoing), collateral assignments, claims or other encumbrances of
any kind whether consensual, statutory or otherwise, and whether filed, recorded or perfected under applicable Law (including any restriction
on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise
or transfer of any other attribute of ownership of any asset, but in any event excluding restrictions under applicable securities Laws).
“Lock-Up Agreements”
has the meaning set forth in the Recitals hereto.
“Loeb”
has the meaning set forth in Section 8.5(a).
“Material Adverse
Effect” means any event, change or circumstance that has a material adverse effect on (i) the assets, business, results
of operations or financial condition of the GCL Companies, taken as a whole; provided, however, that in no event would any
of the following (or the effect of any of the following), alone or in combination, be deemed to constitute, or be taken into account in
determining whether there has been or will be, a “Material Adverse Effect”: (a) any change in applicable Laws or GAAP
after the date hereof or any official interpretation thereof, (b) any change in interest rates or economic, political, business,
financial, commodity, currency or market conditions generally, (c) the announcement or the execution of this Agreement, the pendency
or consummation of the Mergers or the performance of this Agreement, including the impact thereof on relationships, contractual or otherwise,
with customers, suppliers, licensors, distributors, partners, providers and employees (provided, that the exceptions in this clause (c) shall
not be deemed to apply to references to “Material Adverse Effect” in the representations and warranties set forth in Section 3.10
and, to the extent related thereto, the condition in Section 9.2(a)), (d) any change generally affecting any of the industries
or markets in which the Company operates or the economy as a whole, (e) the compliance with the terms of this Agreement or the taking
of any action required by this Agreement or with the prior written consent of SPAC, (f) any earthquake, hurricane, tsunami, tornado,
flood, mudslide, wild fire or other natural disaster, pandemic, weather condition, explosion fire, act of God or other force majeure event,
and any Law, directive, pronouncement or guideline issued by a Governmental Authority, the Centers for Disease Control and Prevention,
the World Health Organization or any industry group providing for business closures, changes to business operations, “sheltering-in-place”
or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak or any change in such Law, directive,
pronouncement or guideline or interpretation thereof following the date of this Agreement or the Company’s compliance therewith,
(g) any national or international political or social conditions in countries in which, or in the proximate geographic region of
which, the Company operates, including the engagement by the United States or such other countries in hostilities or the escalation thereof,
whether or not pursuant to the declaration of a national emergency or war, or the occurrence or the escalation of any military or terrorist
attack (including any internet or “cyber” attack or hacking) upon the United States or such other country, or any territories,
possessions, or diplomatic or consular offices of the United States or such other countries or upon any United States or such other country
military installation, equipment or personnel, (h) any failure of any GCL Company to meet any projections, forecasts or budgets or
(i) any actions taken, or failures to take action, or such other changes or events, in each case, which SPAC has requested or to
which it has consented; provided, that clause (h) shall not prevent or otherwise affect a determination that any change
or effect underlying such failure to meet projections or forecasts has resulted in, or contributed to, or would reasonably be expected
to result in or contribute to, a Material Adverse Effect (to the extent such change or effect is not otherwise excluded from this definition
of Material Adverse Effect), except in the case of clause (a), (b), (d), (f) and (g) to the extent that such change does
not have a disproportionate impact on the Company as compared to other industry participants or (ii) the ability of the Company to
consummate the Transactions.
“Material Contracts”
has the meaning set forth in Section 3.5(a).
“Material Permits”
has the meaning set forth in Section 3.16.
“Maximum Allowable
SPAC Transaction Expenses” has the meaning set forth in Section 2.6(c).
“Merger Consideration”
means $1,200,000,000.
“Merger Consideration
Shares” has the meaning set forth in Section 2.2(g)(i).
“Merger Sub 1”
has the meaning set forth in the Recitals hereto.
“Merger Sub 1 Board”
has the meaning set forth in the Recitals hereto.
“Merger Sub 1 Share”
has the meaning set forth in Section 5.2(a).
“Merger Sub 2”
has the meaning set forth in the Recitals hereto.
“Merger Sub 2 Board”
has the meaning set forth in the Recitals hereto.
“Merger Sub 2 Share”
has the meaning set forth in Section 5.2(a).
“Mergers”
has the meaning set forth in the Recitals hereto.
“Nasdaq”
means the Nasdaq Global Market or Nasdaq Capital Market.
“NYSE”
means the New York Stock Exchange.
“Non-U.S. Plan”
has the meaning set forth in Section 3.21(a).
“Non-U.S. Subsidiaries”
has the meaning set forth in Section 8.5(b).
“OFAC”
means the United States Office of Foreign Assets Control.
“Ordinary Course”
means, with respect to an action taken by a Person, that (i) such action is consistent with the past practices of such Person and
is taken in the ordinary course of the normal day-to-day operations of such Person’s business, including (with respect to the use
of such term in Article III or Article IV as to the period prior to the date of this Agreement); and (ii) such
action complies with, in all material respects, all applicable Laws.
“Owned Company Software”
means all Software owned or purported to be owned by a GCL Company.
“Owned Intellectual
Property” means any and all Intellectual Property owned or purported to be owned by the GCL Companies.
“Patents”
means all (a) U.S. and foreign patents (including certificates of invention and other patent equivalents), utility models, and applications
for any of the foregoing, including provisional applications, and all patents of addition, improvement patents, continuations, continuations-in-part,
divisionals, reissues, re-examinations, renewals, confirmations, substitutions and extensions thereof or related thereto, and all applications
or counterparts in any jurisdiction pertaining to any of the foregoing, including applications filed pursuant to any international patent
law treaty, (b) inventions, discoveries, improvements, idea submissions and invention disclosures, whether or not patentable, whether
or not reduced to practice, and whether or not yet made the subject of a pending patent application or applications, and (c) other
patent rights and any other Governmental Authority- issued indicia of invention ownership (including inventors’ certificates, petty
patents and innovation patents), together with all worldwide rights and priorities afforded under any Law with respect to any of the foregoing.
“Payment Spreadsheet”
has the meaning set forth in Section 2.1(b)(iii).
“PCAOB”
means the United States Public Company Accounting Oversight Board and any division or subdivision thereof.
“Permit”
means any consent, franchise, approval, registration, variance, license, permit, grant, certificate, registration or other authorization
or approval of a Governmental Authority or pursuant to any Law, and all pending applications for any of the foregoing.
“Permitted Liens”
means (i) statutory or common law Liens of mechanics, materialmen, warehousemen, landlords, carriers, repairmen, construction contractors
and other similar Liens (A) that arise in the Ordinary Course, (B) that relate to amounts not yet delinquent or (C) that
are being contested in good faith through appropriate Actions, and either are not material or appropriate reserves for the amount being
contested have been established in accordance with GAAP or IFRS, as applicable, (ii) Liens arising under original purchase price
conditional sales contracts and equipment leases with third parties entered into in the Ordinary Course, (iii) Liens for current
period Taxes not yet delinquent or for Taxes that are being contested in good faith in the Ordinary Course through appropriate Actions
by the Person responsible for the payment thereof, and for which adequate accruals or reserves have been established in accordance with
GAAP, IFRS or other applicable accounting principles with respect thereto, (iv) non-monetary Liens, encumbrances and restrictions
on real property (including easements, covenants, rights of way and similar restrictions of record) that do not materially interfere with
the present uses of such real property, (v) non-exclusive licenses of Owned Intellectual Property entered into in the Ordinary Course,
(vi) Liens that secure obligations that are reflected as liabilities on the balance sheet included in the Company Unaudited Financial
Statements or Liens the existence of which is referred to in the notes to the balance sheet included in the Company Unaudited Financial
Statements, (vii) in the case of Leased Real Property, matters that would be disclosed by an accurate survey or inspection of such
Leased Real Property, which do not materially interfere with the current use or occupancy of any Leased Real Property, (viii) requirements
and restrictions of zoning, building and other applicable Laws and municipal by-laws, and development, site plan, subdivision or other
agreements with municipalities, which do not materially interfere with the current use or occupancy of any Leased Real Property, (ix) statutory
Liens of landlords for amounts that (A) are not due and payable, (B) are being contested in good faith by appropriate proceedings
and either are not material or appropriate reserves for the amount being contested have been established in accordance with GAAP or (C) may
thereafter be paid without penalty, and (x) Liens described on Section 1.1 of the Company Disclosure Schedules.
“Person”
means any individual, firm, corporation, partnership, limited liability company, incorporated or unincorporated association, trust, estate,
joint venture, joint stock company, Governmental Authority or instrumentality or other entity of any kind.
“Personal Information”
means (a) all data and information that, whether alone or in combination with any other data or information, identifies, relates
to, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with a natural person,
household, or his, her or its device, including name, street address, telephone number, e-mail address, photograph, social security number,
driver’s license number, passport number, government-issued ID number, customer or account number, health information, financial
information, credit report information, device identifiers, transaction identifier, cookie ID, browser or device fingerprint or other
probabilistic identifier, IP addresses, physiological and behavioral biometric identifiers, viewing history, platform behaviors,
and any other similar piece of data or information; and (b) all other data or information that is otherwise protected by any
Privacy Laws or otherwise considered personally identifiable information or personal data under applicable Law.
“Plan of Initial
Merger” means a Plan of Merger in form and substance reasonably satisfactory to SPAC and the Company, prepared in accordance
with the provisions of the Cayman Companies Act.
“Price per Company
Share” means the quotient, expressed as a dollar number, obtained by dividing the Merger Consideration by the Fully-Diluted
Company Shares.
“Privacy Laws”
means all Laws concerning the privacy, secrecy, security, protection, disposal, international transfer or other Processing of Personal
Information, including incident reporting and security incident notifying requirements.
“Privacy and Security
Requirements” means, to the extent applicable to any GCL Company, (a) all Privacy Laws; (b) any Laws relating to wiretapping,
eavesdropping, or passive or surreptitious tracking in connection with the use of online platforms; (c) the PCI DSS and any other
privacy- or data security- related industry standards to which any GCL Company is legally or contractually bound or has publicly represented
with which it complies; (d) all Contracts between a GCL Company and any Person that are applicable to the Processing of Protected
Data; and (e) all policies and procedures applicable to any GCL Company relating to the Processing of Protected Data, including without
limitation all website and mobile application privacy policies and internal information security procedures.
“Private Placement”
means the offer, issuance and sale to private investors in one or more transactions exempt from registration under the Securities Act
of debt or equity interests of any of the GCL Companies on or prior to Closing.
“Process”
or “Processing” means, with respect to data, the use, collection, creation, processing, receipt, storage, recording,
organization, structuring, adaption, alteration, transfer, retrieval, consultation, disclosure, dissemination, making available, alignment,
combination, restriction, protection, security, erasure or destruction of such data.
“Proprietary Information”
means all rights under applicable Laws in and to trade secrets, confidential information, proprietary information, designs, formulas,
algorithms, procedures, methods, techniques, discoveries, developments, know-how, research and development, technical data, tools, materials,
specifications, processes, inventions (whether patentable or unpatentable and whether or not reduced to practice), apparatus, creations,
improvements, recordings, graphs, drawings, reports, analyses, documented and undocumented information, information and materials not
generally known to the public, protocols, schematics, compositions, sketches, photographs, websites, content, images, graphics, text,
artwork, audiovisual works, build instructions, Software, Databases, pricing, customer and user lists, market studies, business plans,
systems, structures, architectures, devices, concepts, methods and information, together with any and all notes, analysis, compilations,
lab reports, notebooks, invention disclosures, studies, summaries, and other material containing or based, in whole or in part, on any
information included in the foregoing, including all copies and tangible embodiments of any of the foregoing in whatever form or medium.
“Protected Data”
means data regulated by the PCI-DSS, Personal Information and all data for which any GCL Company is required by Law, Contract or written
policy to safeguard and/or keep confidential or private.
“PubCo”
has the meaning set forth in the Recitals hereto.
“PubCo 5% Shareholder”
has the meaning set forth in Section 8.5(c).
“PubCo Board”
has the meaning set forth in the Recitals hereto.
“PubCo Governing
Documents” means the Amended and Restated Memorandum of Association and Articles of Association of PubCo, to be adopted by PubCo
and registered by the Cayman Registrar prior to Closing.
“PubCo Incentive
Equity Plan” has the meaning set forth in Section 5.11.
“PubCo Shares”
has the meaning set forth in the Recitals hereto.
“Publicly Available
Software” means (i) any Software that is distributed as free software or open source software (including Software distributed
under the GNU General Public License, the GNU Lesser General Public License, the Affero General Public License, any Creative Commons “ShareAlike”
license, the Server Side Public License, or the Apache Software License), or pursuant to open source, copyleft, or similar licensing and
distribution models; and (ii) any Software that requires as a condition of use, modification, and/or distribution of such Software
that such Software or other Software incorporated into, linked to, derived from, or distributed with such Software (A) be disclosed
or distributed in source code form, (B) be licensed for the purpose of making derivative works, or (C) be redistributable at
no or minimal charge.
“Real Property Lease”
has the meaning set forth in Section 3.5(a)(viii).
“Registered Intellectual
Property” means all Intellectual Property that is registered, filed, certified, applied for, perfected, recorded, renewed or
issued under the authority of, with or by any Governmental Authority, domain name registrar or other public or quasi-public legal authority
anywhere in the world.
“Registration Rights
Agreement” has the meaning set forth in the Recitals hereto.
“Registration Statement”
has the meaning set forth in Section 8.3(a)(i).
“Regulatory Approvals”
has the meaning set forth in Section 8.2(a).
“Related Party”
has the meaning set forth in Section 3.19(a).
“Remedial Action”
means all action required under applicable Laws: (x) to cleanup, remove, treat or in any other way remediate any chemical, Hazardous
Material or waste containing any chemical or Hazardous Material in the environment; (y) to prevent the release of any chemical,
Hazardous Material or waste containing any chemical or Hazardous Material so that they do not endanger or otherwise adversely affect the
environment or public health or welfare; or (z) to perform pre-remedial studies, investigations or monitoring, in or under any
real property, assets or facilities.
“Representatives”
of a Person means, collectively, officers, directors, employees, accountants, consultants, legal counsel, agents and other representatives
of such Person or its Affiliates.
“Restructuring”
means a sequential three-step transaction involving (a) the transfer from GCL BVI to GCL Global SG of all outstanding shares of EPIC
MY; followed by (b) the transfer from GCL BVI to GCL Global of its equity interests in GCL Global SG; and followed by (c) the
issuance of shares by GCL Global to the shareholders of GCL BVI (“GCL Shareholders”), such that each GCL Shareholder
owns the same ownership percentage of GCL Global that he, she, or it, as applicable, owns in GCL BVI, resulting in (i) GCL Shareholders
holding all issued and outstanding equity interests in GCL Global, (ii) GCL Global holding all outstanding equity interests in GCL
Global SG, and (iii) GCL Global SG holding all outstanding equity interests of the Group Subsidiaries, as depicted on Annex I
attached hereto.
“Restructuring Agreements”
has the meaning set forth in the Recitals hereto.
“Sanctions”
means any sanctions administered or enforced by OFAC, the United Nations Security Council, the European Union, His Majesty’s Treasury,
or other relevant sanctions authority.
“Sarbanes-Oxley Act”
means the Sarbanes-Oxley Act of 2002.
“SEC” means
the United States Securities and Exchange Commission.
“Securities Act”
means the United States Securities Act of 1933, as amended.
“Shareholder Support
Agreement” has the meaning set forth in the Recitals hereto.
“Software”
means all (a) computer software, programs, applications, scripts, middleware, firmware, interfaces, tools, operating systems, software
code of any nature, (including object code, source code, interpreted code, data files, rules, definitions and methodology derived from
the foregoing) and any derivations, updates, enhancements and customization of any of the foregoing, together with all related processes,
technical data, algorithms, APIs, subroutines, operating procedures, report formats, development tools, templates and user interfaces,
(b) electronic data, Databases and data collections, and (c) documentation, including user manuals, technical manuals, programming
comments, descriptions, flow charts and other work products used to design, plan, organize and develop any of the foregoing, and training
materials related to any of the foregoing.
“SPAC”
has the meaning set forth in the preamble hereto.
“SPAC Board”
has the meaning set forth in the Recitals hereto.
“SPAC Board Recommendation”
has the meaning set forth in Section 8.3(b)(ii).
“SPAC Bylaws”
means the bylaws of SPAC in effect immediately prior to the SPAC Merger Effective Time, as amended and/or restated from time to time.
“SPAC Capital Stock”
means, collectively, the SPAC Common Stock and the SPAC Preferred Stock.
“SPAC Charter”
means the Amended and Restated Certificate of Incorporation of SPAC, dated March 23, 2022, as amended and/or restated from time to
time.
“SPAC Class A
Common Stock” means Class A common stock of SPAC, par value $0.0001 per share.
“SPAC Class B
Common Stock” means Class B common stock of SPAC, par value $0.0001 per share.
“SPAC Common Stock”
means, collectively, the SPAC Class A Common Stock and the SPAC Class B Common Stock.
“SPAC Cure Period”
has the meaning set forth in Section 10.1(f).
“SPAC Disclosure
Schedules” has the meaning set forth in Article IV.
“SPAC Extension Proposal”
means the proposal to be submitted to the SPAC Stockholders pursuant to a definitive proxy statement filed by SPAC with the SEC and provided
to the SPAC Stockholders for the purpose of amending the SPAC Governing Documents to extend the time period for SPAC to consummate a business
combination (currently December 28, 2023) to September 30, 2024 as well as any related proposals that the parties hereto may
deem necessary or appropriate in connection with such extension, including any required amendment to the Investment Management Trust Agreement
between the SPAC and Continental.
“SPAC Financial Statements”
has the meaning set forth in Section 4.4(a).
“SPAC Financing Certificate”
has the meaning set forth in Section 2.1(b)(ii).
“SPAC Governing Documents”
means, collectively, the SPAC Charter and the SPAC Bylaws.
“SPAC Merger”
has the meaning set forth in the Recitals hereto.
“SPAC Merger Certificate”
has the meaning set forth in Section 2.2(c).
“SPAC Merger Constituent
Corporations” has the meaning set forth in Section 2.2(b).
“SPAC Merger Effective
Time” has the meaning set forth in Section 2.3(a).
“SPAC Preferred Stock”
means preferred stock of SPAC, par value $0.0001 per share.
“SPAC Rights”
means rights to acquire one-tenth of one share of SPAC Class A Common Stock.
“SPAC SEC Filings”
has the meaning set forth in Section 4.12.
“SPAC Share Redemption
Amount” means the aggregate amount payable from the Trust Account with respect to all SPAC Share Redemptions.
“SPAC Share Redemption”
means the election of an eligible (as determined in accordance with the SPAC Governing Documents) holder of shares of SPAC Common Stock
to redeem all or a portion of the shares of SPAC Common Stock held by such holder pursuant to the SPAC Governing Documents in connection
with the Transaction Proposals.
“SPAC Stockholder”
means any holder of any shares of SPAC Capital Stock.
“SPAC Stockholders’
Approval” means the approval of the Transaction Proposals, in each case, by an affirmative vote of the holders of at least a
majority of the outstanding shares of SPAC Common Stock entitled to vote, who attend and vote thereupon (as determined in accordance with
the SPAC Governing Documents) at a SPAC Stockholder Meeting duly called by the SPAC Board and held for such purpose.
“SPAC Stockholders
Meeting” has the meaning set forth in Section 8.3(a)(i).
“SPAC Transaction
Expenses” means, without duplication and excluding those fees and expenses already paid from IPO proceeds, fees and disbursements
incurred by SPAC or the Sponsor in connection with the Transactions for the categories listed on Schedule 2.1(b)(ii) hereto.
“SPAC Units”
means units of SPAC, each unit comprising one share of SPAC Class A Common Stock, one SPAC Right, and one SPAC Warrant.
“SPAC Warrant Agreement”
means that certain Warrant Agreement, dated March 23, 2022, by and between SPAC and Continental.
“SPAC Warrants”
means redeemable warrants to, in each case, purchase one share of SPAC Class A Common Stock for $11.50 per share.
“Sponsor”
has the meaning set forth in the Recitals hereto.
“Sponsor Nominated
Directors” has the meaning set forth in Section 6.2(a).
“Sponsor Support
Agreement” has the meaning set forth in the Recitals hereto.
“Stockholder Litigation”
has the meaning set forth in Section 8.6.
“Stockholder Merger
Consideration” means, with respect to each SPAC Stockholder or Company Shareholder, as applicable, subject to the terms and
conditions of this Agreement, the sum of all PubCo Shares receivable by such SPAC Stockholder pursuant to Section 2.3(g)(iii) or
Company Shareholder pursuant to Section 2.2(g)(i) (and with respect to each such Company Shareholder, as allocated in
accordance with the Payment Spreadsheet).
“Subsidiary”
means, with respect to a Person, any corporation or other organization (including a limited liability company or a general or limited
partnership), whether incorporated or unincorporated, of which such Person directly or indirectly owns or controls a majority of the securities
or other interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar
functions with respect to such corporation or other organization or any organization of which such Person or any of its Subsidiaries is,
directly or indirectly, a general partner or managing member.
“Surviving Corporation”
has the meaning set forth in the Recitals hereto.
“Surviving Corporation
Governing Documents” has the meaning set forth in Section 2.2(d).
“Tax Return”
means any return, declaration, report, claim for refund, statement, information statement or other document (including any related or
supporting schedules, statements or information) filed or required to be filed by the applicable party with any Governmental Authority
in connection with the determination, assessment or collection of any Taxes or the administration of any Laws or administrative requirements
relating to any Taxes.
“Taxes”
means any and all federal, state, provincial, territorial, local, foreign and other net income, alternative or add-on minimum, franchise,
gross income, adjusted gross income or gross receipts, employment, withholding, payroll, ad valorem, transfer, franchise, license, excise,
severance, stamp, occupation, premium, personal property, real property, capital stock, profits, disability, registration, Value Added
Tax, estimated, customs duties, sales, use, or other taxes, governmental fees or other like assessments, together with any interest, penalty,
addition to tax or additional amounts imposed with respect thereto by a Governmental Authority.
“Terminating Company
Breach” has the meaning set forth in Section 10.1(e).
“Terminating SPAC
Breach” has the meaning set forth in Section 10.1(f).
“Termination Date”
means September 30, 2024.
“Trademarks”
means all trademarks, service marks, trade names, business names, corporate names, trade dress, look and feel, product and service names,
logos, brand names, slogans, 800 numbers, Internet domain names, URLs, social media usernames, handles, hashtags and account names,
symbols, emblems, insignia and other distinctive identification and indicia of source of origin, whether or not registered, including
all common law rights thereto, and all applications and registrations therefor, and all goodwill associated with any of the foregoing
or the business connected with the use of and symbolized by the foregoing.
“Trading Day”
means any day on which Nasdaq or NYSE is open for trading.
“Transaction Financing”
has the meaning set forth in Section 8.10.
“Transaction Investor”
means any investor in the Transaction Financing.
“Transaction Proposals”
has the meaning set forth in Section 8.3(a)(i).
“Transactions”
means, collectively, the Mergers and each of the other transactions contemplated by this Agreement or any of the Ancillary Agreements,
but excludes, for the avoidance of doubt, the Restructuring.
“Transfer Taxes”
has the meaning set forth in Section 8.5(d).
“Trust Account”
has the meaning set forth in Section 11.1.
“Trust Agreement”
has the meaning set forth in Section 4.13.
“Trustee”
has the meaning set forth in Section 4.13.
“Value Added Tax”
means value added tax or any similar, replacement or additional tax.
“Willful Breach”
means, with respect to any agreement, a party’s knowing and intentional material breach of any of its representations or warranties
as set forth in such agreement, or such party’s material breach of any of its covenants or other agreements set forth in such agreement,
which material breach constitutes, or is a consequence of, a purposeful act or failure to act by such party with the knowledge that the
taking of such act or failure to take such act would cause a material breach of such agreement.
“Winston”
has the meaning set forth in Section 8.5(a).
“Working Capital
Loans” means any loans provided by the Sponsor or its Affiliates to SPAC for the purpose of funding working capital expenses
incurred in good faith by SPAC in the Ordinary Course.
Section 1.2 Construction.
(a) Unless
the context of this Agreement otherwise requires or unless otherwise specified, (i) words of any gender shall be construed as masculine,
feminine, neuter or any other gender, as applicable; (ii) words using the singular or plural number also include the plural
or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby,” “herewith,”
“hereto” and derivative or similar words refer to this entire Agreement; (iv) the terms “Article” or
“Section” refer to the specified Article or Section of this Agreement; (v) the terms “Schedule”,
“Exhibit” or “Annex” refer to the specified Schedule, Exhibit or Annex of this Agreement; (vi) the
words “including,” “included,” or “includes” shall mean “including, without limitation;”
(vii) the word “extent” in the phrase “to the extent” means the degree to which a subject or thing extends
and such phrase shall not simply mean “if;” and (viii) the word “or” shall be disjunctive but not exclusive.
(b) Unless
the context of this Agreement otherwise requires, references to statutes shall include all regulations promulgated thereunder and references
to statutes or regulations shall be construed as including all statutory and regulatory provisions consolidating, amending or replacing
the statute or regulation.
(c) References
to “$,” “US$,” “USD” or “dollars” are to the lawful currency of the United States of America.
(d) Whenever
this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified. Time periods within
or following which any payment is to be made or act is to be done under this Agreement shall be calculated by excluding the calendar day
on which the period commences and including the calendar day on which the period ends, and by extending the period to the next following
Business Day if the last calendar day of the period is not a Business Day.
(e) All
accounting terms used herein and not expressly defined herein shall have the meanings given to them under GAAP (with respect to SPAC)
and IFRS (with respect to the GCL Companies).
(f) Unless
the context of this Agreement otherwise requires, references to the Company with respect to periods following the Initial Merger Effective
Time shall be construed to mean the Surviving Corporation and vice versa.
(g) Unless
the context of this Agreement otherwise requires, references to the Company with respect to period prior to the completion of the Restructuring
shall be construed to mean GCL BVI, and following the completion of the Restructuring shall be construed to mean GCL Global.
(h) The
phrases “delivered”, “provided to”, “furnished to”, or “made available” and phrases of
similar import when used herein, unless the context otherwise requires, means that a copy of the information or material referred to has
been (i) provided no later than one calendar day prior to the date of this Agreement to the party to which such information or material
is to be provided or furnished (A) in the virtual “data room” set up by the Company in connection with this Agreement
or (B) by delivery to such party or its legal counsel via electronic mail or hard copy form, or (ii) with respect to SPAC, filed
with the SEC by SPAC on or prior to the date hereof.
Section 1.3 Knowledge.
As used herein, (a) the phrase “to the knowledge of the Company” or “to the Company’s knowledge” shall
mean the actual knowledge of the individuals identified on Section 1.3 of the Company Disclosure Schedules; (b) the
phrase “to the knowledge of SPAC” shall mean the actual knowledge of the individuals identified on Section 1.3
of the SPAC Disclosure Schedules.
Article II
TRANSACTIONS; CLOSING
Section 2.1 Pre-Closing
Actions.
(a) Restructuring.
As soon as reasonably practicable (but in any event, within 60 days of the date hereof), GCL BVI and GCL Global shall, and shall cause
the GCL Companies to, complete the Restructuring.
(b) Company
Transaction Expenses Certificate; SPAC Financing Certificate; Payment Spreadsheet.
(i) No
later than three Business Days prior to the Closing Date, the Company shall provide to SPAC a written report setting forth a list of all
of the Company Transaction Expenses actually incurred in the items listed on Schedule 2.1(b)(i) hereto (together with written
invoices and wire transfer instructions for the payment thereof), solely to the extent such fees and expenses are incurred and expected
to remain unpaid as of the close of business on the Business Day immediately preceding the Closing Date, in an aggregate amount not to
exceed $4,500,000 (the “Company Transaction Expenses Certificate”).
(ii) No
later than three Business Days prior to the Closing Date, SPAC shall deliver to the Company written notice setting forth: (A) the
aggregate amount of cash proceeds that will be required to satisfy the exercise of the SPAC Share Redemption; (B) a written
report setting forth a list of all of the SPAC Transaction Expenses actually incurred in the items listed on Schedule 2.1(b)(ii) hereto
(together with written invoices and wire transfer instructions for the payment thereof), solely to the extent such fees and expenses are
incurred and expected to remain unpaid or reimbursed, without duplication, as of the close of business on the Business Day immediately
preceding the Closing Date, and (C) an evidence of any amounts of SPAC Transaction Expenses that will be satisfied through the exercise
of rights of conversion into PubCo Shares in connection with the Closing (the “SPAC Financing Certificate”).
(iii) Promptly
following delivery by (A) the Company of the Company Transaction Expenses Certificate pursuant to Section 2.1(b)(i) and
(B) SPAC of the SPAC Financing Certificate pursuant to Section 2.1(b)(ii) and, in any event, not less than two Business
Days prior to the Closing Date the Company shall (1) deliver to SPAC a spreadsheet schedule (the “Payment Spreadsheet”)
in excel format with underlying calculations setting forth the portion of the Merger Consideration payable to each Company Shareholder
(including the allocation of PubCo Shares). As promptly as practicable following the Company’s delivery of the Payment Spreadsheet,
the parties hereto shall work together in good faith to finalize the Payment Spreadsheet in accordance with this Agreement. The allocation
of a portion of the Merger Consideration to the Company Shareholders pursuant to the Payment Spreadsheet shall, to the fullest extent
permitted by applicable Law, be final and binding on all parties and shall be used by parties hereof for purposes of issuing the Merger
Consideration to the Company Shareholders pursuant to this Article II, absent manifest error. In issuing the Merger Consideration,
the parties hereof shall, to the fullest extent permitted by applicable Law, be entitled to rely fully on the information set forth in
the Payment Spreadsheet, absent manifest error. The Payment Spreadsheet shall be prepared solely by the Company, and the Company acknowledges
that SPAC and its Affiliates are not responsible for, and shall have no liability with respect to, the Payment Spreadsheet or any allocations,
errors or omissions therein.
Section 2.2 The
Initial Merger.
(a) Initial
Merger. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the Cayman Companies Act,
at the Initial Merger Effective Time, Merger Sub 1 shall be merged with and into the Company, and the separate corporate existence of
Merger Sub 1 shall cease, and the Company, as the Surviving Corporation, shall thereafter continue its corporate existence as a wholly
owned subsidiary of PubCo.
(b) Effect
of the Initial Merger. From and after the Initial Merger Effective Time, the Surviving Corporation shall thereupon and thereafter
possess all of the rights, privileges, immunities, powers and franchises, of a public as well as a private nature, of the Company and
Merger Sub 1 (the Company and Merger Sub 1 sometimes being referred to herein as the “Initial Merger Constituent Corporations”),
and shall become subject to all the debts, restrictions, liabilities and duties of each of the Initial Merger Constituent Corporations;
and all rights, privileges, powers and franchises of each of the Initial Merger Constituent Corporations, and all property, real, personal
and mixed, and all debts due to each such Initial Merger Constituent Corporation, on whatever account, and all things in action or belonging
to each Initial Merger Constituent Corporations shall become vested in the Surviving Corporation; and all property, rights, privileges,
powers and franchises, and all and every other interest shall become thereafter the property of the Surviving Corporation as they are
of each of the Initial Merger Constituent Corporations; and the title to any real property vested by deed or otherwise or any other
interest in real estate vested by any instrument or otherwise in either of such Initial Merger Constituent Corporations shall not revert
or become in any way impaired by reason of the Initial Merger; but all Liens upon any property of an Initial Merger Constituent Corporation
shall thereafter attach to the Surviving Corporation and shall be enforceable against it to the same extent as if said debts, restrictions,
liabilities and duties had been incurred or contracted by it; all of the foregoing in accordance with the applicable provisions of
this Agreement, the Plan of Initial Merger and the Cayman Companies Act.
(c) Execution
and Filing of Initial Merger Filing Documents. At the Closing, and immediately prior to the SPAC Merger, subject to the satisfaction
or waiver of all of the conditions set forth in this Agreement, and provided this Agreement has not been earlier terminated pursuant to
its terms, Merger Sub 1 and the Company shall cause the Plan of Initial Merger, together with such other documents as may be required
in accordance with the applicable provisions of the Cayman Companies Act or by any other applicable Law to make the Initial Merger effective
(collectively, the “Initial Merger Filing Documents”), to be executed and duly submitted for filing with the Cayman
Registrar in accordance with the applicable provisions of the Cayman Companies Act. The Initial Merger shall become effective at such
time as the Plan of Initial Merger is duly registered by the Cayman Registrar, or at such later time as Merger Sub 1 and the Company mutually
agree in writing with the written consent of SPAC (subject to the requirements of the Cayman Companies Act) and as set forth in the Plan
of Initial Merger (such date and time as the Initial Merger becomes effective, the “Initial Merger Effective Time”).
(d) Organizational
Documents of the Company. At the Initial Merger Effective Time, the Company Articles and Company Memorandum, as in effect immediately
prior to the Initial Merger Effective Time, shall be amended and restated in the forms to be agreed to by PubCo and SPAC (the “Surviving
Corporation Governing Documents”), respectively, and as so amended and restated shall be the memorandum and articles of the
Surviving Corporation, until thereafter amended as provided therein and under the Cayman Companies Act.
(e) Directors
and Officers of the Surviving Corporation and PubCo.
(i) From
and after the Initial Merger Effective Time, the officers of the Company holding such positions as set forth on Section 6.2(b) of
the Company Disclosure Schedules shall be the officers of the Surviving Corporation and shall be appointed as officers of PubCo, each
such officer to hold office in accordance with the Surviving Corporation Governing Documents, or the PubCo Governing Documents, respectively.
(ii) From
and after the Initial Merger Effective Time, the Persons identified as the initial directors of the Surviving Corporation in accordance
with the provisions of Section 6.2(a) shall be the directors of the Surviving Corporation and shall be appointed as directors
of PubCo, each to hold office in accordance with the Surviving Corporation Governing Documents and the PubCo Governing Documents, respectively.
(f) Effect
of the Initial Merger on Merger Sub 1 Shares. At the Initial Merger Effective Time, by virtue of the Initial Merger and without any
action on the part of any party hereto or the holders of shares of Merger Sub 1, each share of Merger Sub 1 that is issued and outstanding
immediately prior to the Initial Merger Effective Time shall automatically be converted into an equal number and class of shares of the
Surviving Corporation, which shares shall constitute the only outstanding shares of the Surviving Corporation.
(g) Effect
of the Initial Merger on Company Shares.
(i) Company
Shares. At the Initial Merger Effective Time, by virtue of the Initial Merger and without any action on the part of any party hereto
or the holders of Company Shares, each Company Share that is issued and outstanding immediately prior to the Initial Merger Effective
Time (other than any Company Share excluded pursuant to subsection (ii) below and any Dissenting Share), shall automatically be cancelled
and cease to exist in exchange for the right to receive, such number of newly issued PubCo Shares that is equal to the Company Exchange
Ratio (rounded up to the nearest whole share), as such calculations are set forth in the Payment Spreadsheet as to each holder set forth
therein (the “Merger Consideration Shares”), without interest. As of the Initial Merger Effective Time, each Company
Shareholder shall cease to have any other rights in and to the Company or the Surviving Corporation (other than the rights set forth in
Section 2.7(a)). Prior to the payment of the Merger Consideration Shares to any Company Shareholder, such Company Shareholder
shall deliver to SPAC a duly completed and executed letter of transmittal in such form as is typical for transactions of this type together
with the certificate (if the Company Shares are certificated) representing the Company Shares owned by such Company Shareholder. Such
letter of transmittal will include, without limitation: a release in favor of PubCo, the GCL Companies and SPAC in such holders’
capacity as a Company Shareholder, from any Action or liability whatsoever, based upon, relating to or arising out of such Company Shareholder’s
ownership of share capital of the Company and/or the Transactions.
(ii) Company
Treasury Shares. Notwithstanding clause (i) above or any other provision of this Agreement to the contrary, at the Initial Merger
Effective Time, if there are any Company Shares that are owned by the Company as treasury shares or any Company Shares owned by any direct
or indirect Subsidiary of the Company immediately prior to the Initial Merger Effective Time, such Company Shares shall be canceled and
shall cease to exist without any conversion thereof or payment therefor.
(iii) Dissenting
Shares. Each of the Dissenting Shares issued and outstanding immediately prior to the Initial Merger Effective Time shall be canceled
and cease to exist in accordance with Section 2.7(a) and shall thereafter represent only the right to receive the applicable
payments set forth in Section 2.7(a).
Section 2.3 The
SPAC Merger.
(a) SPAC
Merger. Upon the terms and subject to the conditions set forth in this Agreement, in accordance with the DGCL, immediately following
confirmation of the effective filing of the Initial Merger, and effective on such date and time as the SPAC Merger becomes effective (the
“SPAC Merger Effective Time”), Merger Sub 2 shall be merged with and into SPAC, and the separate corporate existence
of Merger Sub 2 shall cease, and SPAC, as the surviving corporation, shall thereafter continue its corporate existence as a wholly owned
subsidiary of PubCo. The completion of the Initial Merger is a condition precedent for the completion of the SPAC Merger.
(b) Effect
of the SPAC Merger. From and after the SPAC Merger Effective Time, SPAC shall thereupon and thereafter possess all of the rights,
privileges, immunities, powers and franchises, of a public as well as a private nature, of SPAC and Merger Sub 2 (SPAC and Merger Sub
2 sometimes being referred to herein as the “SPAC Merger Constituent Corporations”), and shall become subject to all
the debts, restrictions, liabilities and duties of each of the SPAC Merger Constituent Corporations; and all rights, privileges,
immunities, powers and franchises of each SPAC Merger Constituent Corporation, and all property, real, personal and mixed, and all debts
due to each such SPAC Merger Constituent Corporation, on whatever account, and all things in action or belonging to each SPAC Merger Constituent
Corporations shall become vested in SPAC; and all property, rights, privileges, immunities, powers and franchises, and all and every
other interest shall become thereafter the property of SPAC as they are of the SPAC Merger Constituent Corporations; and the title
to any real property vested by deed or otherwise or any other interest in real estate vested by any instrument or otherwise in either
of such SPAC Merger Constituent Corporations shall not revert or become in any way impaired by reason of the SPAC Merger; but all
Liens upon any property of a SPAC Merger Constituent Corporation shall thereafter attach to SPAC and may be enforceable against it to
the same extent as if said debts, restrictions, liabilities and duties had been incurred or contracted by it; all of the foregoing
in accordance with the applicable provisions of this Agreement and the DGCL.
(c) Filing
of Certificate of Merger. At the Closing, and immediately following confirmation of the effective filing of the Initial Merger (subject
to the satisfaction or waiver of all of the conditions set forth in this Agreement as of the filing of the Initial Merger), and provided
this Agreement has not theretofore been terminated pursuant to its terms, Merger Sub 2 and SPAC shall cause (or if Merger Sub 2 and SPAC
do not cause, the Company shall cause) a certificate of merger in respect of the SPAC Merger and such other documents as may be required
in accordance with the applicable provisions of the DGCL or by any other applicable Law to make the SPAC Merger effective (collectively,
the “SPAC Merger Certificate”), to be executed and duly submitted for filing with the Delaware Secretary of State in
accordance with the applicable provisions of the DGCL. The SPAC Merger shall become effective at the time specified in the SPAC Merger
Certificate pursuant to Section 2.3(a).
(d) Organizational
Documents of SPAC. At the SPAC Merger Effective Time, the SPAC Charter and SPAC Bylaws, as in effect immediately prior to the SPAC
Merger Effective Time, shall be amended and restated, each in customary form and substance mutually agreeable to SPAC and the Company
(the “New SPAC Charter” , and the “New SPAC Bylaws”, and collectively, the “New SPAC Governing
Documents”), respectively, and as so amended and restated shall be the certificate of incorporation and bylaws of the SPAC,
until thereafter amended as provided therein and under the DGCL.
(e) Directors
and Officers of SPAC.
(i) From
and after the SPAC Merger Effective Time, the officers of the Company holding such positions as set forth on Section 2.3(e) of
the Company Disclosure Schedules shall be appointed the officers of SPAC, each such officer to hold office in accordance with the SPAC
Governing Documents.
(ii) From
and after the SPAC Merger Effective Time, the Persons identified as the initial directors of the Surviving Corporation on Section 2.3(e) of
the Company Disclosure Schedules shall be appointed the directors of SPAC, each to hold office in accordance with the SPAC Governing Documents.
(f) Effect
of the SPAC Merger on Merger Sub 2 Stock. At the SPAC Merger Effective Time, by virtue of the SPAC Merger and without any action on
the part of any party hereto or the holders of securities of Merger Sub 2, each share of capital stock of Merger Sub 2 that is issued
and outstanding immediately prior to the SPAC Merger Effective Time shall automatically be converted into an equal number of shares of
common stock of SPAC, which shares shall, subject to Section 2.3(g), constitute the only shares of capital stock of SPAC.
(g) Effect
of the SPAC Merger on SPAC Capital Stock.
(i) SPAC
Units. At the SPAC Merger Effective Time, each SPAC Unit that is outstanding immediately prior to the SPAC Merger Effective Time shall
be automatically separated and the holder thereof shall be deemed to hold one share of SPAC Class A Common Stock, one SPAC Warrant,
and one SPAC Right in accordance with the terms of the applicable SPAC Unit, which underlying securities of SPAC shall be adjusted in
accordance with the applicable terms of this Section 2.3(g).
(ii) SPAC
Rights. At the SPAC Merger Effective Time, and immediately following the separation of each SPAC Unit in accordance with Section 2.3(g)(i) above,
by virtue of the SPAC Merger and conditioned on the consummation of the Mergers and without any action on the part of any party hereto
or the holders of SPAC Capital Stock, each holder of 10 or more SPAC Rights shall be deemed to hold one share of SPAC Class A Common
Stock for each 10 such SPAC Rights (including all SPAC Rights that were included in the SPAC Units).
(iii) SPAC
Common Stock. At the SPAC Merger Effective Time, and immediately following the separation of each SPAC Unit in accordance with Section 2.3(g)(i) above
and the exchange of each SPAC Right in accordance with Section 2.3(g)(ii) above, by virtue of the SPAC Merger and conditioned
on the consummation of the Mergers and without any action on the part of any party hereto or the holders of SPAC Capital Stock each share
of SPAC Class A Common Stock that is issued and outstanding immediately prior to the SPAC Merger Effective Time, shall automatically
be cancelled and cease to exist in exchange for the right to receive a newly issued PubCo Share. As of the SPAC Merger Effective Time,
each SPAC Stockholder shall cease to have any other rights in and to SPAC.
(iv) SPAC
Treasury Stock. Notwithstanding clause (ii) above or any other provision of this Agreement to the contrary, at the SPAC Merger
Effective Time, if there are any shares of SPAC Capital Stock that are owned by SPAC as treasury shares or any shares of SPAC Capital
Stock owned by any direct or indirect Subsidiary of SPAC immediately prior to the SPAC Merger Effective Time, such shares of SPAC Capital
Stock shall be canceled and shall cease to exist without any conversion thereof or payment or other consideration therefor.
(v) SPAC
Warrants. At the SPAC Merger Effective Time, without any action on the part of any holder of a SPAC Warrant, each SPAC Warrant that
is issued and outstanding immediately prior to the SPAC Merger Effective Time (but after giving effect to the separation of each SPAC
Unit in accordance with Section 2.3(g)(i)) shall, pursuant to and in accordance with Section 4.5 of the SPAC Warrant
Agreement and the Assignment and Assumption Agreement, automatically and irrevocably be modified to provide that such SPAC Warrant shall
no longer entitle the holder thereof to purchase the number of shares of SPAC Class A Common Stock set forth therein and in substitution
thereof such SPAC Warrant shall entitle the holder thereof to acquire such equal number of PubCo Shares (each, an “Assumed Warrant”).
Each Assumed Warrant shall continue to have and be subject to substantially the same terms and conditions as were applicable to such SPAC
Warrant as of immediately prior to the SPAC Merger Effective Time, except that each Assumed Warrant shall be exercisable for shares of
PubCo Shares rather than SPAC Class A Common Stock In connection therewith and prior to the SPAC Merger Effective Time, SPAC and
PubCo shall take all actions necessary to execute an Assignment and Assumption Agreement (as defined below) pursuant to Section 7.5.
Section 2.4 EQUITABLE
ADJUSTMENTS. If, between the date of this Agreement and the Closing, the issued and outstanding Company Shares or shares of SPAC Capital
Stock shall have been changed into a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification,
reorganization, recapitalization, split, combination or exchange of shares, or any similar event shall have occurred, then any number,
value (including dollar value) or amount contained herein which is based upon the number of shares of Company Shares or shares of SPAC
Capital Stock, as applicable, will be appropriately adjusted to provide to the holders of Company Shares or the holders of shares of SPAC
Capital Stock, as applicable, the same economic effect as contemplated by this Agreement prior to such event; provided, however, that
this Section 2.4 shall not be construed to permit SPAC, the Company, PubCo, Merger Sub 1 or Merger Sub 2 to take any action with
respect to their respective securities that is prohibited by the terms and conditions of this Agreement.
Section 2.5 Closing.
In accordance with the terms and subject to the conditions of this Agreement, the closing of the Initial Merger, the SPAC Merger, and
the other Transactions contemplated by this Agreement to occur or become effective in connection therewith (including all Transactions
contemplated to occur or become effective at the Closing, the “Closing”) shall take place electronically through the
exchange of documents via e-mail or facsimile on the date which is three Business Days after the first date on which all conditions set
forth in Article IX shall have been satisfied or waived (other than those conditions that by their terms are to be satisfied
at the Closing, but subject to the satisfaction or waiver thereof) or at such other time and place or in such other manner as shall be
agreed upon by SPAC and the Company in writing. The date on which the Closing actually occurs is referred to in this Agreement as the
“Closing Date”.
Section 2.6 Closing
Deliverables.
(a) At
the Closing, the Company will deliver or cause to be delivered to SPAC:
(i) a
certificate signed by an officer of the Company and each Acquisition Entity, dated as of the Closing Date, certifying that the conditions
specified in Section 9.2(a) and Section 9.2(b) have been fulfilled;
(ii) the
Payment Spreadsheet;
(iii) a
copy of the executed Registration Rights Agreement duly executed by PubCo and the Company Shareholders thereto;
(iv) a
copy of each Lock-Up Agreement, duly executed by the applicable Company Shareholder and PubCo (for avoidance of doubt, no holder of less
than 5% of the outstanding shares of the Company will be required to enter into such Lock-Up Agreement);
(v) a
copy of the executed Assignment and Assumption Agreement, duly executed by PubCo;
(vi) evidence
reasonably satisfactory to SPAC of the completion of the Restructuring; and
(vii) copies
of the approvals, waivers or consents called for by Section 9.2(f), if any.
(b) At
the Closing, SPAC will deliver or cause to be delivered to the Company:
(i) a
certificate signed by an officer of SPAC, dated as of the Closing Date, certifying that the conditions specified in Section 9.3(a) and
Section 9.3(d) have been fulfilled;
(ii) copies
of the written resignations of all the directors and officers of SPAC, effective as of the SPAC Merger Effective Time;
(iii) a
copy of the executed Registration Rights Agreement duly executed the SPAC Stockholders thereto;
(iv) a
copy of the executed Assignment and Assumption Agreement, duly executed by SPAC and Continental; and
(v) a
copy of each Lock-Up Agreement, duly executed by Sponsor.
(c) Provided
SPAC has satisfied the Minimum Cash condition set forth in Section 9.3(b), PubCo shall pay, or cause to be paid, by wire transfer
of immediately available funds at Closing, (i) accrued and unpaid Company Transaction Expenses as set forth in the Company Transaction
Expenses Certificate pursuant to Section 2.1(b)(i) for an amount up to $4,500,000, which shall include the respective
amounts and wire transfer instructions for the payment thereof and (ii) accrued and unpaid SPAC Transaction Expenses as set forth
in the SPAC Financing Certificate pursuant to Section 2.1(b)(ii) for an amount up to $9,500,000 (the “Maximum
Allowable SPAC Transaction Expenses”). Prior to Closing, Sponsor will have arranged to pay for any SPAC Transaction Expenses
in excess of the Maximum Allowable SPAC Transaction Expenses that have been incurred by the SPAC and/or the Sponsor at Closing.
(d) Notwithstanding
the foregoing, the Company shall be responsible for paying any extension fees up to $100,000 per month on or after March 28, 2024,
and up to $100,000 for fees associated with the completion of the Form 10-K for the fiscal year ended December 31, 2023 and
if applicable, the Form 10-Q for the fiscal quarter ended March 31, 2024, and if applicable, up to an additional $25,000 for
the Form 10-Q for the fiscal quarter ended June 30, 2024.
(e) For
avoidance of doubt, the total amount payable by PubCo pursuant to Section 2.6(c) (including the value of any shares issued in
satisfaction of outstanding expenses) shall not exceed $14,000,000. Notwithstanding anything to the contrary in the foregoing, PubCo shall
not be obligated to pay for SPAC Transaction Expenses in excess of the Maximum Allowable SPAC Transaction Expenses which the Sponsor has
agreed to pay for. PubCo’s failure or refusal to pay anything over and above the Maximum Allowable SPAC Transaction Expenses will
not be deemed to constitute a breach or a default of any kind by the Company or PubCo under this Agreement.
Section 2.7 Appraisal
and Dissenter’s Rights.
(a) Notwithstanding
any provision of this Agreement to the contrary and to the extent available under the Cayman Companies Act, Company Shares that are issued
and outstanding immediately prior to the Initial Merger Effective Time and that are held by Company Shareholders who have not voted in
favor of the Initial Merger nor consented thereto in writing and who have given a notice of election to dissent pursuant to section 238
of the Cayman Companies Act and otherwise complied with all of the provisions of the Cayman Companies Act relevant to the exercise and
perfection of dissenters’ rights (the “Dissenting Shares”) shall not be converted into, and any such Company
Shareholder shall have no right to receive, any Stockholder Merger Consideration, and shall cease to have any of the rights as a shareholder
of the Company (save for the right to be paid fair value for the Company Shares). Any Company Shareholder who prior to the Initial Merger
Effective Time fails to perfect or validly withdraws a notice of election to dissent or otherwise loses his, her or its rights to payment
for their Company Shares pursuant to section 238 of the Cayman Companies Act shall be treated in the same manner as a Company Shareholder
who did not give a notice of election to dissent pursuant to section 238 of the Cayman Companies Act.
(b) Prior
to the Initial Merger Effective Time, the Company shall give SPAC (i) prompt notice of any notices of election to dissent pursuant
to section 238 of the Cayman Companies Act received by the Company and any withdrawals of such notices, and (ii) the opportunity
to participate in all negotiations and proceedings with respect to the exercise of dissent rights pursuant to section 238 of the Cayman
Companies Act. Subject to the requirements of the Cayman Companies Act, the Company shall not, except with the prior written consent of
SPAC (which consent shall not be unreasonably withheld, conditioned or delayed), make any payment with respect to any Dissenting Shares
or offer to settle or settle any demand made pursuant to Section 238 of the Cayman Companies Act.
Section 2.8 Withholding.
Each of PubCo, the Surviving Corporation, SPAC, Merger Sub 1 and Merger Sub 2 and their agents shall be entitled to deduct and withhold
from the consideration otherwise payable pursuant to this Agreement such amounts as it is required to deduct and withhold with respect
to the making of such payment under the Code, or any provision of state, local or non-U.S. Tax Law; provided that PubCo, the Surviving
Corporation, SPAC, Merger Sub 1 and Merger Sub 2 or their agent, as applicable, shall cooperate to reduce or eliminate any such requirement
to deduct or withhold to the extent permitted by Law. Without limiting the foregoing, PubCo may give effect to withholding hereunder by
withholding any consideration issued in the form of PubCo Shares or other consideration issued in kind, and then selling such portion
of such PubCo Shares or other consideration issued in kind as it may determine and using the proceeds thereof to satisfy applicable withholding
obligations and remitting such proceeds to appropriate Governmental Authorities. To the extent that amounts are so withheld by PubCo,
the Surviving Corporation, SPAC, Merger Sub 1 or Merger Sub 2 or their agents, as the case may be, and paid over to the appropriate Governmental
Authority, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which
such deduction and withholding was made.
Section 2.9 TAX
CONSEQUENCES. The parties hereto hereby agree and acknowledge that for U.S. federal income tax
purposes, it is intended that (a) taken together, the Mergers will qualify as an exchange under Section 351 of the Code and
(b) the SPAC Merger will not result in gain being recognized under Section 367(a)(1) of the Code by any SPAC Stockholder
(other than for any stockholder that would be a “five-percent transferee shareholder” (within the meaning of United States
Treasury Regulations Section 1.367(a)-3(c)(5)(ii)) of PubCo following the Transactions that does not enter into a five-year gain
recognition agreement (“GRA”) pursuant to United States Treasury Regulations Section 1.367(a)-8(c)) ((a) and
(b), together, the “Intended Tax Treatment”). To the extent permitted under applicable Law, (i) the parties intend
that the Mergers also qualify as a “reorganization” under Section 368(a) of the Code and (ii) this Agreement
is intended to constitute and hereby is adopted as a “plan of reorganization” with respect to the Mergers within the meaning
of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a) for purposes of Sections 354, 361 and 368 of the Code and the Treasury
Regulations thereunder, as well as an integrated plan of formation and combination among various constituent parties pursuant to Section 351
of the Code and the Treasury Regulations thereunder.
Article III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company hereby represents
and warrants to SPAC the following, except as set forth in the Disclosure Schedules delivered to SPAC by the Company on the date of this
Agreement (the “Company Disclosure Schedules”), which exceptions shall be deemed to be part of the representations
and warranties made hereunder subject to, and in accordance with, Section 11.9 (and any reference in this Agreement or any
Ancillary Agreement to this Article III or any provision thereof shall be deemed to refer to such Article or provision
as modified by the Company Disclosure Schedules in accordance with Section 11.9).
Section 3.1 Organization,
Good Standing, Corporate Power and Qualification. The Company is duly incorporated, validly existing
and in good standing under the Laws of its jurisdiction of incorporation. The Company has the requisite corporate power and authority
to own and operate its properties and assets, to carry on its business as presently conducted and contemplated to be conducted, to execute
and deliver this Agreement and the Ancillary Agreements to which it is or will be a party, and to perform its obligations pursuant hereto,
thereto and to the Company Governing Documents. The Company is presently qualified to do business as a foreign corporation in each jurisdiction
in which it is required to be so qualified and in good standing in each such jurisdiction (except where the failure to be so qualified
has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect). Prior to the date
of this Agreement, the Company has made available to SPAC true, correct and complete copies of the Company Governing Documents and the
governing documents of each other GCL Company, including all amendments thereto, as in effect as of the date of this Agreement.
Section 3.2 Subsidiaries;
Capitalization.
(a) The
Company does not own or control, directly or indirectly, any interest in any corporation, partnership, limited liability company, association
or other business entity, other than the Subsidiaries of the Company set forth on Section 3.2(a) of the Company Disclosure
Schedules. Each of the Company’s Subsidiaries has been duly organized and is validly existing and in good standing under the Laws
of its jurisdiction of incorporation and has requisite corporate or other entity power and authority to own and operate its properties
and assets, to carry own its business as presently conducted and contemplated to be conducted. Each of the Company’s Subsidiaries
is presently qualified to do business as a foreign corporation or other entity in each jurisdiction in which it is required to be so qualified
and is in good standing in each such jurisdiction (except where the failure to be so qualified or in good standing has not had and would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect). All shares or other equity securities
of the Company’s Subsidiaries that are issued and outstanding have been duly authorized and validly issued in compliance with applicable
Laws, are fully paid and nonassessable, and have not been issued in violation of any purchase option, call option, right of first refusal,
preemptive right, subscription right or other similar right.
(b) The
capitalization of the Company (both as of the date of this Agreement, and the capitalization of the Company as will exist following the
completion of the Restructuring) is set forth on Section 3.2(b) of the Company Disclosure Schedules. Other than such
Company Shares set forth on set forth on Section 3.2(b) of the Company Disclosure Schedules, the Company is not authorized
to issue any other class or series of Company Shares.
(c) All
Company Shares that are issued and outstanding (or that will be issued and outstanding following the completion of the Restructuring)
have been (or will be) duly authorized and validly issued in compliance with applicable Laws, are (or will be) fully paid and nonassessable,
and have not (or will not have) been issued in violation of any purchase option, call option, right of first refusal, preemptive right,
subscription right or other similar right. The Company Shares have the rights, preferences, privileges and restrictions set forth in the
Company Governing Documents.
(d) There
are no authorized or outstanding options, restricted stock, warrants or other equity appreciation, phantom equity, profit participation
or similar rights for the purchase or acquisition from the Company of any Company Shares. Except as set forth on Section 3.2(d) of
the Company Disclosure Schedules, and the Company Governing Documents, the Company is not a party to or subject to any agreement or understanding
and there is no agreement or understanding between any Persons that affects or relates to the voting or giving of written consents with
respect to any security or by a director of the Company. To the Company’s knowledge, no officer or director has made any representations
or promises regarding equity incentives to any officer, employee, director or consultant of the Company that is not reflected in the issued
and outstanding share and option numbers contained in this Section 3.2.
(e) The
only Company Shares that will be issued and outstanding immediately after the Closing will be such share(s) owned by PubCo following
the consummation of the Initial Merger.
Section 3.3 Due
Authorization. All corporate action on the part of each of the GCL Companies and their respective
directors, officers and shareholders necessary for the (a) authorization, execution and delivery by GCL Global and GCL BVI of this
Agreement and the Ancillary Agreements to which either is or will be a party, (b) consummation of the Transactions and the Restructuring,
and (c) performance of all of GCL Global’s, GCL BVI’s and each GCL Company’s obligations hereunder or thereunder
has been taken or will be taken prior to the Restructuring or the Closing, as applicable, subject to (i) obtaining the Company Written
Consent, (ii) the filing of the Initial Merger Filing Documents and (iii) the receipt of the Regulatory Approvals (as defined
below). This Agreement and the Ancillary Agreements to which it is or will be a party assuming due authorization, execution and delivery
by each other party constitute valid and binding obligations of GCL Global and GCL BVI, as applicable, enforceable against GCL Global
and GCL BVI in accordance with their respective terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other Laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by
Laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity.
Section 3.4 Financial
Statements.
(a) Attached
as Section 3.4(a) of the Company Disclosure Schedules are (i) the unaudited consolidated statement of financial
position of the GCL Companies as of March 31, 2023 and March 31, 2022 and the related consolidated statements of profit or loss,
changes in equity and cash flows for the years then ended, (the “Unaudited Company Financial Statements”). The Unaudited
Company Financial Statements present fairly, in all material respects, the consolidated financial position, results of operations, income
(loss), changes in equity and cash flows of the Company as of the dates and for the periods indicated in such Unaudited Company Financial
Statements in conformity with GAAP (except for the absence of footnotes and other presentation items and subject to audit adjustments)
and were derived from the books and records of the Company.
(b) The
Company has in place disclosure controls and procedures that are designed to reasonably ensure that material information relating to the
GCL Companies (including any fraud that involves management or other employees who have a significant role in the internal controls of
the GCL Companies) is made known to the management of the Company by others within any of the GCL Companies and are effective in recording,
processing, summarizing and reporting financial data. The GCL Companies maintain a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.
(c) Since
March 31, 2022, neither the Company nor, to the knowledge of the Company, any Representative of any of the GCL Companies has received
or otherwise had or obtained knowledge of any written complaint, allegation, assertion or claim regarding the accounting or auditing practices,
procedures, methodologies or methods of any of the GCL Companies with respect to the Unaudited Company Financial Statements or the internal
accounting controls of any of the GCL Companies, including any written complaint, allegation, assertion or claim that any of the GCL Companies
has engaged in questionable accounting or auditing practices. No attorney representing any of the GCL Companies, whether or not employed
by any of the GCL Companies, has reported evidence of a violation of securities Laws, breach of fiduciary duty or similar violation by
any of the GCL Companies or any of their respective Representatives to the Company Board or the board of directors (or similar governing
body) of any of its Subsidiaries or any committee thereof or to any director or officer of any of the GCL Companies.
(d) None
of the GCL Companies has any liability or obligation, absolute or contingent, individually or in the aggregate, that would be required
to be set forth on a consolidated balance sheet of the GCL Companies prepared in accordance with GAAP applied and in accordance with past
practice, other than (i) obligations and liabilities that have not had and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect, (ii) obligations and liabilities under Contracts incurred in the Ordinary Course
(other than due to a breach under such Contracts, or any act or omission that with the giving of notice, the lapse of time or otherwise,
would constitute a breach thereunder), (iii) any Company Transaction Expenses, (iv) obligations incurred by the Company’s
execution of this Agreement (other than due to a breach hereunder, or any act or omission that with the giving of notice, the lapse of
time or otherwise, would constitute a breach hereunder), and (v) obligations and liabilities reflected, or reserved against, in the
Unaudited Company Financial Statements.
Section 3.5 Material
Contracts.
(a) Section 3.5(a) of
the Company Disclosure Schedules lists all Contracts to which any GCL Company is a party, by which any GCL Company is bound or to which
any GCL Company or any of its assets or properties are subject that are in effect as of the date of this Agreement and constitute or involve
the following (together with all amendments, waivers or other changes thereto, each of the following, a “Material Contract”):
(i) each
employee collective bargaining Contract;
(ii) obligations
of, or payments to, any of the GCL Companies of $500,000 or more;
(iii) any
Contract under which any GCL Company has created, incurred, assumed or guaranteed Indebtedness, has the right to draw upon credit that
has been extended for Indebtedness, or has granted a Lien on its assets, whether tangible or intangible, to secure any Indebtedness, in
each case, in an amount in excess of $500,000;
(iv) any
Contract that is a definitive purchase and sale or similar agreement entered into in connection with an acquisition or disposition by
any GCL Company since March 31, 2022 of any Person or of any business entity or division or business of any Person (including through
merger or consolidation or the purchase of a controlling equity interest in or substantially all of the assets of such Person or by any
other manner), but excluding any Contracts in which the applicable acquisition or disposition has been consummated and there are no material
obligations ongoing;
(v) any
Contract with outstanding obligations for the sale or purchase of personal property, fixed assets or real estate, other than sales or
purchases in the Ordinary Course;
(vi) any
Contract not made in the Ordinary Course and not disclosed pursuant to any other clause under this Section 3.5(a) and
expected to result in revenue or require expenditures in excess of $500,000 in the calendar year ending March 31, 2023;
(vii) any
joint venture Contract, partnership agreement, limited liability company agreement or similar Contract that is material to the business
of the GCL Companies, taken as a whole;
(viii) any
real property leasehold interest (each, a “Real Property Lease”);
(ix) all
leases or master leases of personal property reasonably likely to result in annual payments of $500,000 or more in a 12-month period;
(x) any
Contract pursuant to which any GCL Company (A) licenses or is granted rights from a third party under Intellectual Property that
is material to the business of the GCL Companies, taken as a whole, excluding click-wrap, shrink-wrap, off-the-shelf software licenses
and any other software licenses that are commercially available on reasonable terms to the public generally with license, maintenance,
support and other fees less than $250,000 per year provided such software is not combined with, linked to or distributed with any Owned
Company Software or any Company Product or (B) licenses or grants to a third party to any rights in or to use Owned Intellectual
Property or Owned Company Software (excluding non-exclusive licenses granted to customers, contractors, suppliers or service providers
in the Ordinary Course);
(xi) the
grant of rights to manufacture, produce, assemble, license, market or sell any Company Products;
(xii) Contracts
with any Governmental Authority;
(xiii) any
Contract which restricts in any material respect or contains any material limitations on the ability of any GCL Company to compete in
any line of business or in any geographic territory, in each case excluding customary confidentiality agreements (or clauses) or non-solicitation
agreements (or clauses);
(xiv) Contracts
between (A) on the one hand, any of the GCL Companies, and (B) on the other hand, any Company Shareholder;
(xv) all
broker, distributor, dealer, manufacturer’s representative, franchise, agency, sales promotion, market research, marketing consulting
and advertising Contracts to which a GCL Company is a party that provide for payments by any GCL Company or to any GCL Company in excess
of $250,000, in the aggregate, over any 12-month period;
(xvi) all
Contracts that result in any Person holding an irrevocable power of attorney from any GCL Company that relates to any GCL Company or its
business;
(xvii) Contracts
to which any GCL Company is a party that are of the type that would be required to be filed with the Registration Statement under applicable
SEC requirements pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities Act if the Company
was the registrant.
(b) True,
correct and complete copies of the Contracts required to be listed on Section 3.5(a) of the Company Disclosure Schedules,
have been delivered to or made available to SPAC prior to the date of this Agreement, together with all amendments thereto.
(c) Except
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) all Material Contracts
to which any of the GCL Companies is a party or by which its assets are bound are valid, binding and in full force and effect, except
as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other Laws of general application affecting enforcement
of creditors’ rights generally and by Laws relating to the availability of specific performance, injunctive relief or other equitable
remedies, (ii) none of the GCL Companies (nor, to the knowledge of the Company, any other party to any such Contract) is or, with
the giving of notice, the lapse of time or otherwise, would be in default under any Material Contract to which any of the GCL Companies
is or will be a party or by which its assets are bound, (iii) since March 31, 2022, none of the GCL Companies has received any
written or, to the Company’s knowledge, oral claim or notice of material breach of or material default under any Material Contract,
(iv) to the Company’s knowledge, no event has occurred which, individually or together with other events, would reasonably
be expected to result in a material breach of or a material default under any Material Contract by a GCL Company or, to the Company’s
knowledge, any other party thereto (in each case, with or without notice or lapse of time or both), and (v) since March 31,
2022 through the date hereof, none of the GCL Companies has received written notice from any customer or supplier that is a party to any
Material Contract that such party intends to terminate or not renew any Material Contract.
Section 3.6 Intellectual
Property.
(a) Section 3.6(a) of
the Company Disclosure Schedules sets forth, as of the date hereof, a true and complete list, including the record owner, legal owner,
jurisdiction, serial and application numbers, and registration number of all Registered Intellectual Property and all material unregistered
Trademarks that are Owned Intellectual Property and all Owned Company Software. All Owned Intellectual Property is subsisting and, to
the knowledge of the Company, is valid and enforceable except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other Laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by
Laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity.
All Registered Intellectual Property has been maintained effective by the filing of all necessary filings, maintenance, and renewals,
and timely payment of requisite fees.
(b) Except
as set forth on Section 3.6(b) of the Company Disclosure Schedules, each item of Owned Intellectual Property is owned
by a GCL Company free and clear of all Liens, other than Permitted Liens. Except as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect, the GCL Companies collectively own all right, title, and interest in, or have a valid and
enforceable written license or other permission to use, all Company Intellectual Property.
(c) Except
as set forth on Section 3.6(c) of the Company Disclosure Schedules, or as would not reasonably be expected to result
in a Material Adverse Effect, no Actions are pending or have been threatened in writing, or to the knowledge of the Company have been
threatened orally, against any GCL Company by any Person claiming that any GCL Company has infringed, misappropriated or otherwise violated
their Intellectual Property rights or rights of publicity, or challenging the ownership, use, patenting, registration, validity, or enforceability
of any Owned Intellectual Property. Except as set forth on Section 3.6(c) of the Company Disclosure Schedules, no GCL
Company is a party to any pending Action, as of the date of this Agreement, claiming infringement, misappropriation or other violation
by any Person of any Owned Intellectual Property. Except as set forth on Section 3.6(c) of the Company Disclosure Schedules,
or as would not reasonably be expected to result in a Material Adverse Effect, to the Company’s knowledge, within the five years
preceding the date of this Agreement the GCL Companies, their products and services, the conduct of the GCL Companies’ business,
and the use of the Owned Intellectual Property, have not infringed, misappropriated or otherwise violated, and currently do not infringe,
misappropriate, or otherwise violate, the Intellectual Property right or right of publicity of any Person. No Person has notified a GCL
Company in writing that any of such Person’s Intellectual Property rights or right of publicity are infringed, misappropriated,
or otherwise violated by a GCL Company or that a GCL Company requires a license to any of such Person’s Intellectual Property rights.
To the Company’s knowledge, as of the date of this Agreement no Person is infringing, misappropriating or otherwise violating any
Owned Intellectual Property. No written or, to the Company’s knowledge, oral claims alleging any infringement, misappropriation,
or other violation have been made against any Person by a GCL Company.
(d) Except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the GCL Companies have undertaken
commercially reasonable efforts to protect: (i) the confidentiality of all Proprietary Information that is Owned Intellectual Property
and (ii) any confidential information owned by any Person to whom a GCL Company has a confidentiality obligation. No such Proprietary
Information has been disclosed by a GCL Company to any Person other than pursuant to a written confidentiality agreement restricting the
disclosure and use of such Proprietary Information by such Person.
(e) No
Person (including current and former founders, employees, contractors, and consultants of the GCL Companies) has any right, title, or
interest, directly or indirectly, in whole or in part, in any Owned Intellectual Property. The GCL Companies have implemented policies
whereby employees who create or develop any Intellectual Property in the course of their employment with a GCL Company are required to
assign to the applicable GCL Company all of such employee’s rights therein, and all employees and contractors of the GCL Companies
who have created or developed any Intellectual Property in the course of their employment or provision of services for such GCL Company
have executed written agreements pursuant to which such Persons have assigned (or are obligated to assign) to such GCL Company all of
such employee’s or contractor’s rights in and to such Intellectual Property that did not vest automatically in the GCL Company
by operation of law (and, in the case of contractors, to the extent such Intellectual Property was intended to be proprietary to the GCL
Company), except in each case, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(f) Except
as set forth on Section 3.6(f) of the Company Disclosure Schedules, no government funding and no facilities or other
resources of any university, college, other educational institution or research center were used in the development of any Owned Intellectual
Property. No Governmental Authority, university or other educational institution, research organization or standards setting organization
has any right, title or interest in or to any Owned Intellectual Property.
(g) The
Owned Company Software operates in all material respects with its specifications established by the GCL Companies. Material reported defects
and reports of errors with respect to Owned Company Software are monitored in accordance with Company practices. To the Company’s
knowledge, no Person other than the GCL Companies possesses a copy, in any form (print, electronic, or otherwise), of any source code
for any Owned Company Software (other than contractors engaged to develop or maintain Owned Company Software), and the GCL Companies have
undertaken commercially reasonable efforts to protect the confidentiality of all such source code. The GCL Companies have no obligation
to afford any Person access to any such source code.
(h) No
Publicly Available Software has been incorporated in, linked to, distributed with, or otherwise used in connection with any Owned Company
Software in any manner that (i) requires, or conditions the use or distribution of any Owned Company Software on the disclosure,
licensing, or distribution of any source code for any portion of such Owned Company Software or (ii) otherwise imposes any material
limitation, restriction, or condition on the right or ability of the GCL Companies to use, allow third parties to use, distribute, or
enforce any Owned Intellectual Property. To the Company’s knowledge, the GCL Companies have complied and are in compliance with
the terms of all licenses for Publicly Available Software used by the GCL Companies in all material respects.
(i) In
connection with its collection, storage, transfer (including without limitation, any transfer across national borders) Processing and/or
use of any Personal Information, each GCL Company is and has been, within the five years preceding the date of this Agreement, in material
compliance with all applicable Privacy and Security Requirements. Each GCL Company has commercially reasonable physical, technical, organizational
and administrative security measures and policies in place to protect the confidentiality, integrity and availability of all Protected
Data maintained and collected by it. Except as set forth in Section 3.6(i), within the five years preceding the date of this
Agreement the Company, and to the Company’s knowledge any third party processing Protected Data on behalf of any GCL Company, has
not experienced any Computer Security Incident, and to the Company’s knowledge, the Company has not received any written notices
or written complaints from any Person regarding a Computer Security Incident relating to any GCL Company. Within the five years preceding
the date of this Agreement the Company has not received, nor provided, any notice of any written claims, actions, investigations, inquiries
or alleged violations of Privacy and Security Requirements by any GCL Company. To the Company’s knowledge, within the five years
preceding the date of this Agreement no GCL Company has been subject to, and there are no complaints, audits, investigations or Actions
pending against the Company by any Governmental Authority (including any audits relating to the Cybersecurity Maturity Model Certification
(CMMC)), or by any Person, in respect of the collection, use, storage, disclosure or other Processing of Protected Data.
(j) Except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (i) the IT Systems are
operational and adequate and sufficient for the current and reasonably anticipated future needs of the business of the GCL Companies,
(ii) to the Company’s knowledge, there have been no unremediated material failures of the IT Systems currently used to provide
material products to customers in the conduct of their business as it is currently conducted during the two year period preceding the
date hereof, and (iii) the GCL Companies have in place commercially reasonable security controls and backup and disaster recovery
plans and procedures.
(k) No
GCL Company engages in the sale, as defined by applicable Law, of Personal Information. All sales and marketing activities by the GCL
Companies have been in material compliance with all applicable Laws that require the provision of notice and obtaining of consent from
potential customers to receive such sales and marketing materials. To the Company’s knowledge, the GCL Companies have valid and
legal rights to Process all Protected Data that is Processed by the GCL Companies in connection with the use and/or operation of its products,
services and business, and the execution, delivery, or performance of this Agreement will not affect these rights or violate any applicable
Privacy and Security Requirements.
Section 3.7 Title
to Properties and Assets; Liens. Each of the GCL Companies has good and marketable title
to its properties, assets and rights, including the Company Intellectual Property, and has good title to all its leasehold interests,
in each case free and clear of any Lien, other than Permitted Liens. With respect to the properties, assets and rights it leases, each
of the GCL Companies is in compliance with such leases in all material respects and, to the Company’s knowledge, holds a valid leasehold
interest free of any Liens, other than Permitted Liens. The properties, assets and rights owned, leased or licensed by the GCL Companies
(including any Company Intellectual Property) constitute all the properties, assets and rights used in connection with the businesses
of the GCL Companies. Such properties, assets and rights constitute all the properties, assets and rights necessary for the GCL Companies
to continue to conduct their respective businesses following the Closing as they are currently being conducted.
Section 3.8 Real
Property.
(a) None
of the GCL Companies owns, or has ever owned, any real property.
(b) No
GCL Company is in default under any Real Property Lease, and, to the Knowledge of the Company, there is no default by any lessor under
the Real Property Lease.
(c) To
the Knowledge of the Company, all buildings, structures, improvements, fixtures, building systems and equipment included in the Leased
Real Property are in reasonable operating condition and repair (ordinary wear and tear excepted).
(d) Each
GCL Company has a valid and enforceable leasehold interest under each Real Property Lease and each Real Property Lease is in full force
and effect and constitutes a valid and binding obligation of the applicable GCL Company that is the lessee, or lessor, enforceable against
such GCL Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other Laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by Laws relating
to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity.
(e) To
the knowledge of the Company, there are no pending condemnation, eminent domain, or any other taking by public authority with or without
payment of consideration therefor or similar actions with respect to any of the Leased Real Properties. No notice of such a proposed condemnation
has been received by any GCL Company.
(f) Each
GCL Company has the right to conduct its business in each Leased Real Property for the remaining term of the applicable Real Property
Lease.
Section 3.9 Environmental
Matters. Except as set forth in Section 3.9 of the Company Disclosure Schedules:
(a) except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each GCL Company is and, during
the last five years, has been in compliance in all material respects with all Environmental Laws.
(b) except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each GCL Company timely obtained
and currently possesses all Environmental Permits required for the operation of its business and each Environmental Permit is valid and
in full force and effect. The Company is and during the last five years, has been in compliance in all material respects with all Environmental
Permits.
(c) there
has been no release of any Hazardous Materials at, in, on or under any Leased Real Property or, to the Knowledge of the Company, at, in,
on or under any formerly owned or leased real property, in each case (i) during the time that a GCL Company owned or leased such
property, and (ii) that requires notice, further investigation or response action by a GCL Company pursuant to Environmental Law.
(d) no
GCL Company is subject to and no GCL Company has received any Governmental Order that remains unresolved relating to any non-compliance
with Environmental Laws by the Company or the investigation, sampling, monitoring, treatment, remediation, removal or cleanup of Hazardous
Materials.
(e) no
Action is pending or, to the knowledge of the Company, threatened in writing and no investigation, to the knowledge of the Company, is
pending or threatened in writing, in each case with respect to any GCL Company’s compliance with or liability under Environmental
Law;
(f) the
GCL Companies have not generated, stored, used, transported, treated or disposed of any Hazardous Materials other than in compliance in
all material respects with all Environmental Laws; and
(g) the
Company has made available to SPAC all material environmental reports (including any Phase One or Phase Two environmental site assessments)
and audits relating to the Leased Real Property or any formerly owned or operated real property in its possession, custody or reasonable
control.
Section 3.10 Compliance
with Other Instruments. None of the GCL Companies is in material violation of any term of its
Governing Documents. None of the GCL Companies is in violation of any term or provision of any Governmental Order to which it is party
or by which it is bound which has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
The execution and delivery by the Company and the performance by the Company of its obligations pursuant to this Agreement and the Ancillary
Agreements to which it is or will be a party will not result in, by the giving of notice, the lapse of time or otherwise, (a) any
violation of, conflict with, or except for obtaining the Company Written Consent, (ii) the filing of the Initial Merger Filing Documents
and (iii) the receipt of the Regulatory Approvals, require any consent, filing, notice, waiver or approval or constitute a default
under (i) the Company’s Governing Documents, (ii) any Contract to which any of the GCL Companies is a party or by which
any of the GCL Companies’ assets are bound or (iii) any applicable Law, Permit or Governmental Order, nor (b) the creation
of any Lien upon any of the properties or assets of the Company (other than Permitted Liens), except, in the case of clauses (a)(ii),
(a)(iii) and (b), to the extent that the occurrence of the foregoing has not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect.
Section 3.11 Compliance
with Laws.
(a) Each
GCL Company is, and since March 31, 2021 has been, in compliance in all material respects with all applicable Laws. The GCL Company
has not received any written notice from any Governmental Authority of a violation of any applicable Law by the any GCL Company at any
time since March 31, 2021, which violation would, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.
(b) Since
March 31, 2021, and except where the failure to be, or to have been, in compliance with such Laws would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, (i) there has been no action taken by the GCL Company or, to
the Company’s knowledge, any officer, director, manager, employee, agent or representative of the GCL Companies, in each case, acting
on behalf of the GCL Companies, in violation of any applicable Anti-Bribery Law, (ii) none of the GCL Companies have been convicted
of violating any Anti-Bribery Laws or subjected to any investigation by a Governmental Authority for violation of any applicable Anti-Bribery
Laws, (iii) none of the GCL Companies has conducted or initiated any internal investigation or made a voluntary, directed, or involuntary
disclosure to any Governmental Authority regarding any alleged act or omission arising under or relating to any noncompliance with any
Anti-Bribery Law and (iv) none of the GCL Companies has received any written notice or citation from a Governmental Authority for
any actual or potential noncompliance with any applicable Anti-Bribery Law.
(c) Since
March 31, 2021, and except where the failure to be, or to have been, in compliance with such Laws would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, (i) there has been no action taken by any GCL Company, or, to
the Company’s knowledge, any officer, director, manager, employee, agent or representative of any GCL Company, in each case, acting
on behalf of any GCL Company, in violation of any applicable Export Laws, (ii) no GCL Company has been convicted of violating any
Export Laws or subjected to any investigation by a Governmental Authority for violation of any applicable Export Laws, (iii) no GCL
Company has conducted or initiated any internal investigation or made a voluntary, directed, or involuntary disclosure to any Governmental
Authority regarding any alleged act or omission arising under or relating to any noncompliance with any Export Laws and (iv) no GCL
Company has received any written notice or citation from a Governmental Authority for any actual or potential noncompliance with any applicable
Export Law.
Section 3.12 Absence
of Changes. Since the date of the most recent Company Audited Financial Statements (a) there
has not been, individually or in the aggregate, any Material Adverse Effect, and (b) the GCL Companies have conducted their businesses
in all material respects in the Ordinary Course (other than with respect to the evaluation of and negotiations in connection with this
Agreement and the Transactions contemplated hereby).
Section 3.13 Litigation.
Except as set forth in Section 3.13 of the Company Disclosure Schedules, as of the date of this Agreement (a) there are
no Actions pending or, to the Company’s knowledge, currently threatened against any of the GCL Companies or their respective assets
or properties before any Governmental Authority that (i) question the validity of this Agreement or any Ancillary Agreement, or the
right of the Company to enter into this Agreement or any Ancillary Agreement, or the right of any of the GCL Companies to perform its
obligations contemplated by this Agreement or any Ancillary Agreement, or (ii) if determined adversely to any GCL Company, would
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or result in any change in the current equity
ownership of the Company; (b) none of the GCL Companies is a party or subject to the provisions of any Governmental Order;
and (c) there is no Action initiated by any of the GCL Companies currently pending or which any of the GCL Companies currently intends
to initiate, except, in the case of each of clauses (a), (b) and (c), as has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.
Section 3.14 Insurance.
Section 3.14 of the Company Disclosure Schedules contains a list of all material policies or programs of self-insurance of
property, fire and casualty, product liability, workers’ compensation and other forms of insurance held by, or for the benefit of,
the GCL Companies as of the date of this Agreement. True, correct and complete copies or comprehensive summaries of such insurance policies
have been made available to SPAC. With respect to each such insurance policy required to be listed on Section 3.14 of the
Company Disclosure Schedules, (i) all premiums due have been paid (other than retroactive or retrospective premium adjustments and
adjustments in the respect of self-funded general liability and automobile liability fronting programs, self-funded health programs and
self-funded general liability and automobile liability front programs, self-funded health programs and self-funded workers’ compensation
programs that are not yet, but may be, required to be paid with respect to any period end prior to the Closing Date), (ii) the policy
is legal, valid, binding and enforceable in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other Laws of general application affecting enforcement of creditors’ rights generally and (ii) as
limited by Laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles
of equity and, except for policies that have expired under their terms in the ordinary course, is in full force and effect, (iii) the
Company is not in breach or default (including any such breach or default with respect to the payment of premiums or the giving of notice),
and, to the Company’s knowledge, no event has occurred which, with notice or the lapse of time or both, would constitute such a
breach or default, or permit termination or modification, under the policy, and to the knowledge of the Company, no such action has been
threatened and (iv) as of the date hereof, no written notice of cancellation, non-renewal, disallowance or reduction in coverage
or claim or termination has been received other than in connection with ordinary renewals.
Section 3.15 Governmental
Consents. Assuming the accuracy of the representations made by SPAC in Article IV,
no consent, approval or authorization of or registration, qualification, designation, declaration or filing with any Governmental Authority
on the part of any of the GCL Companies is required in connection with the valid execution and delivery of this Agreement or any Ancillary
Agreement, or the consummation of any Transaction contemplated hereby or thereby, except (i) for such filings or notices as may be
required under the Securities Act or under applicable state securities Laws, including the filing of the Initial Merger Filing Documents
and any other filings or notices required for the consummation of the Initial Merger, (ii) the Regulatory Approvals, and (iii) where
the failure to obtain such consents, approvals or authorizations of or registrations, qualifications, designations, declarations or filings,
individually or in the aggregate, has not had, and would not reasonably be expected to have, a Material Adverse Effect.
Section 3.16 Permits.
Each GCL Company has timely obtained and holds all material Permits (the “Material Permits”) that are required to own,
lease or operate its properties and assets and to conduct its business as currently conducted, except where the failure to obtain the
same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect, (a) each Material Permit is in full force and effect
in accordance with its terms, (b) no outstanding written notice of revocation, cancellation or termination of any Material Permit
has been received by a GCL Company, (c) to the Company’s knowledge, none of such Permits upon its termination or expiration
in the ordinary due course will not be renewed or reissued in the Ordinary Course upon terms and conditions substantially similar to its
existing terms and conditions, (d) there are no Actions pending or, to the knowledge of the Company, threatened, that seek the revocation,
cancellation, limitation, restriction or termination of any Material Permit and (e) the GCL Companies are in compliance with all
Material Permits.
Section 3.17 Registration
and Voting Rights. Except as set forth in Section 3.17 of the Company Disclosure
Schedules and other than with respect to actions contemplated by the Mergers, this Agreement and the Ancillary Agreements, (a) none
of the GCL Companies is presently under any obligation and has not granted any rights to register under the Securities Act any of its
presently outstanding securities or any of its securities that may hereafter be issued and (b) to the Company’s knowledge,
no shareholder of any of the GCL Companies has entered into any agreements with respect to the voting of Company Shares.
Section 3.18 Brokers
or Finders; Transaction Expenses. Except as set forth in Section 3.18 of the
Company Disclosure Schedules, none of the GCL Companies has incurred, or will incur, directly or indirectly, as a result of any action
taken by the GCL Companies, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in
connection with this Agreement or any of the other Transactions.
Section 3.19 Related-Party
Transactions. Except as set forth in Section 3.19 of the Company Disclosure Schedules
(and other than with respect to actions expressly contemplated by this Agreement and the Ancillary Agreements):
(a) No
director, officer or employee of any of the GCL Companies or any member of such Person’s immediate family or any corporation, partnership
or other entity in which such Person has a significant ownership interest or otherwise controls (each, a “Related Party”)
is indebted to any of the GCL Companies, nor is any of the GCL Companies indebted (or committed to make loans or extend or guarantee credit)
to any Related Party.
(b) To
the Company’s knowledge, no Related Party has any direct or indirect ownership interest in (i) any Person with which any of
the GCL Companies is party to a Contract or has a material business relationship or (ii) any Person that competes with any of the
GCL Companies, except that Related Parties may own stock in publicly traded companies that may compete with each of the GCL Companies.
(c) No
Related Party is directly or indirectly interested in any Contract with any of the GCL Companies, other than any such Contracts related
to such Person’s (i) ownership of Company Shares, options or other securities of the Company, (ii) indemnification by
the Company or (iii) salary, commission and other employment benefits provided by the Company to such Person.
Section 3.20 Labor
Agreements and Actions; Employee Compensation.
(a) None
of the GCL Companies is bound by or subject to (and none of their assets or properties is bound by or subject to) any Contract with any
labor union, and, to the Company’s knowledge, no labor union has requested or has sought to represent any of the employees of any
of the GCL Companies. There is no strike or other labor dispute involving any of the GCL Companies pending, or to the Company’s
knowledge, threatened, that has had or would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect,
nor, to the knowledge of the Company, is there any labor organization activity involving the employees of any of the GCL Companies.
(b) To
the Company’s knowledge, no officer, management employee, or any group of management employees, intends to terminate their employment
with any of the GCL Companies, nor does any of the GCL Companies have a present intention to terminate the employment of any of the foregoing.
Each officer and management employee of each of the GCL Companies is currently providing full-time services to the conduct of the business
of each of the GCL Companies. To the Company’s knowledge, no officer or management employee is currently working for a competitive
enterprise.
(c) Except
as set forth in the Company Disclosure Schedules, the employment of each officer and employee of each of the GCL Companies is terminable
at the will of each of the GCL Companies and no such individual is entitled to any material compensation upon termination of employment,
except as required by Law applicable to the jurisdiction in which such officer or employee is employed.
(d) Except
as expressly set forth in the Company Disclosure Schedules and except as has been mandated by Governmental Authority, as of the date of
this Agreement, the GCL Companies have not had, nor are there any facts that would give rise to, any material workforce changes due to
COVID-19, whether directly or indirectly, including any actual or expected terminations, layoffs, furloughs, shutdowns (whether voluntary
or by Governmental Order), or any material changes to benefit or compensation programs, nor are any such changes currently contemplated.
(e) With
respect to all current and former Persons who have performed services for or on behalf of any of the GCL Companies, each of the GCL Companies
is in compliance, and during the past three years) has complied in all material respects with all applicable state and federal equal employment
opportunity, wage and hour, compensation and other Laws related to employment, including overtime requirements, classification of employees
and independent contractors under federal and state Laws (including for Tax purposes and for purposes of determining eligibility to participate
in any Company Benefit Plan (as defined below)), hours of work, leaves of absence, equal opportunity, sexual and other harassment, whistleblower
protections, immigration, occupational health and safety, workers’ compensation, and the withholding and payment of all applicable
Taxes, and there are no arrears in the payments of wages, unemployment insurance premiums or other similar obligations.
(f) The
GCL Companies have for the past three years properly classified for all purposes (including for Tax purposes, for Fair Labor Standards
Act exemption purposes and for purposes of determining eligibility to participate in any Company Benefit Plan) all current and former
employees, officers, directors or independent contractors who have performed services for or on behalf of any of the GCL Companies and
have properly withheld and paid all applicable Taxes and made all required filings in connection with services provided by such Person
to the applicable GCL Company in accordance with such classifications except as would not result in a material liability to the GCL Companies.
(g) Set
forth on Section 3.20(g) of the Company Disclosure Schedules is a complete and accurate list, as of the date of this
Agreement and separately for each GCL Company, of all their employees with monthly compensation in excess of SGD 12,000 per month including
for each such employee his or her (i) name; (ii) job title; (iii) location; (iv) status as a full-time
or part-time employee; (v) base salary or wage rate; (vi) 2022 bonus; and (vii) 2023 bonus opportunity.
Section 3.20(g) of the Company Disclosure Schedules also lists, as of the date of this Agreement, each employee of each
of the GCL Companies who is not actively at work for any reason other than vacation, and the reason for such absence.
(h) Set
forth on Section 3.20(h) of the Company Disclosure Schedules are complete and accurate lists, as of the date of this
Agreement and separately for each GCL Company, of all individuals who perform services for any of the GCL Companies as (i) an independent
contractor, (ii) a leased employee, (iii) an unpaid intern, including for each such individual his or her name, services performed,
and rate of compensation (if any), and (iv) location at which such individual performs services for such GCL Company.
(i) There
are no material claims, disputes, grievances, or controversies pending or, to the knowledge of the Company, threatened involving any employee
or group of employees. To the knowledge of the Company there are no material charges, investigations, administrative proceedings or formal
complaints of (i) discrimination or retaliation (including discrimination, harassment or retaliation based upon sex, age, marital
status, race, national origin, sexual orientation, disability or veteran status), (ii) unfair labor practices, (iii) violations
of health and safety Laws, (iv) workplace injuries or (v) whistleblower retaliation against the Company, in each case that (y) pertain
to any current or former employee and (z) have been threatened in writing by such employee or are pending before the Equal Employment
Opportunity Commission, the National Labor Relations Board, the U.S. Department of Labor, the U.S. Occupational Health and Safety Administration,
the Workers Compensation Appeals Board, or any other Governmental Authority.
Section 3.21 Employee
Benefit Plans.
(a) The
Company Disclosure Schedules sets forth a complete list, as of the date of this Agreement, of each material Company Benefit Plan (whether
written or unwritten), and separately identifies each material Company Benefit Plan that is primarily for the benefit of any current or
former employee, officer, independent contractor or director of any of the GCL Companies based outside of the United States (or their
spouses, beneficiaries or dependents) (the “Non-U.S. Plans”). For purposes of this Agreement, a “Company Benefit
Plan” means (i) any “employee benefit plan” as defined in Section 3.3(3) of the United States Employee
Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) any other employee benefit plan, agreement,
arrangement, program, policy or practice, including any equity or equity-based compensation (including stock option, stock purchase, stock
award, stock appreciation, phantom stock, restricted stock or restricted stock unit), deferred compensation, pension, retirement, savings,
bonus, profit sharing, incentive compensation, retention, change-in-control, medical, dental, vision, prescription drug, life insurance,
death benefit, cafeteria, flexible spending, dependent care, fringe benefit, vacation, paid time off, holiday pay, disability, sick pay,
workers compensation, unemployment, severance, employee loan or educational assistance plan, agreement, arrangement, program, policy or
practice, and (iii) any employment, consulting, or other individual services agreement, which in the case of each of clauses (i),
(ii) and (iii), is sponsored or maintained by any of the GCL Companies, or to which any of the GCL Companies contributes or is required
to contribute or is a party, on behalf of current or former employees, officers, independent contractors or directors of any of the GCL
Companies or their spouses, beneficiaries or dependents, or with respect to which any of the GCL Companies has or may have any liability,
contingent or otherwise. No Company Benefit Plan covers individuals other than current or former employees, officers, independent contractors
or directors (or spouses, beneficiaries or dependents thereof) of any of the GCL Companies. None of the GCL Companies has communicated
to present or former employees of any of the GCL Companies, or formally adopted or authorized, any additional Company Benefit Plan or
any change in or termination of any existing Company Benefit Plan. With respect to each material Company Benefit Plan, the Company has
delivered to SPAC, to the extent applicable, true, complete and correct copies of (A) the plan document (or a written summary of
any unwritten Company Benefit Plan), including all amendments thereto (B) trust agreements, insurance policies or other funding vehicles,
third party administrator agreements, and all amendments to any of these, (C) the most recent summary plan description, including
any summary of material modifications, (D) the three most recent annual reports (Form 5500 series) filed with the IRS with respect
to such Company Benefit Plan, (E) the three most recent actuarial reports or other financial statements relating to such Company
Benefit Plan, and (F) the most recent determination or opinion letter, if any, issued by the IRS with respect to any Company Benefit
Plan and any pending request for such a determination letter.
(b) Each
Company Benefit Plan has been operated and administered in compliance in all material respects with its terms and all applicable Laws,
including ERISA and the Code if applicable, and each Company Benefit Plan which is intended to be qualified within the meaning of Section 401(a) of
the Code has received a favorable determination or opinion letter from the IRS as to its qualification or may rely upon an opinion letter
for a prototype plan and, to the knowledge of the Company, no fact or event has occurred that would reasonably be expected to adversely
affect the qualified status of any such Company Benefit Plan.
(c) All
contributions and premium payments required to have been paid under or with respect to any Company Benefit Plan have been timely paid
in accordance with the terms of such Company Benefit Plan and applicable Law except as would not result in material liability to the GCL
Companies.
(d) Except
as set forth in Section 3.21 of the Company Disclosure Schedules, no Company Benefit Plan provides health, life insurance
or other welfare benefits to retired or other terminated employees, officers, independent contractors, or directors of any of the GCL
Companies (or any spouse, beneficiary or dependent thereof), other than “COBRA” continuation coverage required by Section 4980B
of the Code or Sections 601-608 of ERISA or similar state Law.
(e) To
the knowledge of the Company, no event has occurred and no condition exists with respect to any Company Benefit Plan or any other employee
benefit plan, agreement, arrangement, program, policy or practice currently or previously sponsored, maintained or contributed to by any
of the GCL Companies which could subject any Company Benefit Plan, any of the GCL Companies, PubCo, SPAC or any of their employees, agents,
directors or Affiliates, directly or indirectly (through an indemnification agreement or otherwise), to a material liability for a breach
of fiduciary duty, a non-exempt “prohibited transaction”, within the meaning of Section 406 of ERISA or Section 4975
of the Code, a Tax, penalty or fine under Section 502 or 4071 of ERISA or Subtitle D, Chapter 43 of the Code or any other excise
Tax, penalty or fine under ERISA or the Code, or which could result in the imposition of a Lien on the assets of any of the GCL Companies.
(f) None
of the GCL Companies nor any of their respective ERISA Affiliates have sponsored or contributed to, been required to contribute to, or
had any actual or contingent liability under (i) a pension plan that is subject to Title IV of ERISA or (ii) a multiemployer
pension plan (as defined in Section 3(37) of ERISA), in each case, at any time within the previous six (6) years. None of the
GCL Companies nor any ERISA Affiliates has incurred any withdrawal liability under Section 4201 of ERISA within the previous six
(6) years that has not been fully satisfied and no non-U.S. Company Benefit Plan is a defined benefit pension plan and none of the
GCL Companies has any liability, contingent or otherwise, with respect to any such Company Benefit Plan.
(g) Except
as would not result in material liability therefor, with respect to each Company Benefit Plan, no Actions (other than routine claims for
benefits in the Ordinary Course) are pending or, to the knowledge of the Company, threatened in writing, and, to the knowledge of the
Company, no facts or circumstances exist that would reasonably be expected to give rise to any such Actions. To the knowledge of the Company,
no Company Benefit Plan is currently under investigation or audit by any Governmental Authority and, to the knowledge of the Company,
no such investigation or audit is contemplated or under consideration.
(h) To
the knowledge of the Company and except as would not result in material liability therefor, no event has occurred and no condition exists
with respect to any employee benefit plan, agreement, arrangement, program, policy or practice currently or previously sponsored, maintained
or contributed to by any Person who is or was an ERISA Affiliate of any of the GCL Companies (other than the Company or one of its Subsidiaries)
which could subject any of the GCL Companies, PubCo, SPAC or any of their employees, agents, directors, or Affiliates, directly or indirectly
(through an indemnification agreement or otherwise), to a liability, including liability under Section 412, 430, 4971 or 4980B of
the Code or Title IV of ERISA, or which could result in the imposition of a Lien on the assets of any of the GCL Companies.
(i) Except
as set forth in Section 3.21 of the Company Disclosure Schedules, the execution of this Agreement and the consummation of
the Transactions will not, either alone or in combination with another event (such as termination following the consummation of the Transactions,
and regardless of whether that other event has or will occur), (i) entitle any current or former director, employee, officer or other
service provider of any of the GCL Companies to any severance pay or any other compensation payable by any of the GCL Companies, except
as expressly provided in this Agreement, (ii) accelerate the time of payment or vesting, or increase the amount of compensation due
to any director, employee, officer or other individual service provider by any of the GCL Companies, or (iii) result in any payment
being considered an “excess parachute payment” within the meaning of Section 280G of the Code to any “disqualified
individual” within the meaning of Section 280G of the Code.
(j) Each
Company Benefit Plan that is a “nonqualified deferred compensation plan” subject to Section 409A of the Code has been
maintained and administered, in all material respects, in accordance with its terms and in operational and documentary compliance, in
all material respects, with Section 409A of the Code and all regulations and other applicable regulatory guidance (including notices
and rulings) thereunder.
(k) None
of the GCL Companies has any obligation to gross up, indemnify or otherwise reimburse any current or former employee, officer, independent
contractor, or director of any of the GCL Companies for any Taxes, interest or penalties incurred in connection with any Company Benefit
Plan (including any Taxes, interest or penalties incurred pursuant to Section 409A or 4999 of the Code).
(l) The
GCL Companies and each Company Benefit Plan that is a “group health plan” as defined in Section 733(a)(1) of ERISA
(each, a “Company Health Plan”) is in compliance, in all material respects, with the Patient Protection and Affordable
Care Act, P.L. 111-148 and the Health Care and Education Reconciliation Act of 2010, P.L. 111-152, each as amended and the regulations
and other applicable regulatory guidance issued thereunder (collectively, the “Healthcare Reform Laws”). To the knowledge
of the Company, no event has occurred and no condition or circumstance exists that could subject any of the GCL Companies or any Company
Health Plan to material penalties, fines or Taxes under Sections 4980D or 4980H of the Code or any other provision of the Healthcare Reform
Laws.
Section 3.22 TaXES
AND RETURNS.
(a) Each
GCL Company has timely filed, or caused to be timely filed, all income and other material Tax Returns required to be filed by it, which
Tax Returns are true, accurate, correct and complete in all material respects. Each GCL Company has timely paid, or caused to be timely
paid, all material Taxes required to be paid by it, other than such Taxes being contested in good faith by appropriate proceedings and
for which adequate reserves have been established in the Unaudited Company Financial Statements in accordance with GAAP.
(b) Each
GCL Company has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of Taxes, and all
material amounts of Taxes required by applicable Tax Laws to be withheld by a GCL Company have been withheld and timely paid over to the
appropriate Governmental Authority, including with respect to any amounts owing to or from any employee, independent contractor, shareholder,
creditor, or other third party.
(c) There
are no material claims, assessments, audits, examinations, investigations or other Actions pending, in progress or threatened against
any GCL Company, in respect of any Tax, and no GCL Company has been notified in writing of any material proposed Tax claims or assessments
against any GCL Company.
(d) There
are no material Liens with respect to any Taxes upon any GCL Company’s assets, other than Permitted Liens. No GCL Company has any
outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding
requests by any GCL Company for any extension of time within which to file any Tax Return or within which to pay any Taxes. No written
claim which remains outstanding has been made by any Governmental Authority with respect to a jurisdiction in which a GCL Company does
not file a Tax Return that such GCL Company is or may be subject to Tax in that jurisdiction that would be the subject of or covered by
such Tax Return.
(e) No
GCL Company has, or has ever had, a permanent establishment, branch or representative office in any country other than the country of
its organization, and no GCL Company is treated for any Tax purpose as a resident in a country other than the country of its incorporation
or formation.
(f) No
GCL Company is or, to the Knowledge of the Company, has ever been a member of any consolidated, combined, unitary or affiliated group
of corporations for any Tax purposes (other than a group the common parent of which is or was the Company). To the Knowledge of the Company,
no GCL Company has any liability for the Taxes of another Person under Treasury Regulation Section 1.1502-6 (or similar provision
of state, local or non-U.S. Law), as a transferee or successor, by contract, or otherwise. No GCL Company is a party to or bound by any
Tax indemnity agreement, Tax sharing agreement, Tax allocation agreement or similar agreement, arrangement or practice with respect to
Taxes (including any closing agreement or other agreement relating to Taxes with any Governmental Authority).
(g) No
GCL Company has requested, or is the subject of or bound by any material private letter ruling, technical advice memorandum, closing agreement,
settlement agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to Taxes, nor is any such
request outstanding.
(h) No
GCL Company has made any change in accounting method (except as required by a change in Law) that would reasonably be expected to have
a material impact on its Taxes following the Closing.
(i) Each
GCL Company is duly registered for Value Added Tax in all jurisdictions in which it is required to be registered and has complied in all
material respects with all requirements concerning Value Added Tax.
(j) No
GCL Company (i) is treated as a domestic corporation (as such term is defined in Section 7701 of the Code) for U.S. federal
income tax purposes, (ii) is or was a “surrogate foreign corporation” within the meaning of Section 7874(a)(2)(B) of
the Code or (iii) is treated as a U.S. corporation under Section 7874(b) of the Code.
(k) No
GCL Company has in any year for which the applicable statute of limitations remains open distributed stock of another person, nor has
had its shares distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Section 355
or Section 361 of the Code.
(l) No
GCL Company is currently a “passive foreign investment company” within the meaning of Section 1297 of the Code.
(m) No
GCL Company has been a party to a transaction that is or is substantially similar to a “listed transaction,” as such term
is defined in Treasury Regulations Section 1.6011-4(b)(2), or any other transaction requiring disclosure under analogous provisions
of state, local or foreign Tax law.
(n) No
GCL Company will be required to include any material item of income in, or exclude any material item of deduction from, taxable income
for any period (or any portion thereof) ending after the Closing Date as a result of any (i) installment sale, excess loss account,
intercompany transaction described in the Treasury Regulations under Section 1502 of the Code (or any similar provision of state,
local or foreign Tax Law) or open transaction disposition made on or prior to the Closing Date, (ii) the use of an improper method
of accounting or change in any method of accounting for any taxable period (or portion thereof) ending on prior to the Closing, (iii) any
“closing agreement” as described in Section 7121 of the Code (or any comparable, analogous or similar provision under
any state, local or foreign Tax law) executed prior to the Closing or (iv) any prepaid amount or deferred revenue received or accrued
on or prior to the Closing. No GCL Company has made an election under Section 965(h) of the Code.
(o) Each
GCL Company has duly retained all records that it is required to retain for Tax purposes, or that would be needed to substantiate any
claim made or position taken in relation to Taxes.
(p) No
GCL Company has taken, or agreed to take, any action not contemplated by this Agreement and/or any Ancillary Agreements that could reasonably
be expected to prevent the Transactions from qualifying for the Intended Tax Treatment. To the knowledge of each GCL Company, there are
no facts or circumstances that could reasonably be expected to prevent the Transactions from qualifying for the Intended Tax Treatment.
No GCL Company is aware of any plan or intention to cause PubCo or SPAC to be liquidated (for U.S. federal income tax purposes) following
the Mergers. To the knowledge of the GCL Companies, no SPAC Stockholder or Company Shareholder has entered into, or has any current plan
or intention to enter into, any Contract to dispose of any PubCo Shares received in the Transactions.
(q) It
is the present intention of the Company to cause SPAC to use its cash to make one or more loans to the Surviving Corporation or its affiliates
or otherwise transfer cash to the Surviving Corporation or its affiliates for use in a trade or business as provided in Section 8.5(a) of
this Agreement. The Company has no plan or intention to cause SPAC or the Surviving Corporation to liquidate (for federal income tax purposes)
following the Transactions.
Section 3.23 Books
and Records. The minute books of each of the GCL Companies contain complete and accurate records
in all material respects of all meetings and other corporate actions of each of the Company Shareholders, the Company Board or the Subsidiaries’
shareholders or board of directors (or similar governing body) and all committees, if any, appointed by the Company Board or the Subsidiaries’
board of directors (or similar governing body), as applicable. The registers of members of each of the GCL Companies is complete and reflects
all issuances, transfers, repurchases and cancellations of shares of capital stock of each of the GCL Companies.
Section 3.24 ANTI-Money
Laundering. The operations of each of the GCL Companies are and have been conducted at all times
in compliance with Anti-Money Laundering Laws, in each case, to the extent applicable to each of the GCL Companies, and, no Action by
or before any Governmental Authority involving any of the GCL Companies with respect to Anti-Money Laundering Laws is pending or, to the
knowledge of the Company, threatened.
Section 3.25 Takeover
Statutes and Charter Provisions. The Company Board has taken all action necessary so that the
restrictions on a “business combination”, contained under any foreign Laws will be inapplicable to this Agreement and the
other Transactions. As of the date of this Agreement, no “fair price”, “moratorium”, “control share acquisition”,
or other antitakeover statute or similar domestic or foreign Law applies with respect to any of the GCL Companies in connection with this
Agreement or the Transactions. As of the date of this Agreement, there is no stockholder rights plan, “poison pill”, or similar
antitakeover agreement or plan in effect to which any of the GCL Companies is subject, party or otherwise bound.
Section 3.26 Registration
Statement. The information supplied by the Company for inclusion or incorporation by reference
in the Registration Statement, any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K shall not,
(i) in the case of the Registration Statement, on the effective date of the Registration Statement, (ii) in the case of the
Proxy/Registration Statement or any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K, when filed,
made available, mailed or distributed, as the case may be, and (iii) in the case of the Registration Statement, at the time of the
SPAC Stockholder Meeting and the Merger Effective Time, contain any untrue statement of a material fact or fail to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. All documents that the Company is responsible for filing with the SEC in connection with the Transactions will
comply as to form and substance in all material respects with the applicable requirements of the Securities Act and the Exchange Act.
Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with respect to any information supplied by or
on behalf of SPAC, its Affiliates or any holder of SPAC Capital Stock.
Section 3.27 Board
Approval. The Company Board (including any required committee or subgroup of such board) (including
each of the board of directors of GCL Global and the board of directors of GCL BVI) has, as of the date of this Agreement, (a) declared
the advisability of the Restructuring and the transactions contemplated by this Agreement, (b) determined that the Restructuring
and the transactions contemplated hereby are advisable and in the best interests of the Company Shareholders, and (c) subject to
the effectiveness of the Registration Statement and receipt of the Regulatory Approvals, recommended that the Company Shareholders approve
and adopt the Restructuring Agreements, this Agreement, the Restructuring, the Mergers and the other Transactions and execute the Company
Written Consent.
Section 3.28 No
Additional Representations or Warranties. Except as otherwise expressly provided in this Article III
(as modified by the Company Disclosure Schedules), the Company expressly disclaims any representations or warranties of any kind or nature,
express or implied, including as to the condition, value or quality of the Company or the Company’s assets, and the Company specifically
disclaims any representation or warranty with respect to merchantability, usage, suitability or fitness for any particular purpose with
respect to the Company’s assets, or as to the workmanship thereof, or the absence of any defects therein, whether latent or patent,
it being understood that such subject assets are being acquired “as is, where is” on the Closing Date, and in their present
condition, and SPAC shall rely on its own examination and investigation thereof. None of the Company’s Affiliates or any of their
respective directors, officers, employees, stockholders, partners, members or representatives has made, or is making, any representation
or warranty whatsoever to SPAC or its Affiliates, and no such party shall be liable in respect of the accuracy or completeness of any
information provided to SPAC or its Affiliates.
Article IV
REPRESENTATIONS AND WARRANTIES OF SPAC
SPAC hereby represents and
warrants to the Company the following, except as set forth in (i) the SPAC SEC Filings (excluding “risk factors” or predictive
or forward-looking statements) or (ii) the Disclosure Schedules delivered to the Company by SPAC on the date of this Agreement (the
“SPAC Disclosure Schedules”), which exceptions shall, in the case of clause (ii), be deemed to be part of the representations
and warranties made hereunder subject to, and in accordance with, Section 11.9 (and any reference in this Agreement or any
Ancillary Agreement to this Article IV or any provision thereof shall be deemed to refer to such Article or provision
as modified by the SPAC Disclosure Schedules in accordance with Section 11.9).
Section 4.1 Organization,
Good Standing, Corporate Power and Qualification. SPAC is a corporation duly organized, validly
existing and in good standing under the Laws of the State of Delaware. SPAC has the requisite corporate power and authority to own and
operate its properties and assets and to carry on its business as presently conducted and contemplated to be conducted, to execute and
deliver this Agreement and the Ancillary Agreements to which it is or will be a party, and to perform its obligations pursuant hereto,
thereto and to its Governing Documents. As of the date of this Agreement, SPAC has either delivered or made available to the Company,
including via the SEC’s Electronic Data Gathering Analysis and Retrieval system database, accurate and complete copies of the certificate
of incorporation and bylaws of SPAC, including all amendments thereto as in effect as of the date of this Agreement.
Section 4.2 Capitalization.
(a) The
authorized capital stock of SPAC consists of (i) 380,000,000 shares of SPAC Class A Common Stock, 7,183,027 of which are issued
and outstanding, (ii) 20,000,000 shares of SPAC Class B Common Stock, none of which is issued or outstanding, and (iii) 1,000,000
shares of SPAC Preferred Stock, none of which are issued or outstanding.
(b) All
shares of SPAC Capital Stock that are issued and outstanding have been duly authorized and validly issued in compliance with applicable
Laws, are fully paid and nonassessable, and have not been issued in violation of any purchase option, call option, right of first refusal,
preemptive right, subscription right or other similar right. The SPAC Capital Stock has the rights, preferences, privileges and restrictions
set forth in the SPAC Charter.
(c) Except
for (i) the SPAC Rights and (ii) SPAC Warrants, there are no outstanding options, warrants or other equity appreciation, phantom
equity, profit participation or similar rights for the purchase or acquisition from SPAC of any shares of SPAC Capital Stock. Except as
set forth on Section 4.2(c) of the SPAC Disclosure Schedules and the Ancillary Agreements, SPAC is not a party to or
subject to any agreement or understanding and, to SPAC’s knowledge, there is no agreement or understanding between any Persons,
that affects or relates to the voting or giving of written consents with respect to any security or by a director of SPAC.
(d) SPAC
does not own or control, directly or indirectly, any interest in any corporation, partnership, limited liability company, association
or other business entity.
(e) The
only shares of capital stock of SPAC that will be outstanding immediately after the Closing will be such share(s) owned by PubCo
following the consummation of the SPAC Merger.
(f) Other
than the SPAC Warrants, there are no options, warrants, preemptive rights, calls, convertible securities, conversion rights or other rights,
agreements, arrangements or commitments of any character relating to the issued or unissued capital stock of SPAC or obligating SPAC to
issue or sell any shares of capital stock of, or other equity interests in, SPAC. SPAC is not a party to, or otherwise bound by, and has
not granted, any equity appreciation rights, participations, phantom equity or similar rights. There are no voting trusts, voting agreements,
proxies, shareholder agreements or other agreements with respect to the voting or transfer of SPAC Common Stock or any of the equity interests
or other securities of SPAC. SPAC does not own any equity interests in any person.
(g) Other
than rights to exercise the SPAC Share Redemption and other rights in respect of disbursements from and liquidation of the trust under
the Trust Agreement, there are no outstanding contractual obligations of SPAC to repurchase, redeem or otherwise acquire any SPAC Common
Stock or to provide funds to or make any investment (in the form of a loan, capital contribution or otherwise) in any person.
Section 4.3 Due
Authorization. All corporate action on the part of SPAC and its respective directors, officers
and stockholders necessary for the (a) authorization, execution and delivery by SPAC of this Agreement and the Ancillary Agreements
to which it is or will be a party, (b) consummation of the Transactions and (c) performance of each of their obligations hereunder
or thereunder has been taken, subject to (i) obtaining the SPAC Stockholders’ Approval, (ii) the filing of the SPAC Merger
Certificate and (iii) the receipt of the Regulatory Approvals. This Agreement and the Ancillary Agreements to which it is or will
be a party assuming due authorization, execution and delivery by each other party constitute valid and binding obligations of SPAC, enforceable
against such Person in accordance with their respective terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other Laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by
Laws relating to the availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity.
Section 4.4 Financial
Statements.
(a) The
financial statements of SPAC contained in the SPAC SEC Filings (the “SPAC Financial Statements”) are true and correct
in all material respects and present fairly the financial condition, operating results, stockholders equity and cash flows of SPAC as
of the dates and during the periods indicated. The SPAC Financial Statements have been prepared in accordance with GAAP and Regulation
S-X, applied on a consistent basis throughout the periods indicated (except, in the case of unaudited interim financial statements, that
they are subject to normal and recurring year-end adjustments and as may be indicated in the notes thereto as permitted by Form 10-Q
of the SEC). The books of account, ledgers, order books, records and other financial documents of SPAC accurately and completely reflect
all material information relating to SPAC’s business, the nature, acquisition, maintenance, location and collection of its assets
and the nature of all transactions giving rise to its obligations and accounts receivable.
(b) SPAC
has in place disclosure controls and procedures that are designed to reasonably ensure that material information relating to SPAC (including
any fraud that involves management or other employees who have a significant role in the internal controls of SPAC) is made known to the
management of SPAC by others within SPAC and are effective in recording, processing, summarizing and reporting financial data. SPAC maintains
a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance
with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any differences.
(c) Since
the formation of SPAC, neither SPAC nor, to the knowledge of SPAC, any Representative of SPAC has received or otherwise had or obtained
knowledge of any written complaint, allegation, assertion or claim, regarding the accounting or auditing practices, procedures, methodologies
or methods of SPAC or Merger Sub with respect to the SPAC Financial Statements or the internal accounting controls of SPAC or Merger Sub,
including any written complaint, allegation, assertion or claim that SPAC or Merger Sub has engaged in questionable accounting or auditing
practices. Since the formation of SPAC, no attorney representing SPAC, whether or not employed by SPAC, has reported evidence of a violation
of securities Laws, breach of fiduciary duty or similar violation by SPAC or any of its Representatives to the SPAC Board or any committee
thereof or to any director or officer of SPAC.
(d) SPAC
has no liability or obligation absolute or contingent, individually or in the aggregate, that would be required to be set forth on a consolidated
balance sheet of SPAC prepared in accordance with GAAP applied and in accordance with past practice, other than (i) obligations and
liabilities that have not had and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect,
(ii) obligations and liabilities under Contracts incurred in the Ordinary Course (other than due to a breach under any such Contracts,
or any act or omission that with the giving of notice, the lapse of time or otherwise, would constitute a breach thereunder), (iii) SPAC
Transaction Expenses, (iv) obligations incurred by SPAC’s execution of this Agreement (other than due to a breach hereunder,
or any act or omission that with the giving of notice, the lapse of time or otherwise, would constitute a breach hereunder), and (v) obligations
and liabilities reflected, or reserved against, in the SPAC Financial Statements or as set forth in Section 4.4(d) of
the SPAC Disclosure Schedules.
Section 4.5 Compliance
with Other Instruments. SPAC is not in violation of any term of its respective Governing Documents.
SPAC is not in violation of any term or provision of any Governmental Order by which it is bound which has had or would reasonably be
expected to have, individually or in the aggregate, a material adverse effect. The execution, delivery and the performance by SPAC of
its obligations pursuant to this Agreement and the Ancillary Agreements to which it is or will be a party will not result in, by the giving
of notice, the lapse of time or otherwise, (a) any violation of, conflict with, or subject to obtaining the SPAC Stockholders’
Approval, the filing of the SPAC Merger Certificate and the receipt of the Regulatory Approvals, require any consent, filing, notice,
waiver or approval or constitute a default under, (i) its Governing Documents, (ii) any Contract to which it is a party or by
which its assets are bound or (iii) any applicable Law, Permit or Governmental Order, nor (b) the creation of any Lien upon
any of its properties or assets (other than Permitted Liens) except, in the case of clauses (a)(ii), (a)(iii) and (b), to the extent
that the occurrence of the foregoing has not had, and would not reasonably be expected to have, individually or in the aggregate, a material
adverse effect.
Section 4.6 Absence
of Changes. (a) Since the date of the most recent SPAC Financial Statements there has not
been, individually or in the aggregate, any material adverse effect. (b) Since the date of the most recent SPAC Financial Statements
to the date of this Agreement, SPAC has conducted its business in all material respects in the Ordinary Course (other than with respect
to the evaluation of and negotiations in connection with this Agreement and the Transactions contemplated hereby).
Section 4.7 Litigation.
(a) There are no Actions pending or, to SPAC’s knowledge, currently threatened against SPAC or its assets or properties before
any Governmental Authority that (i) question the validity of this Agreement or any Ancillary Agreement, or the right of SPAC to enter
into this Agreement or any Ancillary Agreement, or the right of SPAC to perform its obligations contemplated by this Agreement or any
Ancillary Agreement, or (ii) if determined adversely to SPAC, would reasonably be expected to have, individually or in the aggregate,
a material adverse effect; (b) SPAC is not a party or subject to the provisions of any Governmental Order; and (c) there
is no Action initiated by SPAC currently pending or which SPAC currently intends to initiate, except, in the case of each of clauses (a)(i),
(b) and (c), as has not had, and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect.
Section 4.8 Governmental
Consents. Assuming the accuracy of the representations made by the Company in Article III
and Article V, no consent, approval or authorization of or registration, qualification, designation, declaration or filing
with any Governmental Authority on the part of SPAC is required in connection with the valid execution and delivery of this Agreement
or any Ancillary Agreement, or the consummation of any Transaction contemplated hereby or thereby, except (i) for such filings or
notices as may be required under the Securities Act or under applicable state securities Laws, including the filing of the SPAC Merger
Certificate and any other filings or notices required for the consummation of the SPAC Merger, (ii) the Regulatory Approvals and
(iii) where the failure to obtain such consents, approvals or authorizations of or registrations, qualifications, designations, declarations
or filings, individually or in the aggregate, has not had, and would not reasonably be expected to have, a material adverse effect.
Section 4.9 Brokers
or Finders; Transaction Expenses. Except as set forth on the SPAC Disclosure Schedules,
SPAC has not incurred, or will incur, directly or indirectly, as a result of any action taken by SPAC, any liability for brokerage or
finders’ fees or agents’ commissions or any similar charges in connection with this Agreement or any of the other Transactions.
Section 4.10 TaxES
AND RETURNS.
(a) SPAC
has timely filed, or caused to be timely filed, all income and other material Tax Returns required to be filed by it, which Tax Returns
are true, accurate, correct and complete in all material respects. SPAC has timely paid, or caused to be timely paid, all material Taxes
required to be paid by it, other than such Taxes being contested in good faith by appropriate proceedings and for which adequate reserves
have been established in accordance with GAAP.
(b) SPAC
has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of Taxes, and all material amounts
of Taxes required by applicable Tax Laws to be withheld by SPAC have been withheld and timely paid over to the appropriate Governmental
Authority, including with respect to any amounts owing to or from any employee, independent contractor, shareholder, creditor, or other
third party.
(c) There
are no material claims, assessments, audits, examinations, investigations or other Actions pending, in progress or threatened against
SPAC, in respect of any Tax, and SPAC has not been notified in writing of any material proposed Tax claims or assessments against SPAC.
(d) There
are no material Liens with respect to any Taxes upon any of SPAC’s assets, other than Permitted Liens. SPAC has no outstanding waivers
or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests by SPAC
for any extension of time within which to file any Tax Return or within which to pay any Taxes. No written claim which remains outstanding
has been made by any Governmental Authority with respect to a jurisdiction in which SPAC does not file a Tax Return that SPAC is or may
be subject to Tax in that jurisdiction that would be the subject of or covered by such Tax Return.
(e) SPAC
has not had a permanent establishment, branch or representative office in any country other than the country of its organization. SPAC
is not treated for any Tax purpose as a resident in a country other than the country of its incorporation.
(f) SPAC
has not in any year for which the applicable statute of limitations remains open distributed stock of another person, nor has had its
shares distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Section 355
or Section 361 of the Code.
(g) SPAC
has not been a party to a transaction that is or is substantially similar to a “listed transaction,” as such term is defined
in Treasury Regulations Section 1.6011-4(b)(2), or any other transaction requiring disclosure under analogous provisions of state,
local or foreign Tax Law.
(h) SPAC
has duly retained all records that it is required to retain for Tax purposes, or that would be needed to substantiate any claim made or
position taken in relation to Taxes.
(i) SPAC
has not taken, and has not agreed to take, any action not contemplated by this Agreement and/or any Ancillary Agreements that could reasonably
be expected to prevent the Transactions from qualifying for the Intended Tax Treatment. To the knowledge of SPAC, there are no facts or
circumstances that could reasonably be expected to prevent the Transactions from qualifying for the Intended Tax Treatment. SPAC is not
aware of any plan or intention to cause PubCo or SPAC to be liquidated (for U.S. federal income tax purposes) following the Mergers. To
the knowledge of SPAC, no SPAC Stockholder or Company Shareholder has entered into, or has any current plan or intention to enter into,
any Contract to dispose of any PubCo Shares received in the Transactions.
Section 4.11 Registration
Statement. The information supplied by SPAC for inclusion or incorporation by reference in the
Registration Statement, or any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K shall not, (i) in
the case of the Registration Statement, on the effective date of the Registration Statement, (ii) in the case of the Registration
Statement or any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K, when filed, made available,
mailed or distributed, as the case may be, and (iii) in the case of the Registration Statement, at the time of the SPAC Stockholder
Meeting and the Merger Effective Time, contain any untrue statement of a material fact or fail to state any material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. All documents that SPAC is responsible for filing with the SEC in connection with the Transactions will comply as to form
and substance in all material respects with the applicable requirements of the Securities Act and the Exchange Act. Notwithstanding the
foregoing, SPAC makes no representation, warranty or covenant with respect to any information supplied by or on behalf of the Company,
its Affiliates, the Acquisition Entities or any Company Shareholder.
Section 4.12 SEC
Filings. SPAC has timely filed or furnished all statements, prospectuses, registration statements,
forms, reports and documents required to be filed by it with the SEC, pursuant to the Exchange Act or the Securities Act (collectively,
the “SPAC SEC Filings”). Each of the SPAC SEC Filings, as of the respective date of its filing, and as of the date
of any amendment, complied in all material respects with the requirements of the Securities Act, the Exchange Act or the Sarbanes-Oxley
Act applicable to the SPAC SEC Filings. As of the respective date of its filing (or if amended or superseded by a filing prior to the
date of this Agreement or the Closing Date, then on the date of such filing), the SPAC SEC Filings did not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding
or unresolved comments in comment letters received from the SEC with respect to the SPAC SEC Filings. To the knowledge of SPAC, none of
the SPAC SEC Filings filed on or prior to the date of this Agreement is subject to ongoing SEC review or investigation as of the date
of this Agreement.
Section 4.13 Trust
Account. As of the date of this Agreement, SPAC has at least $43,217,845 in the Trust Account,
such monies invested in United States government securities or money market funds meeting certain conditions under Rule 2a-7 promulgated
under the Investment Company Act pursuant to the Investment Management Trust Agreement, dated as of March 23, 2022, between SPAC
and Continental, as trustee (the “Trustee”, and such Investment Management Trust Agreement, the “Trust Agreement”).
There are no separate Contracts or side letters that would cause the description of the Trust Agreement in the SPAC SEC Filings to be
inaccurate in any material respect or that would entitle any Person (other than (i) SPAC Stockholders holding SPAC Common Stock (prior
to the Effective Time) sold in SPAC’s initial public offering who shall have elected to redeem their shares of SPAC Common Stock
(prior to the Effective Time) pursuant to the SPAC Governing Documents, (ii) EarlyBirdCapital, Inc. with respect to the fees
payable pursuant to the business combination marketing agreement described in the SPAC SEC Filings, and (iii) as contemplated by
the following sentence) to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust
Account may be released other than to pay Taxes and payments with respect to all SPAC Share Redemptions. There are no Actions pending
or, to the knowledge of SPAC, threatened with respect to the Trust Account. SPAC has performed all material obligations required to be
performed by it to date under, and is not in default, breach or delinquent in performance or any other respect (claimed or actual) in
connection with, the Trust Agreement, and no event has occurred which, with due notice or lapse of time or both, would constitute such
a default or breach thereunder. As of the Closing, the obligations of SPAC to dissolve or liquidate pursuant to the SPAC Governing Documents
shall terminate, and as of the Closing, SPAC shall have no obligation whatsoever pursuant to the SPAC Governing Documents to dissolve
and liquidate the assets of SPAC by reason of the consummation of the Transactions. To SPAC’s knowledge, following the Closing,
no SPAC Stockholder shall be entitled to receive any amount from the Trust Account except to the extent such SPAC Stockholder is exercising
a SPAC Share Redemption (or a redemption right in connection with an amendment of SPAC’s Governing Documents to extend SPAC’s
deadline to consummate the Business Combination) or in connection with the payment of SPAC Transaction Expenses, and excluding claims
that a SPAC Stockholder may make against SPAC against assets, properties or funds that are not held in the Trust Account or have been
distributed therefrom (other than to other Public Stockholders exercising redemption rights).
Section 4.14 Investment
Company Act; JOBS Act. SPAC is not an “investment company” or a Person directly
or indirectly “controlled” by or acting on behalf of an “investment company”, in each case within the meaning
of the Investment Company Act. SPAC constitutes an “emerging growth company” within the meaning of the JOBS Act.
Section 4.15 Business
Activities.
(a) Since
its incorporation, SPAC has not conducted any business activities other than activities related to SPAC’s initial public offering
or directed toward the accomplishment of a Business Combination. Except as set forth in the SPAC Governing Documents or as otherwise contemplated
by this Agreement or the Ancillary Agreements and the Transactions, there is no Contract to which SPAC is a party which has or would reasonably
be expected to have the effect of prohibiting or impairing in any material respect any business practice of SPAC or any acquisition of
property by SPAC or the conduct of business by SPAC as currently conducted or as contemplated to be conducted as of the Closing.
(b) SPAC
does not own or have a right to acquire, directly or indirectly, any interest or investment (whether equity or debt) in any corporation,
partnership, joint venture, business, trust or other entity.
(c) Other
than any former officers or as described in the SPAC SEC Filings, SPAC has never had any employees. Other than reimbursement of any out-of-pocket
expenses incurred by SPAC’s officers and directors in connection with activities on SPAC’s behalf, SPAC has no unsatisfied
liability with respect to any employee. SPAC does not currently maintain or have any liability under any employment or employee benefit
plan, program or arrangement, and neither the execution and delivery of this Agreement or any of the Ancillary Agreements nor the consummation
of the Transactions will (i) result in any payment (including severance, unemployment compensation, golden parachute, bonus or otherwise)
becoming due to any director, officer or employee of SPAC, or (ii) result in the acceleration of the time of payment or vesting of
any such benefits. The Transactions shall not be the direct or indirect cause of any amount paid or payable by SPAC being classified as
an “excess parachute payment” under Section 280G of the Code.
Section 4.16 Nasdaq
Quotation. SPAC Class A Common Stock, SPAC Warrants, SPAC Units, and SPAC Rights are each
registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on the Nasdaq under the symbols “RFAC”,
“RFACW”, “RFACU” and “RFACR”, respectively. SPAC is in compliance with the rules of the Nasdaq
and there is no Action pending or, to the knowledge of SPAC, threatened against SPAC by Nasdaq or the SEC with respect to any intention
by such entity to deregister the SPAC Class A Common Stock or the SPAC Warrants or terminate the listing of SPAC Class A Common
Stock, SPAC Warrants, SPAC Units, or SPAC Rights on Nasdaq. SPAC has not taken any action in an attempt to terminate the registration
of SPAC Class A Common Stock, SPAC Warrants or SPAC Units under the Exchange Act except as contemplated by this Agreement.
Section 4.17 Board
Approval. This Agreement and the Transactions have been duly authorized, executed and delivered
by the requisite vote of the SPAC Board (including any required committee or subgroup of such board) and the SPAC Board has (a) declared
the advisability of the transactions contemplated by this Agreement, (b) determined that the transactions contemplated hereby are
in the best interests of the SPAC Stockholders, (c) determined that the transactions contemplated hereby constitutes a Business Combination
and (d) subject to the receipt of the Regulatory Approvals, recommended that the SPAC Stockholders approve the Transaction Proposal.
Article V
REPRESENTATIONS AND WARRANTIES OF PUBCO AND THE ACQUISITION ENTITIES
As of the execution of the
Joinders, PubCo, Merger Sub 1 and Merger Sub 2 jointly and severally represent and warrant to SPAC, the following:
Section 5.1 Organization,
Good Standing, Corporate Power and Qualification. Each Acquisition Entity is a company duly incorporated,
validly existing and in good standing under the Laws of the Cayman Islands or the DGCL, as applicable. Each Acquisition Entity has the
requisite corporate power and authority to own and operate its properties and assets and to carry on its business as presently conducted
and contemplated to be conducted, to execute and deliver this Agreement and the Ancillary Agreements to which it is or will be a party,
and to perform its obligations pursuant hereto, thereto and to its Governing Documents. The PubCo Governing Documents are in full force
and effect.
Section 5.2 Capitalization
and Voting Rights.
(a) Capitalization.
The authorized shares of PubCo consist of US$50,000 divided into 500,000,000 Shares of a par value of US$0.0001 each, of which one PubCo
Share is issued and outstanding. The authorized shares of Merger Sub 1 consist of US$50,000 divided into 500,000,000 Shares of a par value
of US$0.0001 par value each, of which one ordinary share (the “Merger Sub 1 Share”) is issued and outstanding. The
authorized share capital of Merger Sub 2 consists of one share (the “Merger Sub 2 Share”) which is issued and outstanding.
The PubCo Share, the Merger Sub 1 Share and the Merger Sub 2 Share, and any PubCo Shares and shares of Merger Sub 1 and Merger Sub 2 that
will be issued pursuant to the Transactions, (i) have been, or will be prior to such issuance, duly authorized and have been, or
will be at the time of issuance, validly issued and are fully paid, (ii) were, or will be, issued, in compliance in all material
respects with applicable Law, and (iii) were not, and will not be, issued in breach or violation of any preemptive rights or Contract.
(b) Except
as set forth in Section 5.2(a), including any PubCo Shares and shares of Merger Sub 1 and Merger Sub 2 that will be issued
pursuant to the Transactions, there are no outstanding options, warrants or other equity appreciation, phantom equity, profit participation
or similar rights for the purchase or acquisition from any Acquisition Entity of any shares of capital stock of any Acquisition Entity
to which any Acquisition Entity is a party.
(c) PubCo
does not own or control, directly or indirectly, any interest in any corporation, partnership, limited liability company, association
or other business entity, other than, as of the date of this Agreement, Merger Sub 1 and Merger Sub 2 and, as of the Closing Date, SPAC
and the Surviving Corporation. Neither Merger Sub 1 nor Merger Sub 2 owns or controls, directly or indirectly, any interest in any corporation,
partnership, limited liability company, association or other business entity.
Section 5.3 Due
Authorization. All corporate actions on the part of each Acquisition Entity necessary for the
authorization, execution and delivery of this Agreement and the other Transaction Documents to which it is or will be a party and the
performance of all its obligations thereunder (including any board or shareholder approval, as applicable) have been taken (or, in the
case of Merger Sub 1 and Merger Sub 2, will be taken prior to the date of the Closing), subject to the filing of the Initial Merger Filing
Documents and the SPAC Merger Certificate. This Agreement and the other Transaction Document to which an Acquisition Entity is or will
be a party is, or when executed by the other parties thereto, will be, valid and legally binding obligations of such Acquisition Entity
enforceable against it in accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, and other applicable laws now or hereafter in effect of general application affecting enforcement of creditors’ rights
generally, and (b) as limited by applicable laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies.
Section 5.4 Compliance
with Other Instruments. No Acquisition Entity is in violation of any term of its respective Governing
Documents. No Acquisition Entity is in violation of any term or provision of any Governmental Order by which it is bound which has had
or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the ability of any Acquisition
Entity to enter into this Agreement and the Ancillary Agreements and to consummate the Transactions. The execution and delivery by each
Acquisition Entity and the performance by each of Acquisition Entity of its obligations pursuant to this Agreement and the Ancillary Agreements
to which it is or will be a party will not result in, by the giving of notice, the lapse of time or otherwise, (a) any violation
of, conflict with, require any consent, filing, notice, waiver or approval or constitute a default under, (i) its Governing Documents,
(ii) any Contract to which it is a party or by which its assets are bound or (iii) any applicable Law, Permit or Governmental
Order, nor (b) the creation of any Lien upon any of its properties or assets except, in the case of clauses (a)(ii), (a)(iii) and
(b), to the extent that the occurrence of the foregoing has not had, and would not reasonably be expected to have, individually or in
the aggregate, a material adverse effect on the ability of any Acquisition Entity to enter into this Agreement and the Ancillary Agreements
and to consummate the Transactions.
Section 5.5 Absence
of Changes. Since the date of its incorporation (a) there has not been, individually or
in the aggregate, a material adverse effect on the ability of any Acquisition Entity to enter into this Agreement and the Ancillary Agreements
and to consummate the Transactions, (b) each Acquisition Entity has not conducted any business (other than with respect to the evaluation
of and negotiations in connection with this Agreement and the Transactions contemplated hereby).
Section 5.6 Actions.
(a) There are no Actions pending or, to the Company’s knowledge, threatened in writing against any Acquisition Entity;
and (b) there is no judgment or award unsatisfied against any Acquisition Entity, nor is there any Governmental Order in effect and
binding on any Acquisition Entity or its assets or properties that has, individually or in the aggregate, a material adverse effect on
the ability of any Acquisition Entity to enter into this Agreement or the Ancillary Agreements or to consummate the Transactions.
Section 5.7 Brokers
or Finders; Transaction Expenses. No broker, finder or investment banker is entitled to
any brokerage, finder’s or other fee or commission or expense reimbursement in connection with the Transactions contemplated based
upon arrangements made by and on behalf of any Acquisition Entity.
Section 5.8 Registration
Statement. The information supplied by each Acquisition Entity for inclusion or incorporation
by reference in the Registration Statement or any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K
shall not, (i) in the case of the Registration Statement, on the effective date of the Registration Statement, (ii) in the case
of the Registration Statement or any current report of SPAC on Form 8-K or any current report of PubCo on Form 8-K, when filed,
made available, mailed or distributed, as the case may be, and (iii) in the case of the Registration Statement, at the time of the
SPAC Stockholder Meeting and the Merger Effective Time, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. All documents that an Acquisition Entity is responsible for filing with the SEC in connection with the Transactions
will comply as to form and substance in all material respects with the applicable requirements of the Securities Act and the Exchange
Act.
Section 5.9 Investment
Company Act; JOBS Act. No Acquisition Entity is an “investment company” or a
Person directly or indirectly “controlled” by or acting on behalf of an “investment company”, in each case within
the meaning of the Investment Company Act. No Acquisition Entity constitutes an “emerging growth company” within the meaning
of the JOBS Act.
Section 5.10 Business
Activities. Each Acquisition Entity was formed solely for the purpose of effecting the Transactions
and has not engaged in any business activities or conducted any operations other than in connection with the Transactions and has no,
and at all times prior to the Closing except as expressly contemplated by Agreement or the Ancillary Agreements and the Transactions,
will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation.
Section 5.11 PubCo
Incentive Equity Plan. Prior to the Closing Date, and subject to the approval of PubCo’s
shareholders (if required), the board of directors of PubCo shall approve and adopt an equity incentive plan in a form consistent with
the form of equity plan customary for publicly traded companies, with an initial award pool of PubCo Shares equal to no more than 15%
of PubCo’s ordinary shares issued and outstanding immediately after the SPAC Merger Effective Time (rounded up to the nearest whole
share) with a 3% evergreen provision and with other terms to be mutually agreed between the Company and SPAC (the “PubCo Incentive
Equity Plan”).
Section 5.12 TaxES.
None of the Acquisition Entities has taken, or agreed to take, any action not contemplated by this Agreement and/or any Ancillary Agreements
that could reasonably be expected to prevent the Transactions from qualifying for the Intended Tax Treatment. PubCo has no current plan
or intention to liquidate SPAC or the Surviving Corporation (or to cause SPAC or the Surviving Corporation to liquidate for federal income
tax purposes) following the Transactions.
Section 5.13 Foreign
Private Issuer. PubCo is and shall be at all times commencing from the date 30 days prior to
the first filing of the Registration Statement with the SEC through the Closing, a foreign private issuer as defined in Rule 405
under the Securities Act.
Article VI
COVENANTS OF THE COMPANY AND THE ACQUISITION ENTITIES
Section 6.1 Company
Conduct of Business. Except (i) as expressly contemplated by this Agreement or the Ancillary
Agreements, (ii) as required by applicable Law; (iii) as set forth on Section 6.1 of the Company Disclosure
Schedules, or (iv) as consented to by SPAC in writing (which consent shall not be unreasonably conditioned, withheld, or delayed),
from the date of this Agreement through the earlier of the Closing or valid termination of this Agreement pursuant to Article X
(the “Interim Period”), Company shall, and shall cause the other GCL Companies to, and each Acquisition Entity shall,
(y) operate its business in the Ordinary Course and preserve intact the current business organization and ongoing businesses of the
GCL Companies, and maintain the existing relations and goodwill of the GCL Companies with customers, suppliers, joint venture partners,
distributors and creditors of the GCL Companies, and (z) use commercially reasonable efforts to maintain all insurance policies of
the GCL Companies or substitutes therefor. Without limiting the generality of the foregoing, except (A) as expressly contemplated
by this Agreement or the Ancillary Agreements, (B) as required by applicable Law, (C) as set forth on Section 6.1
of the Company Disclosure Schedules, or (D) as consented to by SPAC in writing, the Company shall not, and shall cause the other
GCL Companies not to, and each Acquisition Entity shall not:
(a) change
or amend the Governing Documents of any GCL Company or any Acquisition Entity;
(b) make
or declare any dividend or distribution to its stockholders or members, as applicable, of any GCL Company or any Acquisition Entity or
make any other distributions in respect of any of the GCL Companies’ or any Acquisition Entity’s shares, capital stock or
equity interests, except dividends and distributions by a wholly-owned Subsidiary of a GCL Company to such GCL Company or another wholly-owned
Subsidiary of such GCL Company;
(c) split,
combine, reclassify, recapitalize or otherwise amend any terms of any shares or series of the GCL Companies’ or any Acquisition
Entity’s shares, capital stock or equity interests, except for any such transaction by a wholly-owned Subsidiary of a GCL Company
that remains a wholly- owned Subsidiary of such GCL Company after consummation of such transaction;
(d) purchase,
repurchase, redeem or otherwise acquire any issued and outstanding share capital, outstanding shares, membership interests or other equity
interests of any GCL Company or any Acquisition Entity, except for transactions between an GCL Company and any wholly-owned Subsidiary
of such GCL Company;
(e) enter
into, or amend or modify any material term of (in a manner adverse to any GCL Company), terminate (excluding any expiration in accordance
with its terms), or waive or release any material rights, claims or benefits under, any Material Contract (or any Contract, that if existing
on the date hereof, would have been a Material Contract), any Real Property Lease or any collective bargaining or similar agreement (including
agreements with works councils and trade unions and side letters) to which any GCL Company is a party or by which it is bound, other than
entry into, amendments of, modifications of, terminations of, or waivers or releases under, such agreements in the Ordinary Course;
(f) sell,
assign, transfer, convey, lease or otherwise dispose of any material assets or properties of the GCL Companies or any Acquisition Entity,
except for (i) dispositions of equipment in the Ordinary Course, (ii) sales of inventory in the Ordinary Course, (iii) transactions
solely among the GCL Companies, or (iv) as set forth in Section 6.1 of the Company Disclosure Schedules;
(g) acquire
any ownership interest in any real property;
(h) acquire
by merger or consolidation with, or merge or consolidate with, or purchase substantially all or a material portion of the equity or assets
of, any corporation, partnership, association, joint venture or other business organization or division thereof;
(i) (A) make,
change or revoke any material election in respect of Taxes, except to comply with GAAP or applicable Law, or settle or compromise any
material United States federal, state, local or non-United States Tax liability, except in the Ordinary Course, (B) settle any material
Action in respect of Taxes, (C) make any material change in its accounting or Tax policies or procedures, (D) waive or extend
any statute of limitations in respect of a period within which an assessment or reassessment of material Taxes may be issued (other than
any extension pursuant to an extension to file any Tax Return obtained in the Ordinary Course), (E) enter into a Tax sharing agreement,
Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement, (F) surrender or compromise any right
to receive a refund of or credit for material Taxes, (G) file any amended material Tax Return, (H) file any Tax Return which
is inconsistent with past practices, or (I) enter into or terminate any “closing agreement” as described in Section 7121
of the Code (or any similar settlement or other agreement under similar Law), or any other material agreement pertaining to Taxes, with
any Governmental Authority;
(j) (A) issue
any additional interests of any Acquisition Entity or GCL Company Interests or securities exercisable for or convertible into GCL Company
Interests or interests of any Acquisition Entity, or (B) grant any options, warrants, convertible equity instruments or other equity-based
awards that relate to the equity of any GCL Company;
(k) adopt
a plan of, or otherwise enter into or effect a, complete or partial liquidation, dissolution, restructuring, recapitalization or other
reorganization of any GCL Company or any Acquisition Entity, merge or consolidate with any Person or be acquired by any Person, or file
for bankruptcy in respect of any GCL Company or any Acquisition Entity;
(l) except
as required pursuant to Company Benefit Plans in effect on the date of this Agreement, applicable Law, or policies or Contracts of the
Company or its Affiliates in effect on the date of this Agreement, (i) grant any material increase in compensation, benefits or severance
to any employee or director of or individual consultant or independent contractor to the Company other than increases in the Ordinary
Course for any such individual with annual base compensation of less than $250,000, (ii) adopt, enter into or materially amend any
material Company Benefit Plan or any collective bargaining or similar agreement (including agreements with works councils and trade unions
and side letters) to which any GCL Company is a party or by which it is bound, (iii) grant any new material severance, termination
payments, bonus, change of control, retention, or benefits to any employee of any GCL Company, except in connection with the promotion
or hiring (to the extent permitted by clause (iv) of this paragraph) or separation of any employee in the Ordinary Course, (iv) hire
any employee of any GCL Company or any other individual who is providing or will provide services to the Company other than any employee
with an annual base salary of less than $250,000 (except to replace terminated employees) in the Ordinary Course, (v) adopt, enter
into or materially amend any Consultant Contract other than in the Ordinary Course with respect to Consulting Contracts providing for
annual base compensation of more than $250,000, or (vi) take any action to accelerate the vesting, payment or funding of any cash
compensation, payment or benefit to any employee of any GCL Company;
(m) waive,
release, settle, compromise or otherwise resolve any Action, except in the Ordinary Course or where such waivers, releases, settlements
or compromises involve only the payment of monetary damages in an amount less than $500,000 in the aggregate;
(n) incur,
assume or guarantee any Indebtedness for borrowed money, the principal amount of which does not exceed $1,000,000 in the aggregate provided
that, there shall be no dollar limit on new Indebtedness that, by its terms, will convert into equity securities as part of the Private
Placement prior to the Initial Merger Effective Time nor shall any such Indebtedness count for purposes of this $1,000,000 limit; provided
further, that any such convertible debt shall constitute Transaction Financing and be applied towards Minimum Cash;
(o) enter
into, renew or amend in any material respect, (i) any transaction or Contract with a Company Shareholder or any of their respective
family members or other related Persons that would require disclosure of transactions therewith under Item 404 of Regulation S-K promulgated
by the SEC, or (ii) any Contract between any GCL Company or any Acquisition Entity and any broker, finder, investment banker or financial
advisor with respect to any of the Transactions;
(p) (i) limit
the right of any GCL Company to engage in any line of business or in any geographic area, to develop, market or sell products or services,
or to compete with any Person or (ii) except in the ordinary course of the business of owning, operating, building and launching
satellites and selling of imagery therefrom, grant any exclusive rights to any Person;
(q) (i) fail
to maintain its existence or acquire by merger or consolidation with, or merge or consolidate with, or purchase a material portion of
the assets or equity of, any corporation, partnership, limited liability company, association, joint venture or other business organization
or division thereof; or (ii) adopt or enter into a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization of the Company (other than the transactions contemplated by this Agreement);
(r) enter
into any material new line of business outside of the business currently conducted by the Company as of the date of this Agreement;
(s) disclose
any source code for any Owned Company Software or any other Proprietary Information to any Person (other than pursuant to a written agreement
sufficient to protect the confidentiality thereof); or
(t) enter
into any agreement or otherwise make a binding commitment to do any action prohibited under this Section 6.1.
During the Interim Period, the Company shall,
and shall cause its Subsidiaries to, and each Acquisition Entity shall, comply (1) in all material respects with, and continue performing
under, as applicable, the Company Governing Documents, such Subsidiary’s Governing Documents, and the Governing Documents of each
Acquisition Entity, and all other Material Contracts to which any of the GCL Companies may be a party, and (2) with all applicable
Sanctions and Export Law. If, during the Interim Period, the Company or any Acquisition Entity (A) receives written notice of, any
actual, alleged or potential violation of any Sanctions or Export Law, (B) becomes a party to or the subject of any pending (or to
the knowledge of the Company, threatened) Action by or before any Governmental Authority (including receipt of any subpoena) related to
any actual, alleged or potential violation of any Sanctions or Export Law, or (C) to the knowledge of the Company, otherwise becomes
aware of any actual, alleged, or potential violation of any Sanctions or Export Law, it shall provide written notice to SPAC within one
(1) Business Day of the discovery of the actual, alleged, or potential violation.
Section 6.2 Post-Closing
Directors and Officers of PubCo. Subject to the terms of the PubCo Governing Documents, PubCo
shall take all such action within its power as may be necessary or appropriate such that immediately following the Closing:
(a) the
PubCo Board shall be divided into three class of directors with staggered terms, as set forth in the PubCo Governing Documents, and shall
consist of seven directors, four of whom shall be nominated by the Company, one of whom shall be “Class III Directors”
(as set forth in the PubCo Governing Documents) nominated by the Sponsor (the “Sponsor Nominated Director”) and one
of whom shall be PubCo’s Chief Executive Officer, each such director to hold office in accordance with the PubCo Governing Documents.
At the Effective Time, the PubCo Board shall have at least four independent directors, one of whom shall be a Sponsor Nominated Director;
and
(b) the
officers of the Company holding such positions as set forth on Section 6.2(b) of the Company Disclosure Schedules shall
be appointed as the officers of PubCo, each such officer to hold office in accordance with the PubCo Governing Documents.
Section 6.3 D&O
Indemnification and Insurance.
(a) From
and after the Closing, PubCo and the Surviving Corporation shall jointly and severally indemnify and hold harmless each present and former
director and officer of the GCL Companies, SPAC and any Acquisition Entity (in each case, solely to the extent acting in their capacity
as such and to the extent such activities are related to the business of the GCL Companies, SPAC or such Acquisition Entity, respectively
(the “D&O Indemnified Parties”)) against any costs or expenses (including reasonable attorneys’ fees), judgments,
fines, losses, claims, damages or liabilities incurred in connection with any Action, whether civil, criminal, administrative or investigative,
arising out of or pertaining to matters existing or occurring at or prior to the Closing, whether asserted or claimed prior to, at or
after the Closing, to the fullest extent that the GCL Companies, SPAC or such Acquisition Entity, respectively, would have been permitted
under applicable Law and its respective certificate of incorporation, certificate of formation, bylaws, limited liability company agreement,
limited liability partnership agreement, limited liability limited partnership agreement or other Governing Documents in effect on the
date of this Agreement to indemnify such D&O Indemnified Parties (including the advancing of expenses as incurred to the fullest extent
permitted under applicable Law which shall be conditioned on an undertaking to repay any such expenses if it is ultimately determined
that such D&O Indemnified Party was not entitled thereto). Without limiting the foregoing, PubCo and the Surviving Corporation shall,
and shall cause the other GCL Companies to, (i) maintain for a period of not less than six years from the Closing provisions in its
certificate of incorporation, certificate of formation, bylaws, limited liability company agreement, limited liability partnership agreement,
limited liability limited partnership agreement or other Governing Documents concerning the indemnification and exoneration (including
provisions relating to expense advancement) of the GCL Companies’ and each Acquisition Entity’s or SPAC’s, respectively,
former and current officers, directors, employees, and agents that are no less favorable to those Persons than the provisions of the certificate
of incorporation, certificate of formation, bylaws, limited liability company agreement, operating agreement, limited liability partnership
agreement, limited liability limited partnership agreement and other Governing Documents of the applicable GCL Companies, such Acquisition
Entity or SPAC, respectively, in each case, as of the date of this Agreement; provided that all Governing Documents entered into
or adopted as of the Initial Merger Effective Time or otherwise in connection with the Transactions and a copy of which has been provided
to SPAC shall be deemed to satisfy such requirements, and (ii) not amend, repeal or otherwise modify such provisions in any respect
that would adversely affect the rights of those Persons thereunder, in each case, except as required by Law.
(b) For
a period of six years from the Closing, each of PubCo, the Surviving Corporation and SPAC shall (and the Surviving Corporation shall cause
the other GCL Companies to) maintain in effect one or more directors’ and officers’ liability insurance policies covering
those Persons who are currently covered by the GCL Companies’ (true, correct and complete copies of which have been made available
to SPAC and Company prior to the date of this Agreement or its Representatives, respectively), any Acquisition Entity’s or SPAC’s,
respectively, directors’ and officers’ liability insurance policies (including, in any event, the D&O Indemnified Parties)
on terms not less favorable than the terms of such current insurance coverage, except that in no event shall PubCo, the GCL Companies,
any Acquisition Entity or SPAC be required to pay an annual premium for such insurance in excess of 200% of the aggregate annual premium
payable by the GCL Companies, such Acquisition Entity or SPAC, respectively, for such insurance policy for the year ended March 31,
2022; provided, however, that (i) notwithstanding anything to the contrary contained in this Agreement, each of
PubCo, the Surviving Corporation and SPAC may cause coverage to be extended under the current directors’ and officers’ liability
insurance by obtaining a six-year “tail” policy with respect to claims existing or occurring at or prior to the Closing and
if and to the extent such policies have been obtained prior to the Closing with respect to any such Persons, the GCL Companies, PubCo
and SPAC, respectively, shall maintain such policies in effect and continue to honor the obligations thereunder, and (ii) if any
claim is asserted or made within such six-year period, any insurance required to be maintained under this Section 6.3 shall
be continued in respect of such claim until the final disposition thereof.
(c) Notwithstanding
anything contained in this Agreement to the contrary, this Section 6.3 shall survive the Closing indefinitely and shall be
binding, jointly and severally, on PubCo, the Surviving Corporation, the other GCL Companies, SPAC and all of their respective successors
and assigns (and their respective successive successors and assigns). In the event that PubCo, the Surviving Corporation, any of the other
GCL Companies, SPAC or any of their respective successors or assigns (or their respective successive successors and assigns) consolidates
with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger
or transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, PubCo, Surviving
Corporation or SPAC, respectively, shall ensure (and PubCo, the Surviving Corporation and SPAC shall cause its Subsidiaries to ensure)
that proper provision shall be made so that the successors and assigns (and their respective successive successors and assigns) of PubCo,
the Surviving Corporation, any of the other GCL Companies or SPAC, as the case may be, shall succeed to the obligations set forth in this
Section 6.3.
(d) The
provisions of Section 6.3(a) through (c): (i) are intended to be for the benefit of, and shall be enforceable by,
each Person who is now, or who has been at any time prior to the date of this Agreement or who becomes prior to the Closing, a D&O
Indemnified Party, his or her heirs and his or her personal representatives, (ii) shall be binding on PubCo, the Surviving Corporation,
SPAC and their respective successors and assigns, (iii) are in addition to, and not in substitution for, any other rights to indemnification
or contribution that any such Person may have, whether pursuant to Law, Contract, Governing Documents, or otherwise and (iv) shall
survive the consummation of the Closing and shall not be terminated or modified in such a manner as to adversely affect any D&O Indemnified
Party without the consent of such D&O Indemnified Party.
Section 6.4 No
Trading in SPAC Stock. The Company acknowledges and agrees that it and each other GCL Company
is aware of the restrictions imposed by U.S. federal securities Laws and the rules and regulations of the SEC and Nasdaq promulgated
thereunder or otherwise and other applicable Laws on a Person possessing material nonpublic information about a publicly traded company.
The Company hereby agrees that, while it is in possession of such material nonpublic information, it shall not purchase or sell any securities
of SPAC (except with the prior written consent of SPAC), take any other action with respect to SPAC in violation of such Laws, or cause
or encourage any third party to do any of the foregoing.
Section 6.5 PCAOB
AUDITED FINANCIALS. The Company shall use commercially reasonable efforts to deliver true and
complete copies of the Audited Company Financials not later than December 11, 2023.
Section 6.6 INCENTIVE
SHARES. PubCo shall reserve 2,000,000 PubCo Shares (such shares, the “Incentive Shares”) to be issued at the Closing,
as an incentive in connection with non-redemption or similar agreements or sources of Transaction Financing, to be allocated as determined
by Sponsor, in its sole discretion,. The Company and PubCo also agree that none of the Incentive Shares shall be subject to any lock-up
period. For the avoidance of doubt, Sponsor may direct PubCo to issue all of the Incentive Shares directly to Sponsor at Closing.
Article VII
COVENANTS OF SPAC
Section 7.1 Trust
Account Payments. Upon satisfaction or waiver of the conditions set forth in Article IX
and provision of notice thereof to the Trustee (which notice SPAC shall provide to the Trustee in accordance with the terms of the Trust
Agreement), (i) in accordance with and pursuant to the Trust Agreement, at the Closing, SPAC (a) shall cause any documents,
opinions and notices required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered and (b) shall direct
the Trustee to (1) first, pay as and when due all amounts payable to SPAC Stockholders pursuant to the SPAC Share Redemptions, (2) second,
pay all SPAC Transaction Expenses and Company Transaction Expenses, and (3) immediately thereafter, disburse all remaining amounts
then available in the Trust Account to PubCo, subject to this Agreement and the Trust Agreement and (ii) thereafter, the Trust Account
shall terminate, except as otherwise provided therein.
Section 7.2 SPAC
Nasdaq Listing. From the date of this Agreement until the Closing, SPAC shall use reasonable
best efforts to ensure that the SPAC Class A Common Stock, SPAC Warrants, SPAC Rights and SPAC Units remain listed on Nasdaq.
Section 7.3 SPAC
Conduct of Business.
(a) Except
(i) as expressly contemplated by this Agreement or the Ancillary Agreements, (ii) as required by applicable Law, (iii) as
set forth on Section 7.3(a) of the SPAC Disclosure Schedules, or (iv) as consented to by the Company in writing
(which consent shall not be unreasonably withheld, conditioned or delayed), during the Interim Period, SPAC shall operate its business
in the Ordinary Course and shall not:
(i) (A) change,
modify or amend the Trust Agreement or the SPAC Governing Documents, or seek any approval from the SPAC Stockholders to take any such
action, except as contemplated by the Transaction Proposals or (B) change, modify or amend its Organizational Documents;
(ii) change,
modify or amend the SPAC Warrant Agreement, including by reducing the Warrant Price (as defined in the SPAC Warrant Agreement);
(iii) (x) make
or declare any dividend or distribution to the SPAC Stockholders or make any other distributions in respect its capital stock, share capital
or equity interests, (y) split, combine, reclassify or otherwise amend any terms of any shares or series of its capital stock or
equity interests or (z) purchase, repurchase, redeem or otherwise acquire any issued and outstanding share capital, outstanding shares
of capital stock, share capital or membership interests, warrants or other equity interests, other than a redemption of SPAC Class A
Common Stock (prior to the SPAC Merger Effective Time) made as part of the SPAC Share Redemptions;
(iv) merge,
consolidate or amalgamate with or into, or acquire (by purchasing a substantial portion of the assets of or equity in, or by any other
manner) any other Person or be acquired by any other Person;
(v) (A) make,
change or revoke any material election in respect of Taxes, except to comply with GAAP or applicable Law, or settle or compromise any
material United States federal, state, local or non-United States Tax liability, except in the Ordinary Course, (B) settle any material
Action in respect of Taxes, (C) make any material change in its accounting or Tax policies or procedures, (D) waive or extend
any statute of limitations in respect of a period within which an assessment or reassessment of material Taxes may be issued (other than
any extension pursuant to an extension to file any Tax Return obtained in the Ordinary Course), (E) enter into a Tax sharing agreement,
Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement, (F) surrender or compromise any right
to receive a refund of or credit for material Taxes, (G) file any amended material Tax Return, (H) file any Tax Return which
is inconsistent with past practices, or (I) enter into or terminate any “closing agreement” as described in Section 7121
of the Code (or any similar settlement or other agreement under similar Law), or any other material agreement pertaining to Taxes, with
any Governmental Authority;
(vi) enter
into, renew or amend in any material respect, any transaction or Contract (A) with an Affiliate of SPAC, other than any transaction
or Contract pursuant to which Sponsor or any of its Affiliates provides debt financing to SPAC, or (B) with any SPAC Stockholder
except as permitted or contemplated by this Agreement;
(vii) incur
or assume any Indebtedness or guarantee any Indebtedness of another Person, issue or sell or guaranty any debt securities or warrants
or other rights to acquire any debt securities or guaranty any debt securities of another Person, other than any (a) Indebtedness
for borrowed money or guarantee expressly contemplated by this Agreement or (b) debt financing provided by Sponsor or any of its
Affiliates to SPAC;
(viii) (A) make
any material change in its accounting principles, policies, procedures or methods unless required by an amendment in GAAP made subsequent
to the date hereof, as agreed to by its independent accountants, or (B) engage in any conduct in a new line of business or engage
in any material commercial activities (other than to consummate the transactions contemplated by this Agreement);
(ix) (A) issue,
sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance of, any SPAC Capital
Stock or securities exercisable for or convertible into SPAC Capital Stock, or (B) grant any options, warrants or other equity-based
awards with respect to SPAC Capital Stock not outstanding on the date of this Agreement and disclosed in documents filed publicly with
the SEC;
(x) waive,
release, compromise, settle or agree to waive, release, compromise, or settle any Action except where such waivers, releases, settlements
or compromises involve only the payment of monetary damages in an amount less than $250,000 in the aggregate;
(xi) (A) hire,
or otherwise enter into any employment, consulting or similar agreement with, any person, (B) grant any increase in the compensation
of any current or former officer or director, (C) adopt any benefit plan for the benefit of any current or former officer or director,
or (D) materially amend any existing agreement with any current or former officer or director;
(xii) make
any loans, advances or capital contributions to, or investments in, any other Person (including to any of its officers, directors, agents
or consultants, other than business expenses advanced to officers or directors in the Ordinary Course), make any change in its existing
borrowing or lending arrangements for or on behalf of such Persons, or enter into any “keep well” or similar agreement to
maintain the financial condition of any Person;
(xiii) liquidate,
dissolve, reorganize or otherwise wind-up its business and operations;
(xiv) enter
into any formal or informal agreement or otherwise make a binding commitment to do any action prohibited under this Section 7.3;
(xv) split,
combine, reclassify, recapitalize or otherwise amend any terms of any shares or series of SPAC’s capital stock or equity interests;
or
(xvi) purchase,
repurchase, redeem (except for the exercise of the SPAC Share Redemption) or otherwise acquire any issued and outstanding share capital,
outstanding shares of capital stock, membership interests or other equity interests of SPAC.
(b) During
the Interim Period, SPAC shall comply in all material respects with, and continue performing under, as applicable, its Governing Documents,
the Trust Agreement and all other material Contracts to which it may be a party.
Section 7.4 SPAC
Public Filings. Between the date of this Agreement and the SPAC Merger Effective Time or the
earlier termination of this Agreement, SPAC will timely file all of the forms, reports, schedules, statements and other documents required
to be filed by SPAC with the SEC, including all necessary amendments and supplements thereto, and otherwise comply in all material respects
with applicable securities Laws (the “Additional SEC Reports”). All such Additional SEC Reports (including any financial
statements or schedules included therein) (i) shall be prepared in all material respects in accordance with either the requirements
of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the rules and regulations promulgated
thereunder and (ii) will not, at the time they are filed, or, if amended, as of the date of such amendment, contain any untrue statement
of a material fact or fail to state any material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. As used in this Section 7.4, the term “file”
shall be broadly construed to include any manner in which a document or information is furnished, supplied or otherwise made available
to the SEC or Nasdaq. SPAC shall consult with the Company regarding any Additional SEC Reports which discuss or refer to this Agreement
or the Transactions; provided, however, that SPAC will have the final approval.
Section 7.5 ASSIGNMENT
AND ASSUMPTION OF the SPAC Warrant Agreement. As of immediately prior to the SPAC Merger Effective
Time, PubCo and SPAC shall, and shall direct Continental to, enter into an assignment and assumption agreement (the “Assignment
and Assumption Agreement”) in form and substance reasonably satisfactory to PubCo and SPAC, pursuant to which SPAC will assign
to PubCo all of its rights, interests, and obligations in and under the SPAC Warrant Agreement, implementing the terms and provisions
set forth in Section 2.3(g)(v).
Section 7.6 SPAC
Extension Proposal. The Company and SPAC agree that if it is determined by the Parties that it
is probable that the Transactions will not be consummated by December 28, 2023, the Parties will cooperate with the preparation,
filing and mailing of proxy materials to be sent to the SPAC Stockholders seeking approval of the SPAC Extension Proposal to ensure that
the SPAC Stockholders have sufficient time to vote on the extension prior to December 28, 2023.
Article VIII
JOINT COVENANTS
Section 8.1 PubCo
Listing. From the date of this Agreement through the Closing, PubCo shall apply for, and SPAC
and PubCo shall use reasonable best efforts to cause, the PubCo Shares and PubCo Warrants to be approved for listing on Nasdaq or NYSE
and accepted for clearance by the DTC, subject to official notice of issuance, prior to the Closing Date.
Section 8.2 Regulatory
Approvals; Other Filings.
(a) Each
of the Company, SPAC and the Acquisition Entities shall use their commercially reasonable efforts to cooperate in good faith with any
Governmental Authority and to undertake promptly any and all action required to obtain any necessary or advisable regulatory approvals,
consents, Actions, nonactions or waivers in order to complete lawfully the Transactions (the “Regulatory Approvals”)
as soon as practicable (but in any event prior to the Termination Date) and any and all action necessary to consummate the Transactions
as contemplated hereby. Each of the Company, SPAC and the Acquisition Entities shall take such action as may be required to cause the
expiration or termination of the waiting, notice or review periods under any applicable Regulatory Approval with respect to the Transactions
as promptly as practicable after the execution of this Agreement. Notwithstanding anything to the contrary contained in this Agreement,
nothing contained in this Section 8.2(a), the first sentence of Section 8.2(b) or Section 8.4
shall require any Affiliate of SPAC to take or forbear from any action, and for the avoidance of doubt, it is acknowledged and agreed
by the parties hereto that the obligations in this Section 8.2 and Section 8.4 shall not apply to Sponsor or any
of its Affiliates (other than SPAC).
(b) With
respect to each of the Regulatory Approvals and any other requests, inquiries, Actions or other proceedings by or from Governmental Authorities,
each of the Company, SPAC and the Acquisition Entities shall (i) promptly (and, in the case of the initial filing required under
the HSR Act, within 20 Business Days after the date hereof) submit all notifications, reports, and other filings required to be submitted
to a Governmental Authority in order to obtain the Regulatory Approvals; (ii) diligently and expeditiously defend and use commercially
reasonable efforts to obtain any necessary clearance, approval, consent or Regulatory Approval under any applicable Laws prescribed or
enforceable by any Governmental Authority for the Transactions and to resolve any objections as may be asserted by any Governmental Authority
with respect to the Transactions; and (iii) cooperate fully with each other in the defense of such matters. To the extent not
prohibited by Law, the Company and the Acquisition Entities shall promptly furnish to SPAC, and SPAC shall promptly furnish to the Company,
copies of any substantive notices or written communications received by such party or any of its Affiliates from any Governmental Authority
with respect to the Transactions, and each such party shall permit counsel to the other parties an opportunity to review in advance, and
each such party shall consider in good faith the views of such counsel in connection with, any proposed substantive written communications
by such party or its Affiliates to any Governmental Authority concerning the Transactions; provided, however, that
none of the Company, SPAC or any of the Acquisition Entities shall enter into any agreement with any Governmental Authority relating to
any Regulatory Approval contemplated in this Agreement without the written consent of the other parties. To the extent not prohibited
by Law, the Company and the Acquisition Entities agree to provide SPAC and its counsel, and SPAC agrees to provide to the Company and
its counsel, the opportunity, on reasonable advance notice, to participate in any substantive meetings or discussions, either in person
or by telephone, between such party or any of its Affiliates or Representatives, on the one hand, and any Governmental Authority, on the
other hand, concerning or in connection with the Transactions. Each of the Company, SPAC and the Acquisition Entities agrees to make all
filings, to provide all information reasonably required of such party and to reasonably cooperate with each other, in each case, in connection
with the Regulatory Approvals; provided, further, that such party shall not be required to provide information to the
extent that (w) any applicable Law requires it or its Affiliates to restrict or prohibit access to such information, (x) in
the reasonable judgment of such party, the information is subject to confidentiality obligations to a third party, (y) in the reasonable
judgment of such party, the information is commercially sensitive and disclosure of such information would have a material impact on the
business, results of operations or financial condition of such party, or (z) disclosure of any such information would reasonably
be likely to result in the loss or waiver of the attorney-client, work product or other applicable privilege.
(c) The
Company, on the one hand, and SPAC, on the other, shall each be responsible for and pay one-half of the filing fees payable to the Governmental
Authorities in connection with the Transactions, including such filing fees payable by an Acquisition Entity.
Section 8.3 Preparation
of Registration Statement; SPAC Stockholder Meeting and Approvals; Company Written Consent and Approvals.
(a) Registration
Statement.
(i) As
promptly as reasonably practicable after the execution of this Agreement, the Company and SPAC shall prepare and mutually agree upon and
SPAC and PubCo shall file with the SEC a registration statement on Form F-4 (as amended or supplemented from time to time, and together
with the proxy statement/prospectus to be filed with the SEC as part of the Registration Statement and sent to the SPAC Stockholders relating
to the SPAC Shareholder Meeting (as defined below), the “Registration Statement”) relating to the meeting of SPAC Stockholders
(including any adjournment or postponement thereof, the “SPAC Stockholders Meeting”) (x) in connection with the
registration under the Securities Act of the PubCo Shares and Assumed Warrants to be issued to all of the SPAC Stockholders pursuant to
this Agreement, (y) to provide the Public Stockholders (as defined below) an opportunity in accordance with SPAC Governing Documents
to have their shares of SPAC Class A Common Stock redeemed in the SPAC Share Redemption and (z) to solicit proxies from SPAC
Stockholders for the approval and adoption of: (A) this Agreement, the SPAC Merger and the other Transactions, (B) approval
of the PubCo Incentive Equity Plan to provide for the issuance of a number of securities equal to up to 15% of the PubCo Shares to be
issued and outstanding after the Closing, (C) any other proposals as the SEC (or staff member thereof) may indicate are necessary
in its comments to the Registration Statement or correspondence related thereto, (D) a proposal to remove the requirement from the
SPAC’s Governing Documents limiting redemptions and consummation of a business combination if the surviving company would not have
net tangible assets of at least $5,000,001 (the “NTA Proposal”) and any other proposals as determined by SPAC and PubCo
to be necessary or appropriate in connection with the transactions contemplated hereby, and (E) adjournment of the SPAC Stockholder
Meeting, if necessary, to permit further solicitation of proxies because there are not sufficient votes to approve and adopt any of the
foregoing or for such other reasons as the chairman of the SPAC Stockholder Meeting may deem necessary (such proposals in (A) through
(E), collectively, the “Transaction Proposals”). The Company, each Acquisition Entity and SPAC shall furnish all information
concerning such party as SPAC and the Company may reasonably request in connection with such actions and the preparation of the Registration
Statement. Each such Party each shall use their commercially reasonable efforts to (1) cause the Proxy/ Registration Statement when
filed with the SEC to comply in all material respects with all Laws applicable thereto, including all rules and regulations promulgated
by the SEC, (2) respond as promptly as reasonably practicable to and resolve all comments received from the SEC concerning the Registration
Statement, (3) cause the Registration Statement to be declared effective under the Securities Act as promptly as practicable and
(4) keep the Registration Statement effective as long as is necessary to consummate the Transactions. Prior to the effective date
of the Registration Statement, the Company, SPAC and PubCo shall take all or any action required under any applicable federal or state
securities Laws in connection with the issuance of PubCo Shares and Assumed Warrants pursuant to this Agreement. Each of the Company,
SPAC and PubCo also agrees to use its commercially reasonable efforts to obtain all necessary state securities law or “Blue Sky”
permits and approvals required to carry out the Transactions, and the Company and SPAC shall furnish all information concerning the Company
and its Subsidiaries (in the case of the Company) or SPAC (in the case of SPAC) and any of their respective members or shareholders as
may be reasonably requested in connection with any such action. As promptly as practicable after finalization and effectiveness of the
Registration Statement, SPAC shall mail (or cause to be mailed) the Registration Statement to the SPAC Stockholders. Each of SPAC, PubCo
and the Company shall furnish to the other parties all information concerning itself, its Subsidiaries, officers, directors, managers,
shareholders, and other equityholders and information regarding such other matters as may be reasonably necessary or advisable or as may
be reasonably requested in connection with the Registration Statement, a current report of SPAC on Form 8-K or a current report of
PubCo on Form 8-K pursuant to the Exchange Act in connection with the Transactions, or any other statement, filing, notice or application
made by or on behalf of SPAC, PubCo, the Company or their respective Affiliates to any regulatory authority (including Nasdaq or NYSE,
as applicable) in connection with the Transactions. Subject to Section 11.6, the Company, on the one hand, and SPAC, on the
other, shall each be responsible for and pay one-half of the cost for the preparation, filing and mailing of the Registration Statement
and other related fees. SPAC shall comply in all material respects with all applicable rules and regulations promulgated by the SEC,
any applicable rules and regulations of Nasdaq or NYSE, as applicable, SPAC Governing Documents, and this Agreement in the distribution
of the Registration Statement, any solicitation of proxies thereunder, the calling and holding of the SPAC Stockholder Meeting and the
SPAC Share Redemption.
(ii) Any
filing of, or amendment or supplement to, the Registration Statement will be mutually prepared and agreed upon by SPAC, PubCo and the
Company. PubCo and the Company will advise SPAC, and SPAC will advise PubCo and the Company, as applicable, promptly after receiving notice
thereof, of the time when the Registration Statement has become effective or any supplement or amendment has been filed, of the issuance
of any stop order, of the suspension of the qualification of PubCo Shares to be issued or issuable in connection with this Agreement for
offering or sale in any jurisdiction, or of any request by the SEC for amendment of the Registration Statement or comments thereon and
responses thereto or requests by the SEC for additional information and responses thereto, and shall provide each other with a reasonable
opportunity to provide comments and amendments to any such filing. SPAC and the Company shall cooperate and mutually agree upon (such
agreement not to be unreasonably withheld or delayed) any response to comments of the SEC or its staff with respect to the Registration
Statement and any amendments filed in response thereto.
(iii) If,
at any time prior to the Closing, any event or circumstance relating to SPAC or its officers or directors is discovered by SPAC which
should be set forth in an amendment or a supplement to the Registration Statement, a current report of SPAC on Form 8-K or a current
report of PubCo on Form 8-K, SPAC shall promptly inform the Company and PubCo. If, at any time prior to the Closing, any event or
circumstance relating to an Acquisition Entity, the Company, any of its Subsidiaries or their respective officers or directors is discovered
by an Acquisition Entity or the Company which should be set forth in an amendment or a supplement to the Registration Statement, a current
report of SPAC on Form 8-K or a current report of PubCo on Form 8-K, the Company or PubCo, as the case may be, shall promptly
inform SPAC. Thereafter, SPAC, PubCo and the Company shall promptly cooperate in the preparation of an appropriate amendment or supplement
to the Registration Statement or the Company Written Consent, describing or correcting such information and shall promptly file such amendment
or supplement with the SEC and, to the extent required by Law, disseminate such amendment or supplement to the SPAC Stockholders.
(b) SPAC
Stockholders’ Approval.
(i) Prior
to or as promptly as practicable after the Registration Statement is declared effective under the Securities Act, SPAC shall establish
a record date for, duly call, give notice of, and convene and hold the SPAC Stockholder Meeting (and in any event, such meeting shall
be held not more than thirty (30) days after the date on which the Registration Statement is mailed to the SPAC Stockholders) for the
purpose of voting on the Transaction Proposals and obtaining the SPAC Stockholders’ Approval (including any adjournment or postponement
of such meeting for the purpose of soliciting additional proxies in favor of the adoption of this Agreement), providing SPAC Stockholders
with the opportunity to elect to effect a SPAC Share Redemption and such other matters as may be mutually agreed by SPAC and the Company.
SPAC will use its reasonable best efforts to (A) solicit from its stockholders proxies in favor of the adoption of this Agreement
and the Transaction Proposals, including the SPAC Stockholders’ Approval, and will take all other action necessary or advisable
to obtain such proxies and SPAC Stockholders’ Approval and (B) to obtain the vote or consent of its stockholders required by
and in compliance with all applicable Law, Nasdaq rules or NYSE rules, as applicable, and the SPAC Charter; provided,
that none of SPAC, Sponsor or any of their Affiliates shall be required to pay any additional consideration to any SPAC Stockholder in
order to obtain the SPAC Stockholders’ Approval. SPAC (x) shall consult with the Company regarding the record date and the
date of the SPAC Stockholder Meeting and (y) shall not adjourn or postpone the SPAC Stockholder Meeting without the prior written
consent of Company (which consent shall not be unreasonably withheld, conditioned or delayed); provided, however, that
SPAC may adjourn or postpone the SPAC Stockholder Meeting without any such consent (1) to the extent necessary to ensure that any
supplement or amendment to the Registration Statement that SPAC reasonably determines (following consultation with the Company) is necessary
to comply with applicable Laws, is provided to the SPAC Stockholders in advance of a vote on the adoption of this Agreement, (2) if,
as of the time that the SPAC Stockholder Meeting is originally scheduled, there are insufficient shares of SPAC Common Stock represented
at such meeting (either in person or by proxy) to constitute a quorum necessary to conduct the business of the SPAC Stockholder Meeting,
or (3) if, as of the time that the SPAC Stockholder Meeting is originally scheduled, adjournment or postponement of the SPAC Stockholder
Meeting is necessary to enable SPAC to solicit additional proxies required to obtain SPAC Stockholder Approval. To the extent practicable,
and in any event subject to SPAC’s obligations under Law, SPAC shall provide the Company with (I) reasonable updates with respect
to the tabulated vote counts received by SPAC, and (II) the right to review and discuss all material communication sent to SPAC Stockholders
with respect to the SPAC Stockholder Meeting.
(ii) the
Registration Statement shall include a statement to the effect that SPAC Board has recommended that the SPAC Stockholders vote in favor
of the Transaction Proposals at the SPAC Stockholder Meeting (such statement, the “SPAC Board Recommendation”) and
neither the SPAC Board nor any committee thereof shall withhold, withdraw, qualify, amend or modify, or publicly propose or resolve to
withhold, withdraw, qualify, amend or modify, the SPAC Board Recommendation (a “SPAC Modification in Recommendation”).
(iii) Promptly
following the execution of this Agreement and the formation of each Acquisition Entity and each Acquisition Entity’s execution of
a Joinder, PubCo shall approve and adopt this Agreement and approve the Transactions, as the sole stockholder of Merger Sub 1 and Merger
Sub 2.
(c) Written
Consent of the Key Shareholder.
(i) The
Company shall seek the irrevocable written consent, in form and substance reasonably acceptable to SPAC, of the Key Shareholder in favor
of the approval and adoption of this Agreement, the Initial Merger, the PubCo Incentive Equity Plan, and the other Transactions (including
as required under the Cayman Companies Act and the Company Governing Documents) (the “Company Written Consent”) as
promptly as reasonably practicable, but in any event within five (5) Business Days after the Registration Statement becomes effective.
The Company will use its reasonable best efforts to solicit the Company Written Consent from the Key Shareholder, and to take all other
commercially reasonable action necessary or advisable to obtain the Company Written Consent and to secure the vote or consent of its shareholders
required by and in compliance with all applicable Law, Nasdaq rules or NYSE rules, as applicable, and the Company Governing Documents;
provided, that none of the Company or any of its Affiliates shall be required to pay or provide any additional consideration to any Company
Shareholder in order to obtain the Company Written Consent. To the extent practicable, and in any event subject to the Company’s
obligations under Law, the Company shall provide SPAC with (1) reasonable updates to SPAC regarding the status of and any issues
arising with respect to obtaining the Company Written Consent and (2) the right to review and discuss all material communication
sent to Company Shareholders with respect to the Company Written Consent The Company shall comply in all material respects with Company
Governing Documents, the applicable provisions of the Cayman Companies Act and this Agreement in the solicitation of the Company Written
Consent.
(ii) The
Company Written Consent shall include a statement to the effect that (i) the Company Board has recommended that the Company Shareholders
vote in favor of the approval and adoption of this Agreement, the Mergers and the other Transactions and execute and deliver the Company
Written Consent (the “Company Board Recommendation”) and (ii) neither the Company Board nor any committee thereof
shall withhold, withdraw, qualify, amend or modify, or publicly propose or resolve to withhold, withdraw, qualify, amend or modify, the
Company Board Recommendation (a “Company Modification in Recommendation”).
Section 8.4 Support
of Transaction. (i) The Company shall, and shall cause the other GCL Companies and the Acquisition
Entities to, and (ii) SPAC shall, (a) use reasonable best efforts to obtain all material consents and approvals of third parties
that any GCL Company or any of the Acquisition Entities and SPAC, as applicable, are required to obtain in order to consummate the Transactions,
and (b) take or cause such other action as may be reasonably necessary or as another party hereto may reasonably request to satisfy
the conditions of Article IX or otherwise to comply with this Agreement and to consummate the Transactions as soon as practicable;
provided, that, notwithstanding anything contained herein to the contrary, nothing in this Agreement shall require any GCL Company,
SPAC or the Acquisition Entities or any of their respective Affiliates to (i) commence or threaten to commence, pursue or defend
against any Action (except as required under Section 8.6, and without limiting the express obligations to make regulatory
filings under Section 8.2), whether judicial or administrative, (ii) seek to have any stay or other Governmental Order
vacated or reversed, (iii) propose, negotiate, commit to or effect by consent decree, hold separate order or otherwise, the sale,
divestiture, licensing or disposition of any assets or businesses of the GCL Companies, (iv) take or commit to take actions that
limit the freedom of action of any of the GCL Companies or SPAC with respect to, or the ability to retain, control or operate, or to exert
full rights of ownership in respect of, any of the businesses, product lines or assets of the GCL Companies or SPAC or (v) grant
any financial, legal or other accommodation to any other Person (for the avoidance of doubt, without limiting the express obligations
of such parties under the terms of this Agreement and the Ancillary Agreements).
Section 8.5 Tax
Matters.
(a) Each
of PubCo, SPAC, Merger Sub 1, Merger Sub 2, Surviving Corporation and the Company shall, and shall cause its Affiliates to, take such
actions to cause the Transactions to qualify, and refrain from taking such actions that could prevent or impede the Transactions from
qualifying, for the Intended Tax Treatment. PubCo, SPAC, Merger Sub 1, Merger Sub 2, Surviving Corporation and the Company hereby agree
to file all applicable Tax Returns on a basis consistent with the Intended Tax Treatment, unless otherwise required by a Governmental
Authority as a result of a “determination” within the meaning of Section 1313(a) of the Code (or any similar provision
of applicable state, local or non-U.S. Tax Law). If, in connection with the preparation and filing of the Registration Statement, the
SEC requests or requires that Tax opinions with respect to U.S. federal income tax consequences of the Transactions be prepared and submitted
in such connection, PubCo, SPAC and the Company shall deliver to Winston & Strawn LLP (“Winston”) and Loeb &
Loeb LLP (“Loeb”), respectively, customary Tax representation letters satisfactory to its counsel, dated and executed
as of the date the Registration Statement shall have been declared effective by the SEC and such other date(s) as determined reasonably
necessary by such counsel in connection with the preparation and filing of the Registration Statement. Notwithstanding anything to the
contrary in this Agreement, no party or their Tax advisors are obligated to provide any opinion that the relevant portions of the Transactions
contemplated by this Agreement otherwise qualify for their respective Intended Tax Treatment (other than, to the extent required by the
SEC, a customary opinion regarding the U.S. federal income tax considerations of such transactions included in the Registration Statement
as may be required to satisfy applicable rules and regulations promulgated by the SEC); provided, that, for the avoidance of doubt,
neither this Section 8.5(a) nor any other provision in this Agreement shall require the provision of a Tax opinion by
any party’s counsel or advisors to be an express condition precedent to the Closing. Notwithstanding anything to the contrary in
this Agreement, Loeb shall not be required to provide any opinion to any party regarding the Intended Tax Treatment or tax consequences
of the Transactions. Subject to the following sentence, PubCo shall cause SPAC to use its cash to make one or more loans to the Surviving
Corporation or its Affiliates for use in a trade or business or to otherwise transfer its cash to the Surviving Corporation or its Affiliates
for use in a trade or business, or a combination of the foregoing. Neither PubCo nor any of its Subsidiaries shall transfer or distribute
any assets or stock of SPAC or the Surviving Corporation if such transfer or distribution would not satisfy the requirements of Treasury
Regulation Section 1.368-2(k)(1)(i) or (ii) for a period of one year after the Closing Date. Each of PubCo, SPAC, the Surviving
Corporation and the Company shall not undertake (or cause to be undertaken) any of the following for a period of one year after the Closing
Date: (A) the actual or deemed liquidation of SPAC for U.S. federal income tax purposes, (B) the conversion of SPAC into a “disregarded
entity” (within the meaning of Treasury Regulation Section 301.7701-3). The covenants contained in this Section 8.5(a),
notwithstanding any provision elsewhere in this Agreement, shall survive in full force and effect indefinitely.
(b) Each
of PubCo, SPAC, the Surviving Corporation and the Company shall, and shall cause its Affiliates to, cooperate fully, as and to the extent
reasonably requested by another party, in connection with the filing of relevant Tax Returns, the Tax treatment of any aspect of the Transactions
or any audit or other Action pertaining to Taxes. Such cooperation shall include the retention and (upon the other party’s request)
the provision (with the right to make copies) of records and information reasonably relevant to any GRA, Tax proceeding or audit, making
employees reasonably available on a mutually convenient basis to provide additional information and explanation of any material provided
hereunder (to the extent such information or explanation is not publicly or otherwise reasonably available).
(c) PubCo
acknowledges that any direct or indirect holder of PubCo Shares who is a “five-percent transferee shareholder” (within the
meaning of Treasury Regulations Section 1.367(a)-3(c)(5)(ii)) of PubCo following the Mergers (a “PubCo 5% Shareholder”)
may enter into (and cause to be filed with the Internal Revenue Service) a GRA. Upon the written request of any PubCo 5% Shareholder made
following the Closing Date, PubCo shall (i) furnish to such PubCo 5% Shareholder such information as such PubCo 5% Shareholder reasonably
requests in connection with such PubCo 5% Shareholder’s preparation of a GRA and any necessary Tax forms with respect thereto during
the period in which such GRA is in place under Treasury Regulations Section 1.367(a)-8, and (ii) provide such PubCo 5% Shareholder
with the information reasonably requested by such PubCo 5% Shareholder for purposes of such PubCo 5% Shareholder’s tax compliance
during the period in which such GRA is in place under Treasury Regulations Section 1.367(a)-8, including for purposes of determining
whether there has been a gain “triggering event” (within the meaning of Treasury Regulations Section 1.367(a)-8) under
the terms of such PubCo 5% Shareholder’s GRA, in each case, at the sole cost and expense of such PubCo 5% Shareholder. Each of the
parties shall, and shall cause their Affiliates to, operate in a manner so as not to cause such a triggering event.
(d) All
transfer, documentary, sales, use, stamp, registration, value added or other similar Taxes (“Transfer Taxes”) that
become payable by any of the parties in connection with the Transactions shall constitute Company Transaction Expenses (if incurred by
or on behalf of the Company) or SPAC Transaction Expenses (if incurred by or on behalf of the SPAC). Transfer Taxes, if any, incurred
in connection with the Restructuring shall be paid by the Company prior to Closing. The party responsible for filing any necessary Tax
Returns with respect to Transfer Taxes under applicable Law shall cause such Tax Returns to be filed, and if required by applicable Law,
the other Parties shall join in the execution of any such Tax Returns. Any expenses incurred in connection with the filing of such Tax
Returns or other documentation shall be borne equally by the SPAC and the Company. Notwithstanding any other provision of this Agreement,
the parties shall (and shall cause their respective Affiliates to) cooperate in good faith to minimize, to the extent permissible under
applicable Law, the amount of any such Transfer Taxes.
Section 8.6 Stockholder
Litigation. The Company, the GCL Companies and PubCo shall promptly advise SPAC, and SPAC shall
promptly advise the Company, as the case may be, of any Action commenced (or to the knowledge of the Company or PubCo (as applicable)
or the knowledge of SPAC, as applicable, threatened) on or after the date of this Agreement against such party, any of its Subsidiaries
or any of its directors by any Company Shareholder or SPAC Stockholder relating to this Agreement, the Mergers or any of the other Transactions
(any such Action, “Stockholder Litigation”), and such party shall keep the other party reasonably informed regarding
any such Stockholder Litigation. The Company and PubCo shall give SPAC the opportunity to participate in the defense or settlement of
any such Stockholder Litigation brought against the Company or PubCo, any of its Subsidiaries or any of its directors, and no such settlement
shall be agreed to without SPAC’s prior consent (which consent shall not be unreasonably withheld, conditioned or delayed). SPAC
shall give the Company the opportunity to participate in the defense or settlement of any such Stockholder Litigation brought against
SPAC, any of their respective Subsidiaries or any of their respective directors, and no such settlement shall be agreed to without the
Company’s prior consent (which consent shall not be unreasonably withheld, conditioned or delayed).
Section 8.7 Acquisition
Proposals and Alternative Transactions. Except in connection with the Transaction Financing,
during the Interim Period, each of the Company and SPAC shall not, and shall cause its Representatives not to, (i) initiate any negotiations
with any Person with respect to, or provide any non-public information or data concerning the Company and SPAC or their respective Subsidiaries,
to any Person relating to an Acquisition Proposal or Alternative Transaction or afford to any Person access to the business, properties,
assets or personnel of any GCL Company or SPAC or any of its Subsidiaries in connection with an Acquisition Proposal or Alternative Transaction,
(ii) enter into any acquisition agreement, merger agreement or similar definitive agreement, or any letter of intent, memorandum
of understanding or agreement in principle, or any other agreement relating to an Acquisition Proposal or Alternative Transaction, (iii) grant
any waiver, amendment or release under any confidentiality agreement or the anti-takeover Laws of any state relating to an Acquisition
Proposal or Alternative Transaction, or (iv) otherwise knowingly facilitate any such inquiries, proposals, discussions, or negotiations
or any effort or attempt by any Person to make an Acquisition Proposal or Alternative Transaction. Each of the Company and SPAC shall,
and shall cause its Representatives to, immediately cease any and all existing discussions or negotiations with any person conducted heretofore
with respect to any Alternative Transaction or Acquisition Proposal. Without limiting the foregoing, the parties agree that any violation
of the restrictions set forth in this Section 8.7 by a party or its affiliates or Representatives shall be deemed to be a
breach of this Section 8.7 by such party.
Section 8.8 Access
to Information; Inspection. During the Interim Period, to the extent permitted by applicable
Law, each of the Company, SPAC and the Acquisition Entities shall, and shall cause each of its Subsidiaries to, (i) afford to the
other party and its Representatives reasonable access, during normal business hours and with reasonable advance notice, in such manner
as to not materially interfere with the Ordinary Course of its operations, to all of its respective assets, properties, facilities, books,
Contracts, Tax Returns, records and appropriate officers, employees and other personnel, and shall furnish such Representatives with all
financial and operating data and other information concerning its affairs that are in its possession as such Representatives may reasonably
request, and (ii) cooperate with the other party and its Representatives regarding all due diligence matters, including document
requests. Notwithstanding the foregoing, neither the Company nor SPAC shall be required to directly or indirectly provide access to or
disclose information where the access or disclosure would violate its obligations of confidentiality or similar legal restrictions with
respect to such information, jeopardize the protection of attorney-client privilege or contravene applicable Law (it being agreed that
the parties shall use their reasonable best efforts to cause such information to be provided in a manner that would not result in such
jeopardy or contravention).
Section 8.9 OBLIGATIONS
OF GCL COMPANIES AND ACQUISITION ENTITIES. The Company shall take all action necessary to cause
(a) GCL BVI, GCL Global SG and the Group Subsidiaries to perform their respective obligations
pursuant to this Agreement and the Restructuring Agreements and to consummate the Restructuring, the Mergers and each of the transactions
contemplated hereby and thereby, and (b) the Company and each Acquisition Entity to perform their respective obligations under this
Agreement and to consummate the Mergers upon the terms and subject to the conditions set forth in this Agreement. GCL BVI, GCL Global
and each Company Subsidiary shall be jointly and severally liable for the failure by any of them to perform and discharge any of their
respective covenants, agreements and obligations pursuant to this Agreement or any of the Restructuring Agreements.
Section 8.10 TRANSACTION
FINANCING. As soon as practicable after the signing of this Agreement, each of SPAC, the Company, and , Sponsor, shall jointly exercise
their reasonable best efforts to obtain transaction financing (“Transaction Financing”), in the form of signed agreements
for a private placement of equity, or other alternative financing, from Transaction Investors, to be agreed by SPAC and the Company, in
an aggregate amount of not less than $20,000,000.
Article IX
CONDITIONS TO OBLIGATIONS
Section 9.1 Conditions
to Obligations of SPAC, the Acquisition Entities and the Company. The obligations of each of
SPAC, the Acquisition Entities and the Company to consummate, or cause to be consummated, the Transactions at the Closing is subject to
the satisfaction of the following conditions, any one or more of which may be waived in writing by all of such parties:
(a) the
SPAC Stockholders’ Approval and the Company Written Consent shall have been obtained;
(b) all
Regulatory Approvals shall have been obtained or have expired or been terminated, as applicable;
(c) the
Registration Statement shall have been declared effective under the Securities Act and no stop order suspending the effectiveness of the
Registration Statement shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the SEC and
not withdrawn;
(d) the
PubCo Shares to be issued in connection with the Transactions shall have been approved for listing on Nasdaq or NYSE, subject only to
official notice of issuance thereof; and
(e) no
Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent)
or Governmental Order that is then in effect and which has the effect of making the Transactions illegal or which otherwise prevents or
prohibits consummation of the Transactions.
Section 9.2 Conditions
to Obligations of SPAC. The obligations of SPAC to consummate, or cause to be consummated, the
Transactions at the Closing are subject to the satisfaction of the following additional conditions, any one or more of which may be waived
in writing by SPAC:
(a) each
of the representations and warranties of the Company and of each Acquisition Entity contained in this Agreement shall be true and correct
as of the date hereof and as of the Closing Date as though then made, except with respect to such representations and warranties which
speak as to an earlier date, which representations and warranties shall be true and correct at and as of such date, except for, in each
case, inaccuracies or omissions that (without giving effect to any limitation as to “materiality” or “Material Adverse
Effect” or another similar materiality qualification set forth therein), individually or in the aggregate, have not had, and would
not reasonably be expected to have, a Material Adverse Effect;
(b) each
of the covenants of the Company and of each Acquisition Entity to be performed or complied with as of or prior to the Closing shall have
been performed or complied with in all material respects;
(c) the
GCL Companies shall have provided evidence reasonably satisfactory to SPAC of the completion of the Restructuring;
(d) each
Acquisition Entity shall have executed and delivered to SPAC a Joinder;
(e) there
has not been any event that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect;
and
(f) all
approvals, waivers or consents from any third parties set forth and described on Section 9.2 of the Company Disclosure Schedules
shall have been obtained.
Section 9.3 Conditions
to the Obligations of the Company. The obligations of the Company to consummate, or cause to
be consummated, the Transactions at the Closing is subject to the satisfaction of the following additional conditions, any one or more
of which may be waived in writing by the Company:
(a) The
Sponsor shall have made arrangements to pay any SPAC Transaction Expenses in excess of the Maximum Allowable SPAC Transaction Expenses;
(b) the
aggregate cash available to PubCo at the Closing from the Trust Account and the Transaction Financing (after giving effect to any redemptions
but prior to paying any SPAC Transaction Expenses and Company Transaction Expenses), shall equal or exceed $25,000,000 (“Minimum
Cash”); provided, that, any cash obtained as Transaction Financing that is used by the Company or any of its Affiliates
during the period between the date hereof and Closing shall be applied in the calculation of Minimum Cash.
(c) each
of the representations and warranties of SPAC contained in this Agreement shall be true and correct as of the date hereof and as of the
Closing Date, except with respect to such representations and warranties which speak as to an earlier date, which representations and
warranties shall be true and correct at and as of such date, and except for, in each case, inaccuracies or omissions that (without giving
effect to any limitation as to “materiality” or “material adverse effect” or another similar materiality qualification
set forth therein) individually or in the aggregate, have not had, and would not reasonably be expected to have a material adverse effect;
(d) each
of the covenants of SPAC to be performed or complied with as of or prior to the Closing shall have been performed or complied with in
all material respects; and
(e) there
has not been any event that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect.
Article X
TERMINATION/EFFECTIVENESS
Section 10.1 Termination.
This Agreement may be terminated and the Transactions abandoned:
(a) by
mutual written consent of the Company and SPAC or, if the SPAC Extension Proposal has been approved, if the Transactions have not been
completed by September 30, 2024 or if the SPAC Extension Proposal is not approved by December 28, 2023;
(b) by
written notice from the Company or SPAC to the other if any Governmental Authority shall have enacted, issued, promulgated, enforced or
entered any Governmental Order which has become final and nonappealable and has the effect of making consummation of the Transactions
illegal or otherwise preventing or prohibiting consummation of the Transactions;
(c) by
written notice from the Company or SPAC to the other if the SPAC Stockholders’ Approval shall not have been obtained by reason of
the failure to obtain the required vote at the SPAC Stockholder Meeting duly convened therefor or at any adjournment or postponement thereof;
(d) by
written notice from SPAC to the Company if the Company Written Consent shall not have been obtained within five Business Days after the
Registration Statement becomes effective;
(e) prior
to the Closing, by written notice to the Company from SPAC if (i) there is any breach of any representation, warranty, covenant or
agreement on the part of the Company or any Acquisition Entity set forth in this Agreement, such that the conditions specified in Section 9.2(a) or
Section 9.2(b) would not be satisfied at the Closing (a “Terminating Company Breach”), except that,
if such Terminating Company Breach is curable by the Company or such Acquisition Entity through the exercise of its reasonable best efforts,
then, for a period of up to 30 days (or any shorter period of the time that remains between the date SPAC provides written notice of such
violation or breach and the Termination Date) after receipt by the Company of notice from SPAC of such breach (the “Company Cure
Period”), such termination shall not be effective, and such termination shall become effective only if the Terminating Company
Breach is not cured within the Company Cure Period, or (ii) the Closing has not occurred on or before the Termination Date, unless
SPAC is in material breach of any of its representations, warranties, covenants or agreements under this Agreement; or
(f) prior
to the Closing, by written notice to SPAC from the Company if (i) there is any breach of any representation, warranty, covenant or
agreement on the part of SPAC set forth in this Agreement, such that the conditions specified in Section 9.3(a) and Section 9.3(d) would
not be satisfied at the Closing (a “Terminating SPAC Breach”), except that, if any such Terminating SPAC Breach is
curable by SPAC through the exercise of its reasonable best efforts, then, for a period of up to 30 days (or any shorter period of the
time that remains between the date the Company provides written notice of such violation or breach and the Termination Date) after receipt
by SPAC of notice from the Company of such breach (the “SPAC Cure Period”), such termination shall not be effective,
and such termination shall become effective only if the Terminating SPAC Breach is not cured within the SPAC Cure Period or (ii) the
Closing has not occurred on or before the Termination Date, unless the Company is in material breach of any of its representations, warranties,
covenants or agreements under this Agreement.
Section 10.2 Effect
of Termination. In the event of the termination of this Agreement pursuant to Section 10.1,
this Agreement shall forthwith become void and have no effect, without any liability on the part of any party hereto or its respective
Affiliates, officers, directors, stockholders, or other Representatives, other than liability of the Company, SPAC or any Acquisition
Entity, as the case may be, for any Willful Breach of this Agreement occurring prior to such termination, except that the provisions of
this Section 10.2 and Article XI shall survive any termination of this Agreement. Notwithstanding the foregoing,
a failure by SPAC or the Company, as applicable, to close in accordance with this Agreement when it is obligated to do so shall be deemed
to be a Willful Breach of this Agreement.
Article XI
MISCELLANEOUS
Section 11.1 Trust
Account Waiver. The Company and each Acquisition Entity acknowledges that SPAC is a special purpose
acquisition company with the power and privileges to effect a merger, asset acquisition, reorganization or similar business combination
involving the Company and one or more businesses or assets, and the Company has read SPAC’s final prospectus dated March 23,
2022 and filed with the SEC on March 24, 2022 (Filing No: 333-261765) available at www.sec.gov, and other SPAC SEC Filings, the SPAC
Governing Documents, and the Trust Agreement and understands that SPAC has established the trust account described therein (the “Trust
Account”) for the benefit of SPAC’s public stockholders and that disbursements from the Trust Account are available only
in the limited circumstances set forth therein. The Company and each Acquisition Entity further acknowledge and agree that SPAC’s
sole assets consist of the cash proceeds of SPAC’s initial public offering and private placements of its securities, and that substantially
all of these proceeds have been deposited in the Trust Account for the benefit of its public shareholders. The Company and each Acquisition
Entity further acknowledge that, if the transactions contemplated by this Agreement are not consummated by the Termination Date, SPAC
will be obligated to return to its stockholders the amounts being held in the Trust Account. Accordingly, the Company and each Acquisition
Entity (on behalf of itself and its respective Affiliates) hereby waives any past, present or future claim of any kind against, and any
right to access, the Trust Account, any trustee of the Trust Account and SPAC to collect from the Trust Account any monies that may be
owed to them by SPAC or any of its Affiliates for any reason whatsoever, and will not seek recourse against the Trust Account at any time
for any reason whatsoever. This Section 11.1 shall survive the termination of this Agreement for any reason.
Section 11.2 Waiver.
Any party to this Agreement may, at any time prior to the Closing, by action taken by its board of directors or officers or Persons thereunto
duly authorized, (a) extend the time for the performance of the obligations or acts of the other parties hereto, (b) waive any
inaccuracies in the representations and warranties (of another party hereto) that are contained in this Agreement or (c) waive compliance
by the other parties hereto with any of the agreements or conditions contained in this Agreement, but such extension or waiver shall be
valid only if set forth in an instrument in writing signed by the party granting such extension or waiver.
Section 11.3 Notices.
All notices and other communications among the parties shall be in writing and shall be deemed to have been duly given (i) when delivered
in person, (ii) when delivered after posting in the United States mail having been sent registered or certified mail return receipt
requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight delivery service, or (iv) when
delivered by email during normal business hours at the location of the recipient, and otherwise on the next following Business Day, addressed
as follows:
(a) If
to SPAC, to:
RF Acquisition Corp.
111 Somerset, #05-06
Singapore 238164
Email: tsemeng.ng@ruifengwealth.com
Attention: Tse Meng
Ng
with a copy to (which
shall not constitute notice):
Winston &
Strawn LLP
Henley Building,
6th Floor
5 Queen’s Road
Central, Hong Kong
Email: sluk@winston.com
Attention: Simon Luk
and
Winston &
Strawn LLP
800 Capital Street,
Suite 2400
Houston, Texas 77002
Email: mblankenship@winston.com
Attention: Michael
J. Blankenship
(b) If
to the Company or any Acquisition Entity, to:
GCL Global Limited
29 Tai Seng Avenue
#02-01
Natural Cool Lifestyle
Hub
Singapore 534119
Email: jacky@gcl.asia
Attention: Choo See
Wee
With a copy to (which
shall not constitute notice):
Loeb & Loeb
LLP
901 New York Avenue
NW, Suite 300
Washington, DC 20001
Email: jtam@loeb.com
Attention: Jane Tam
or to such other address or addresses as the parties
may from time to time designate in writing. Copies delivered solely to outside counsel shall not constitute notice.
Section 11.4 Assignment.
No party hereto shall assign this Agreement or any part hereof without the prior written consent of the other parties; provided, the Company
may collaterally assign any or all of its rights and interests hereunder to one or more lenders of the Company. Subject to the foregoing,
this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective permitted successors and assigns.
Any attempted assignment in violation of the terms of this Section 11.4 shall be null and void, ab initio.
Section 11.5 Rights
of Third Parties. Nothing expressed or implied in this Agreement is intended or shall be construed
to confer upon or give any Person, other than the parties hereto, any right or remedies under or by reason of this Agreement; provided,
however, that, notwithstanding the foregoing (a) in the event the Closing occurs, the present and former officers and directors
of the Company and SPAC (and their successors, heirs and representatives) are intended third-party beneficiaries of, and may enforce,
Section 6.3 and (b) the past, present and future directors, officers, employees, incorporators, members, partners, stockholders,
Affiliates, agents, attorneys, advisors and representatives of the parties, and any Affiliate of any of the foregoing (and their successors,
heirs and representatives), are intended third-party beneficiaries of, and may enforce, Section 11.16.
Section 11.6 Expenses.
Except as otherwise set forth in this Agreement, including in Section 8.2(c), each party hereto shall be responsible for and
pay its own expenses incurred in connection with this Agreement and the Transactions, including all fees of its legal counsel, financial
advisers and accountants; provided, that if the Closing shall occur, PubCo shall pay or cause to be paid , as applicable,
(a) SPAC Transaction Expenses up to the Maximum Allowable SPAC Transaction Expenses, in accordance with Section 2.6(c),
and (b) the Company Transaction Expenses.
Section 11.7 Governing
Law. This Agreement, and all claims or causes of action based upon, arising out of, or related
to this Agreement or the Transactions, shall be governed by, and construed in accordance with, the Laws of the State of New York, without
giving effect to principles or rules of conflict of Laws to the extent such principles or rules would require or permit the
application of Laws of another jurisdiction (provided that the fiduciary duties of the Board of Directors of the Company, the Initial
Merger and any exercise of appraisal and dissention rights with respect to the Initial Merger, shall in each case be governed by the laws
of the Cayman Islands).
Section 11.8 Headings;
Counterparts. The headings in this Agreement are for convenience only and shall not be considered
a part of or affect the construction or interpretation of any provision of this Agreement. This Agreement may be executed in two or more
counterparts, and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document,
but all of which together shall constitute one and the same instrument. Copies of executed counterparts of this Agreement transmitted
by electronic transmission (including by email or in .pdf format) or facsimile as well as electronically or digitally executed counterparts
(such as DocuSign) shall have the same legal effect as original signatures and shall be considered original executed counterparts of this
Agreement.
Section 11.9 Disclosure
Schedules. The Company Disclosure Schedules and the SPAC Disclosure Schedules (including, in
each case, any section thereof) referenced herein are a part of this Agreement as if fully set forth herein. All references herein to
the Company Disclosure Schedules and/or the SPAC Disclosure Schedules (including, in each case, any section thereof) shall be deemed references
to such parts of this Agreement, unless the context shall otherwise require. Any disclosure made by a party in the applicable Disclosure
Schedules, or any section thereof, with reference to any section of this Agreement or section of the applicable Disclosure Schedules shall
be deemed to be a disclosure with respect to such other applicable sections of this Agreement or sections of applicable Disclosure Schedules
if it is reasonably apparent on the face of such disclosure that such disclosure is responsive to such other section of this Agreement
or section of the applicable Disclosure Schedules. Certain information set forth in the Disclosure Schedules is included solely for informational
purposes and may not be required to be disclosed pursuant to this Agreement. The disclosure of any information shall not be deemed to
constitute an acknowledgment that such information is required to be disclosed in connection with the representations and warranties made
in this Agreement, nor shall such information be deemed to establish a standard of materiality.
Section 11.10 Entire
Agreement. This Agreement (together with the Company Disclosure Schedules and the SPAC Disclosure
Schedules) and the Ancillary Agreements constitute the entire agreement among the parties to this Agreement relating to the Transactions
and supersede any other agreements, whether written or oral, that may have been made or entered into by or among any of the parties hereto
or any of their respective Subsidiaries relating to the Transactions. No representations, warranties, covenants, understandings, agreements,
oral or otherwise, relating to the Transactions exist between such parties except as expressly set forth in this Agreement and the Ancillary
Agreements.
Section 11.11 Amendments.
This Agreement may be amended or modified in whole or in part, only by a duly authorized agreement in writing executed by each of the
parties hereto in the same manner as this Agreement and which makes reference to this Agreement. The approval of this Agreement by the
stockholders of any of the parties shall not restrict the ability of the board of directors of any of the parties to terminate this Agreement
in accordance with Section 10.1 or to cause such party to enter into an amendment to this Agreement pursuant to this Section 11.11.
Section 11.12 Publicity.
(a) All
press releases or other public communications relating to the Transactions, and the method of the release for publication thereof, shall
prior to the Closing be subject to the prior mutual approval of SPAC and the Company, which approval shall not be unreasonably withheld
by any party; provided, that no party shall be required to obtain consent pursuant to this Section 11.12(a) to the
extent any proposed release or statement is substantially equivalent to the information that has previously been made public without breach
of the obligation under this Section 11.12(a). For the avoidance of doubt, nothing contained in this Section 11.12
shall prevent SPAC or the Company and/or their respective Affiliates from furnishing customary summarized information concerning the Transactions
and publicly available information to their current and prospective investors or Transaction Investors.
(b) The
restriction in Section 11.12(a) shall not apply to the extent the public announcement is required by applicable securities
Law, any Governmental Authority or stock exchange rule; provided, however, that in such an event, the party making the announcement
shall use its reasonable best efforts to consult with the other party in advance as to its form, content and timing. Disclosures resulting
from the parties’ efforts to satisfy or obtain approval or early termination in connection with the Regulatory Approvals and to
make any relating filing shall be deemed not to violate this Section 11.12.
Section 11.13 Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this
Agreement shall remain in full force and effect. The parties further agree that if any provision contained herein is, to any extent, held
invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining
provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or
otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable
provision giving effect to the intent of the parties.
Section 11.14 Jurisdiction;
Waiver of Jury Trial. Any Action based upon, arising out of or related to this Agreement, or
the transactions contemplated hereby, shall be brought in the state and federal courts of the State of New York located in New York County,
New York, and each of the parties irrevocably submits to the exclusive jurisdiction of each such court in any such Action, waives any
objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of
the Action shall be heard and determined only in any such court, and agrees not to bring any Action arising out of or relating to this
Agreement or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed to affect the right of
any party to serve process in any manner permitted by Law, or to commence legal proceedings or otherwise proceed against any other party
in any other jurisdiction, in each case, to enforce judgments obtained in any Action brought pursuant to this Section 11.14.
EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
Section 11.15 Enforcement.
The parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur
in the event that the parties do not perform their obligations under the provisions of this Agreement (including failing to take such
actions as are required of them hereunder to consummate this Agreement) in accordance with its specified terms or otherwise breach such
provisions. The parties acknowledge and agree that (a) the parties shall be entitled to an injunction, specific performance, or other
equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without proof of
damages, prior to the valid termination of this Agreement in accordance with Section 10.1, this being in addition to any other
remedy to which they are entitled under this Agreement, and (b) the right of specific enforcement is an integral part of the transactions
contemplated by this Agreement and without that right, none of the parties would have entered into this Agreement. Each party agrees that
it will not oppose the granting of specific performance and other equitable relief on the basis that the other parties have an adequate
remedy at Law or that an award of specific performance is not an appropriate remedy for any reason at Law or equity. The parties acknowledge
and agree that any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement in accordance with this Section 11.15 shall not be required to provide any bond or other security in connection
with any such injunction.
Section 11.16 Non-Recourse.
This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement
or the transactions contemplated hereby may only be brought against, the parties hereto, and then only with respect to the specific obligations
set forth herein or in an Ancillary Agreement with respect to such party. Except to the extent a party to this Agreement or an Ancillary
Agreement and then only to the extent of the specific obligations undertaken by such party in this Agreement or in the applicable Ancillary
Agreement, (a) no past, present or future director, officer, employee, incorporator, member, partner, stockholder, Affiliate, agent,
attorney, advisor or representative or Affiliate of any party to this Agreement or any Ancillary Agreement, and (b) no past, present
or future director, officer, employee, incorporator, member, partner, stockholder, Affiliate, agent, attorney, advisor or representative
or Affiliate of any of the foregoing shall have any liability (whether in contract, tort, equity or otherwise) for any one or more of
the representations, warranties, covenants, agreements or other obligations or liabilities of any one or more of PubCo, the Company, SPAC,
Merger Sub 1, or Merger Sub 2 under this Agreement or any Ancillary Agreement of or for any claim based on, arising out of, or related
to this Agreement or the Transactions.
Section 11.17 Non-Survival
of Representations, Warranties and Covenants. None of the representations, warranties, covenants,
obligations or other agreements in this Agreement or in any certificate, statement or instrument delivered pursuant to this Agreement,
including any rights arising out of any breach of such representations, warranties, covenants, obligations, agreements and other provisions,
shall survive the Closing and shall terminate and expire upon the occurrence of the Closing (and there shall be no liability after the
Closing in respect thereof), except for (a) those covenants and agreements contained herein or in any Ancillary Agreement that by
their terms expressly apply in whole or in part after the Closing and then only with respect to any breaches occurring after the Closing,
and (b) this Article XI.
[Signature pages follow]
IN WITNESS WHEREOF the parties
have hereunto caused this Agreement to be duly executed as of the date first above written.
|
RF ACQUISITION CORP. |
|
|
|
|
|
By: |
/s/ Tse Meng Ng |
|
|
Name: Tse Meng Ng |
|
|
Title: Chief Executive Officer |
|
|
|
|
|
|
Sponsor is executing this Agreement
for the purposes of complying with Section 2.6(c) hereof. |
|
|
|
RF DYNAMIC LLC |
|
|
|
|
|
By: |
/s/
Tse Meng Ng |
|
|
Name: Tse Meng Ng |
|
|
Title: Manager |
[Signature Page to Agreement and Plan
of Merger]
IN WITNESS WHEREOF the parties
have hereunto caused this Agreement to be duly executed as of the date first above written.
|
GCL GLOBAL HOLDINGS LTD |
|
|
|
|
|
By: |
/s/
Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
|
|
|
|
|
GRAND CENTREX LIMITED |
|
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
|
|
|
|
|
GCL GLOBAL LIMITED |
|
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
[Signature Page to Agreement and Plan
of Merger]
EXHIBIT A
FORM OF LOCK-UP AGREEMENT
[●], 2023
[Shareholder/Sponsor]
Re: Lock-Up Agreement for Company Shares
Ladies and Gentlemen:
This letter (this “Letter
Agreement”) is being delivered to you in accordance with that certain Agreement and Plan of Merger (as may be amended, restated
or supplemented from time to time, the “Merger Agreement”) dated October 18, 2023, entered into by and
among GCL Global Holdings LTD, a Cayman Islands exempted company limited by shares (“PubCo”), RF Acquisition
Corp., a Delaware corporation (“SPAC”), and Grand Centrex Limited, a British Virgin Islands business company
(the “Company”), pursuant to which, among other things, Merger Sub 1 (as defined therein) will merge
with and into the Company (the “Initial Merger”), with the Company being the surviving entity and becoming a
wholly owned subsidiary of PubCo, and Merger Sub 2 (as defined therein) will merge with and into SPAC (the “SPAC Merger”
and together with the Initial Merger, the “Mergers”), with SPAC being the surviving entity and becoming a wholly
owned subsidiary of PubCo. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the
Merger Agreement.
In order to induce PubCo, SPAC,
and the Company to proceed with the Mergers and the other Transactions, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the undersigned (each, a “Shareholder”) hereby agrees with PubCo
as follows:
| 1. | Subject to the exceptions set forth herein, the Shareholder agrees not to, without the prior written consent
of the PubCo Board, (i) sell, offer to sell, contract or agree to sell, assign, lend, offer, encumber, donate, hypothecate, pledge,
grant any option, right or warrant to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly,
or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16
of the Exchange Act, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder, (a) any
PubCo Shares (excepting any Incentive Shares), or (b) any securities convertible into or exercisable or exchangeable for PubCo Shares,
in each case, held by it immediately after the SPAC Merger Effective Time (the “Lock-up Shares”), (ii) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any
of the Lock-up Shares, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (iii) publicly
announce any intention to effect any transaction specified in clause (i) or (ii) (the actions specified in clauses (i)-(iii),
collectively, “Transfer”) until the earlier of (1) 12 months commencing from the Closing Date and (2) subsequent
to the Mergers, (x) the date on which the last sale price of the PubCo Shares equals or exceeds $12.00 per PubCo Share (as adjusted
for share splits, share consolidations, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30 trading day period commencing at least 150 days after the consummation of the Mergers,
or (y) the date on which PubCo completes a liquidation, merger, share exchange, reorganization or other similar transaction that
results in all of PubCo’s shareholders having the right to exchange their PubCo Shares for cash, securities or other property (the
“Lock-Up Period”). |
| 2. | The restrictions set forth in paragraph 1 shall not apply to: |
| (i) | Transfers (a) to another entity that is an affiliate of the undersigned, or to any investment fund
or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned
or who shares a common investment advisor with the undersigned or (b) as part of a distribution to members, partners or shareholders
of the undersigned via dividend or share repurchase; |
| (ii) | Transfers by virtue of the laws of the state of the entity’s organization and the entity’s
organizational documents upon dissolution of the entity; |
| (iii) | transactions relating to PubCo Shares or other securities convertible into or exercisable or exchangeable
for PubCo Shares acquired in open market transactions after the SPAC Merger Effective Time; |
| (iv) | the exercise of stock options or warrants to purchase PubCo Shares or the vesting of share awards of PubCo
Shares and any related transfer of PubCo Shares to PubCo in connection therewith (a) deemed to occur upon the “cashless”
or “net” exercise of such options or warrants or (b) for the purpose of paying the exercise price of such options or
warrants or for paying taxes due as a result of the exercise of such options or warrants, the vesting of such options, warrants or share
awards, or as a result of the vesting of such PubCo Shares, it being understood that all PubCo Shares received upon such exercise, vesting
or transfer will remain subject to the restrictions of this Letter Agreement during the Lock-Up Period; |
| (v) | the entry, by the Shareholder, at any time after the SPAC Merger Effective Time, of any trading plan providing
for the sale of PubCo Shares by the Shareholder, which trading plan meets the requirements of Rule 10b5-1(c) under the Exchange
Act, provided, however, that such plan does not provide for, or permit, the sale of any PubCo Shares during the Lock-Up
Period and no public announcement or filing is voluntarily made or required regarding such plan during the Lock-Up Period; |
| (vi) | transactions in the event of completion of a liquidation, merger, stock exchange or other similar transaction
which results in all of PubCo’s shareholders having the right to exchange their PubCo Shares for cash, securities or other property; |
| (vii) | transactions to satisfy any U.S. federal, state, or local income tax obligations of the Shareholder (or
its direct or indirect owners) arising from a change in the Code or the U.S. Treasury Regulations promulgated thereunder (the “Regulations”)
after the date on which the Merger Agreement was executed by the parties, which change prevents the Mergers from qualifying as either
a “reorganization” pursuant to Section 368(a) of the Code or a transaction governed by Section 351 of the Code
(and the Mergers do not qualify for similar tax-free treatment pursuant to any successor or other provision of the Code or Regulations
taking into account such changes), solely and to the extent necessary to cover any tax liability as a direct result of the transaction;
or |
| (viii) | any Incentive Shares. |
provided, however, that in the case
of clauses (i) through (ii), these permitted transferees must enter into a written agreement, in substantially the form of this Letter
Agreement (it being understood that any references to “immediate family” in the agreement executed by such transferee shall
expressly refer only to the immediate family of the Shareholder and not to the immediate family of the transferee), agreeing to be bound
by these Transfer restrictions. For purposes of this paragraph, “immediate family” shall mean a spouse, domestic partner,
child (including by adoption), father, mother, brother or sister of the undersigned, and lineal descendant (including by adoption) of
the undersigned or of any of the foregoing persons; and “affiliate” shall have the meaning set forth in Rule 405 under
the Securities Act.
| 3. | In furtherance of the foregoing, PubCo, and any duly appointed transfer agent for the registration or
transfer of the securities described in the Merger Agreement, are hereby authorized to decline to make any transfer of securities if such
transfer would constitute a violation or breach of this Letter Agreement. |
| 4. | This Letter Agreement embodies the entire agreement and understanding of the parties hereto in respect
of the subject matter contained herein. There are no restrictions, promises, representations, warranties, covenants or undertakings, other
than those expressly set forth or referred herein or the documents or instrument referred to herein, which collectively supersedes all
prior agreements and the understandings between the parties hereto with respect to the subject matter contained herein. This Letter Agreement
may be amended, supplemented or modified only by execution of a written instrument signed by the undersigned Shareholder and PubCo (and
with respect to PubCo, only with the written consent of a majority of its directors, which shall include a majority of its independent
directors). |
| 5. | This Letter Agreement shall be binding upon and inure solely to the benefit of the parties hereto and
their respective successors and permitted assigns. This Letter Agreement shall not be assigned by any party hereto, by operation of law
or otherwise, without the prior written consent of the other party and any assignment without such consent shall be null and void; provided,
that no such assignment shall relieve the assigning party of its obligations hereunder. |
| 6. | This Letter Agreement and any action, proceeding, claim or dispute (whether in contract, tort or otherwise)
(each, an “Action”) that may be based upon, arise out of or relate to this Letter Agreement or the negotiation,
execution or performance hereof shall be governed by, construed and enforced in accordance with the laws (both substantive and procedural)
of the State of New York, without regard to the conflicts of law principles thereof. All Actions arising out of or relating to this Letter
Agreement shall be heard and determined exclusively in the state and federal courts within the State of New York (and any courts having
jurisdiction over appeals therefrom) (the “Specified Courts”). Each party hereto hereby (i) submits to
the exclusive personal and subject matter jurisdiction of any Specified Court for the purpose of any Action arising out of or relating
to this Letter Agreement by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense, or
otherwise, in any such Action, any claim that it is not subject to the personal or subject matter jurisdiction of the above named courts,
that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue
of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court.
Each party hereto agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on
the judgment or in any other manner provided by laws. |
| 7. | This Letter Agreement shall become effective on the date hereof and terminate on the earlier of (i) the
expiration of the Lock-up Period, (ii) termination of the Merger Agreement, and (iii) the liquidation of PubCo. |
[Signature pages follow]
IN WITNESS WHEREOF, each party
has duly executed this Letter Agreement, as of the date first written above.
|
Very truly yours, |
|
|
|
[Shareholder/Sponsor] |
|
|
|
Signature: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
[Signature Page to Lock-Up Agreement]
|
Acknowledged and agreed by: |
|
|
|
GCL GLOBAL HOLDINGS LTD |
|
|
|
Signature: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
[Signature Page to Lock-Up Agreement]
Exhibit 10.1
Execution Version
SPONSOR
SUPPORT AGREEMENT
This Sponsor Support Agreement
(this “Agreement”), dated as of October 18, 2023, is entered into by and among RF Dynamic LLC, a Delaware
limited liability company (the “Sponsor”), RF Acquisition Corp., a Delaware corporation (“SPAC”),
GCL Global Holdings LTD, a Cayman Islands company (“PubCo”), and Grand Centrex Limited, a British Virgin Islands
business company (the “Company”). Capitalized terms used but not otherwise defined herein shall have the meanings
ascribed to such terms in the Merger Agreement (as defined below).
RECITALS
WHEREAS,
concurrently herewith, PubCo, SPAC, the Company, and, for the limited purposes set forth therein, the Sponsor, are entering into an Agreement
and Plan of Merger (as amended, supplemented, restated or otherwise modified from time to time, the “Merger Agreement”),
pursuant to which (and subject to the terms and conditions set forth therein), among other things, Merger Sub 1 will merge with and into
the Company, with the Company surviving the merger (the “Initial Merger”), and Merger Sub 2 will merge with
and into SPAC, with SPAC surviving the merger (the “SPAC Merger” and together with the Initial Merger, the “Mergers”);
WHEREAS,
the Sponsor is currently the record owner of 2,875,000 shares of SPAC Class A Common Stock and 4,450,500 SPAC Warrants (such SPAC
Class A Common Stock and SPAC Warrants owned by the Sponsor, together with any additional shares of SPAC Capital Stock (or any securities
convertible into or exercisable or exchangeable for SPAC Capital Stock) in which the Sponsor acquires record or beneficial ownership after
the date hereof, including by purchase, as a result of a stock dividend, stock split, recapitalization, combination, reclassification,
exchange or change of such shares, or upon exercise or conversion of any securities, the “Covered Shares”);
and
WHEREAS,
as a condition and inducement to the willingness of the Company to enter into the Merger Agreement, the Company and the Sponsor are entering
into this Agreement.
AGREEMENT
NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be
legally bound hereby, the parties hereto agree as follows:
1. Agreement
to Vote. Subject to the earlier termination of this Agreement in accordance with Section 20 the Sponsor, solely in its
capacity as a stockholder of SPAC, irrevocably and unconditionally agrees that at any meeting of the stockholders of SPAC (whether annual
or special and whether or not an adjourned or postponed meeting, however called and including any adjournment or postponement thereof)
and in connection with any written consent of the stockholders of SPAC, the Sponsor shall, and shall cause any other holder of record
of any of the Sponsor’s Covered Shares to:
(a) when
such meeting is held, appear at such meeting or otherwise cause the Sponsor’s Covered Shares to be counted as present thereat for
the purpose of establishing a quorum;
(b) vote
(or execute and return an action by written consent), or cause to be voted at such meeting (or validly execute and return and cause such
consent to be granted with respect to), all of the Sponsor’s Covered Shares owned as of the record date for such meeting (or the
date that any written consent is executed by the Sponsor) in favor of each Transaction Proposal and any other matters necessary or reasonably
requested by the Company for consummation of the Mergers and the other transactions contemplated by the Merger Agreement, including, but
not limited to, any SPAC Extension Proposal; and
(c) vote
(or execute and return an action by written consent), or cause to be voted at such meeting (or validly execute and return and cause such
consent to be granted with respect to), all of the Sponsor’s Covered Shares against any SPAC Business Combination Proposal (as defined
below) and any other action that would reasonably be expected to materially impede, interfere with, delay, postpone or adversely affect
the Mergers or any of the other transactions contemplated by the Merger Agreement or result in a breach of any covenant, representation
or warranty or other obligation or agreement of SPAC under the Merger Agreement or result in a breach of any covenant, representation
or warranty or other obligation or agreement of the Sponsor contained in this Agreement.
The obligations of the Sponsor
specified in this Section 1 shall apply whether or not the Mergers or any action described above is recommended by the SPAC
Board or the SPAC Board previously recommended the Mergers but changed such recommendation.
2. No
Inconsistent Agreements. The Sponsor hereby covenants and agrees that the Sponsor shall not, at any time prior to the Termination
Date (as defined below), (i) enter into any voting agreement or voting trust with respect to any of the Sponsor’s Covered Shares
that is inconsistent with the Sponsor’s obligations pursuant to this Agreement, (ii) grant a proxy or power of attorney with
respect to any of the Covered Shares that is inconsistent with the Sponsor’s obligations pursuant to this Agreement, or (iii) enter
into any agreement or undertaking that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying,
its obligations pursuant to this Agreement.
3. Representations
and Warranties of the Sponsor. The Sponsor hereby represents and warrants to the Company as follows:
(a) The
Sponsor is the only record holder and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good,
valid and marketable title to, the Covered Shares, free and clear of Liens other than as created by this Agreement or the SPAC Governing
Documents (including, for the purposes hereof, any agreement between or among stockholders of SPAC). As of the date hereof, other than
the Covered Shares, the Sponsor does not own beneficially or of record any shares of SPAC Capital Stock (or any securities convertible
into shares of SPAC Capital Stock) or any interest therein.
(b) The
Sponsor (i) except as provided in this Agreement, has full voting power, full power of disposition and full power to issue instructions
with respect to the matters set forth herein, in each case, with respect to the Covered Shares, (ii) has not entered into any voting
agreement or voting trust with respect to any of the Covered Shares that is inconsistent with the Sponsor’s obligations pursuant
to this Agreement, (iii) has not granted a proxy or power of attorney with respect to any of the Sponsor’s Covered Shares that
is inconsistent with the Sponsor’s obligations pursuant to this Agreement, and (iv) has not entered into any agreement or undertaking
that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to this
Agreement.
(c) The
Sponsor (i) is a legal entity duly organized, validly existing and, to the extent such concept is applicable, in good standing under
the Laws of the jurisdiction of its organization, and (ii) has all requisite limited liability company or other power and authority
and has taken all limited liability company or other action necessary in order to, execute, deliver and perform its obligations under
this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by the Sponsor
and constitutes a valid and binding agreement of the Sponsor enforceable against the Sponsor in accordance with its terms, subject to
applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors’ rights
generally and subject, as to enforceability, to general principles of equity.
(d) Other
than the filings, notices and reports pursuant to, in compliance with or required to be made under the Exchange Act, no filings, notices,
reports, consents, registrations, approvals, permits, waivers, expirations of waiting periods or authorizations are required to be obtained
by the Sponsor from, or to be given by the Sponsor to, or be made by the Sponsor with, any Governmental Authority in connection with the
execution, delivery and performance by the Sponsor of this Agreement, the consummation of the transactions contemplated hereby or the
Mergers and the other transactions contemplated by the Merger Agreement.
(e) The
execution, delivery and performance of this Agreement by the Sponsor does not, and the consummation of the transactions contemplated hereby
or the Mergers and the other transactions contemplated by the Merger Agreement will not, constitute or result in (i) a breach or
violation of, or a default under, the limited liability company agreement or similar governing documents of the Sponsor, (ii) with
or without notice, lapse of time or both, a breach or violation of, a termination (or right of termination) of or a default under, the
loss of any benefit under, the creation, modification or acceleration of any obligations under or the creation of a Lien on any of the
properties, rights or assets of the Sponsor pursuant to any Contract binding upon the Sponsor or, assuming (solely with respect to performance
of this Agreement and the transactions contemplated hereby) compliance with the matters referred to in Section 3(d), under
any applicable Law to which the Sponsor is subject or (iii) any change in the rights or obligations of any party under any Contract
legally binding upon the Sponsor, except, in the case of clause (ii) or (iii) directly above, for any such breach, violation,
termination, default, creation, acceleration or change that would not, individually or in the aggregate, reasonably be expected to prevent
or materially delay or impair the Sponsor’s ability to perform its obligations hereunder or to consummate the transactions contemplated
hereby, the consummation of the Mergers or the other transactions contemplated by the Merger Agreement.
(f) As
of the date of this Agreement, there is no action, proceeding or investigation pending against the Sponsor or, to the knowledge of the
Sponsor, threatened against the Sponsor that questions the beneficial or record ownership of the Covered Shares, the validity of this
Agreement or the performance by the Sponsor of its obligations under this Agreement.
(g) Neither
the Sponsor nor any of its Affiliates has ever been suspended or expelled from membership in any securities or commodities exchange or
association or had a securities or commodities license or registration denied, suspended or revoked.
(h) The
Sponsor understands and acknowledges that PubCo, the SPAC and the Company are entering into the Merger Agreement in reliance upon the
Sponsor’s execution and delivery of this Agreement and the representations, warranties, covenants and other agreements of the Sponsor
contained herein.
(i) Tse
Meng Ng is the sole member and is the manager of the Sponsor.
(j) No
investment banker, broker, finder or other intermediary is entitled to any broker’s, finder’s, financial advisor’s or
other similar fee or commission for which PubCo, SPAC or the Company is or will be liable in connection with the transactions contemplated
hereby based upon arrangements made by Sponsor in its capacity as a stockholder of the SPAC.
4. Certain
Covenants of the Sponsor. The Sponsor hereby covenants and agrees as follows:
(a) No
Solicitation. Prior to the Termination Date, the Sponsor agrees not to, directly or indirectly, (i) solicit, initiate or knowingly
encourage or facilitate any inquiry, proposal or offer which constitutes, or could reasonably be expected to lead to, an Acquisition Proposal,
(ii) engage in, continue or otherwise participate in any negotiations or discussions concerning, or provide access to its properties,
books and records or any confidential information or data to, any Person relating to any proposal, offer, inquiry or request for information
that constitutes, or could reasonably be expected to result in or lead to, any Acquisition Proposal, (iii) approve, endorse or recommend,
or propose publicly to approve, endorse or recommend, any Acquisition Proposal, (iv) execute or enter into, any letter of intent,
memorandum of understanding, agreement in principle, confidentiality agreement, merger agreement, acquisition agreement, exchange agreement,
joint venture agreement, partnership agreement, option agreement or other similar agreement for or relating to any Acquisition Proposal
or (v) resolve or agree to do any of the foregoing. The Sponsor also agrees that immediately following the execution of this Agreement,
the Sponsor shall, and shall use commercially reasonable efforts to cause its Representatives to, cease any solicitations, discussions
or negotiations with any Person (other than the Parties and their respective Representatives) conducted heretofore in connection with
an Acquisition Proposal or any inquiry or request for information that could reasonably be expected to lead to, or result in, an Acquisition
Proposal. The Sponsor shall promptly (and in any event within one Business Day) notify, in writing, PubCo, SPAC and the Company of the
receipt of any inquiry, proposal, offer or request for information received after the date hereof that constitutes, or could reasonably
be expected to result in or lead to, any Acquisition Proposal.
Support
of the Merger. Prior to the Termination Date, the Sponsor shall use reasonable best efforts to take, or cause to be taken,
all actions and to do, or cause to be done, all things reasonably necessary to consummate the Mergers and the other transactions contemplated
by the Merger Agreement on the terms and subject to the conditions set forth therein and shall not take any action that would reasonably
be expected to materially delay or prevent the satisfaction of any of the conditions to the Mergers set forth in Article IX of the
Merger Agreement.
(b) Waiver
of Redemption Rights. The Sponsor hereby irrevocably and unconditionally (but subject to the consummation of the Mergers) agrees not
to redeem any of the Sponsor’s shares of SPAC Common Stock and not to commence or participate in, and to take all actions necessary
to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against SPAC, the Company, any affiliate
or designee of the Sponsor acting in his or her capacity as director or any of their respective successors and assigns relating to the
negotiation, execution or delivery of this Agreement, the Merger Agreement or the consummation of the transactions contemplated hereby
and thereby.
(c) Pre-Closing
Transfer Restrictions. Prior to the Termination Date, the Sponsor hereby agrees not to, directly or indirectly, (i) sell, transfer,
pledge, encumber, assign, hedge, swap, convert or otherwise dispose of (including by merger (including by conversion into securities or
other consideration), by tendering into any tender or exchange offer, by testamentary disposition, by operation of Law or otherwise),
either voluntarily or involuntarily (collectively, “Transfer”), or enter into any Contract or option with respect
to the Transfer of, any of the Sponsor’s Covered Shares, or (ii) take any action that would make any representation or warranty
of the Sponsor contained herein untrue or incorrect or have the effect of preventing or disabling the Sponsor from performing its obligations
under this Agreement; provided, however, that nothing herein shall prohibit a Transfer or forfeiture that is or has been
agreed upon by the Company in writing (including pursuant to the terms of this Agreement and the Merger Agreement).
(d) SPAC
Copy. The Sponsor hereby authorizes SPAC to maintain a copy of this Agreement at either the executive office or the registered office
of SPAC.
5. Further
Assurances. From time to time, at the Company’s request and without further consideration, the Sponsor shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or reasonably requested to effect the actions
and consummate the transactions contemplated by this Agreement. The Sponsor further agrees not to commence or participate in, and to take
all actions necessary to opt out of any class in any class action with respect to, any action or claim, derivative or otherwise, against
SPAC, SPAC’s Affiliates, the Company or the Company’s Affiliates or any of their respective successors and assigns challenging
the transactions contemplated by this Agreement or the Merger Agreement.
6. Disclosure.
The Sponsor hereby authorizes the Company and SPAC to publish and disclose in any announcement or disclosure required by the SEC the Sponsor’s
identity and ownership of the Covered Shares and the nature of the Sponsor’s obligations under this Agreement; provided,
that prior to any such publication or disclosure the Company and SPAC have provided the Sponsor with an opportunity to review and comment
upon such announcement or disclosure, which comments the Company and SPAC will consider in good faith.
7. Changes
in Capital Stock. In the event of a stock split, stock dividend or distribution, or any change in the Company’s capital stock
by reason of any stock split, reverse stock split, recapitalization, combination, reclassification, exchange of shares or the like, equitable
adjustment shall be made to the provisions of this Agreement (including with respect to the nature and number of equity interests covered
by the terms “Covered Shares”) as may be required so that the intended rights, privileges, duties and obligations hereunder
shall be given full effect.
8. Amendment
and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise,
except by an instrument in writing signed by the Sponsor and the Company.
9. Waiver.
No failure or delay by any party hereto exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall
any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.
The rights and remedies of the parties hereto hereunder are cumulative and are not exclusive of any rights or remedies which they would
otherwise have hereunder. Any agreement on the part of a party hereto to any such waiver shall be valid only if set forth in a written
instrument executed and delivered by such party.
10. Notices.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, by email (with confirmation
of receipt) or sent by a nationally recognized overnight courier service, such as Federal Express, to the parties hereto at the following
addresses (or at such other address for a party as shall be specified by like notice made pursuant to this Section 10):
if to PubCo or the Company, to it at:
GCL Global Limited
29 Tai Seng Avenue
#02-01
Natural Cool Lifestyle
Hub
Singapore 534119
Email: jacky@gcl.asia
Attention: Choo See
Wee
with a copy (which shall not constitute
notice) to:
Loeb & Loeb
LLP
901 New York Avenue
NW, Suite 300
Washington, DC 20001
Email:
jtam@loeb.com
Attention: Jane Tam
if to SPAC or the Sponsor, to it at:
111 Somerset, #05-06
Singapore 238164
Attention: Tse Meng Ng
E-mail:
tsemeng.ng@ruifengwealth.com
with a copy (which shall not constitute
notice) to:
Winston &
Strawn LLP
Bank of China Tower,
42nd Floor
1 Garden Road
Central, Hong Kong
Email:
sluk@winston.com
Attention: Simon Luk
11. No
Ownership Interest. Until the Closing, nothing contained in this Agreement shall be deemed to vest in PubCo, the SPAC or the Company
any direct or indirect ownership or incidence of ownership of or with respect to the Covered Shares of the Sponsor. Until the Closing,
all rights, ownership and economic benefits of and relating to the Covered Shares of the Sponsor shall remain vested in and belong to
the Sponsor.
12. Entire
Agreement. This Agreement and the Merger Agreement constitute the entire agreement and supersede all prior agreements and understandings,
both written and oral, between the parties hereto with respect to the subject matter hereof and thereof.
13. No
Third-Party Beneficiaries. The Sponsor hereby agrees that its representations, warranties and covenants set forth herein are solely
for the benefit of PubCo, the SPAC and the Company in accordance with and subject to the terms of this Agreement, and this Agreement is
not intended to, and does not, confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right
to rely upon the representations and warranties set forth herein, and the parties hereto hereby further agree that this Agreement may
only be enforced against, and any Action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution
or performance of this Agreement may only be made against, the Persons expressly named as parties hereto.
14. Governing
Law and Venue; Service of Process; Waiver of Jury Trial.
(a) This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York, without giving effect to conflicts
of laws principles or rules to the extent such principles or rules are not mandatorily applicable and would require or permit
the application of the Law of any jurisdiction other than the State of New York.
(b) In
addition, each of the parties (i) consents to submit itself, and hereby submits itself, to the personal jurisdiction of the state
and federal courts located in the State of New York having subject matter jurisdiction, in the event any dispute arises out of this Agreement
or any of the transactions contemplated by this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any such court, and agrees not to plead or claim any objection to the laying of venue in any
such court or that any judicial proceeding in any such court has been brought in an inconvenient forum, (iii) agrees that it will
not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than the
state or federal courts located in the State of New York having subject matter jurisdiction, and (iv) consents to service of process
being made through the notice procedures set forth in Section 10.
(c) EACH
OF THE PARTIES HEREBY KNOWINGLY, INTENTIONALLY AND VOLUNTARILY IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
15. Assignment;
Successors. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties
hereto in whole or in part (whether by operation of Law or otherwise) without the prior written consent of the other party, and any such
assignment without such consent shall be null and void. This Agreement shall be binding upon, inure to the benefit of and be enforceable
by the parties hereto and their respective successors and permitted assigns.
16. Enforcement.
The rights and remedies of the parties shall be cumulative with and not exclusive of any other remedy conferred hereby. The parties agree
that irreparable damage would occur and that the parties would not have any adequate remedy at law in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement, including the Sponsor’s obligations to vote its Covered Shares as provided
in this Agreement, in the state or federal courts located in the State of New York, without proof of actual damages or otherwise (and
each party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition
to any other remedy to which they are entitled at law or in equity.
17. Severability.
If any term or other provision of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void,
unenforceable or against its regulatory policy, the remainder of the terms and provisions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, so long as the economic and legal substance of the transactions contemplated
hereby, taken as a whole, are not affected in a manner materially adverse to any party hereto. Upon such a determination, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as
possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest
extent possible.
18. Counterparts.
This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, it being understood
that each party need not sign the same counterpart. This Agreement shall become effective when each party shall have received a counterpart
hereof signed by all of the other parties. Signatures delivered electronically or by facsimile shall be deemed to be original signatures.
19. Interpretation
and Construction. The words “hereof,” “herein” and “hereunder” and words of like import used in
this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The descriptive headings
used herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation
of this Agreement. References to Sections are to Sections of this Agreement unless otherwise specified. Any singular term in this Agreement
shall be deemed to include the plural, and any plural term the singular. The definitions contained in this Agreement are applicable to
the masculine as well as to the feminine and neuter genders of such term. Whenever the words “include,” “includes”
or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation,”
whether or not they are in fact followed by those words or words of like import. “Writing,” “written” and comparable
terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any
statute shall be deemed to refer to such statute and to any rules or regulations promulgated thereunder. References to any person
include the successors and permitted assigns of that person. References from or through any date mean, unless otherwise specified, from
and including such date or through and including such date, respectively. In the event an ambiguity or question of intent or interpretation
arises, this Agreement will be construed as if drafted jointly by the Parties, and no presumption or burden of proof will arise favoring
or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.
20. Termination.
This Agreement shall terminate upon the earliest of (i) the SPAC Merger Effective Time, (ii) the termination of the Merger Agreement
in accordance with its terms, and (iii) the time this Agreement is terminated upon the mutual written agreement of the Company and
the Sponsor (the earliest such date under clause (i), (ii) and (iii) being referred to herein as the “Termination
Date”); provided, that the provisions set forth in Sections 9 through 19 shall survive the termination
of this Agreement; provided further, that no party hereto shall be relieved from any liability to the other party hereto resulting
from a Willful Breach.
[The remainder of this page is
intentionally left blank.]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be executed as of the date first written above.
|
RF DYNAMIC LLC |
|
|
|
|
By: |
/s/ Tse Meng Ng |
|
|
Name: Tse Meng Ng |
|
|
Title: Manager |
|
|
|
|
RF ACQUISITION CORP |
|
|
|
|
By: |
/s/ Tse Meng Ng |
|
|
Name: Tse Meng Ng |
|
|
Title: Chief Executive Officer |
Signature Page to Sponsor
Support Agreement
|
GCL GLOBAL HOLDINGS LTD |
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
|
|
|
|
GRAND CENTREX LIMITED |
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
Signature Page to Sponsor
Support Agreement
Exhibit 10.2
Execution Version
SHAREHOLDER
SUPPORT AGREEMENT
This Shareholder Support Agreement
(this “Agreement”), dated as of October 18, 2023, is entered into by and among GCL Global Holdings LTD,
a Cayman Islands company (“PubCo”), RF Acquisition Corp., a Delaware corporation (“SPAC”),
Grand Centrex Limited, a British Virgin Islands business company (the “Company”), and the shareholder of the
Company set forth on the signature page hereto (the “Shareholder”). Capitalized terms used but not otherwise
defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).
RECITALS
WHEREAS,
concurrently herewith, PubCo, SPAC, the Company, and, for the limited purposes set forth therein, RF Dynamic LLC, a Delaware limited liability
company (the “Sponsor”), are entering into an Agreement and Plan of Merger (as amended, supplemented, restated
or otherwise modified from time to time, the “Merger Agreement”), pursuant to which (and subject to the terms
and conditions set forth therein), among other things, Merger Sub 1 will merge with and into the Company, with the Company surviving the
merger (the “Initial Merger”), and Merger Sub 2 will merge with and into SPAC, with SPAC surviving the merger
(the “SPAC Merger” and together with the Initial Merger, the “Mergers”);
WHEREAS,
as of the date hereof, the Shareholder is the record holder and “beneficial owner” (within the meaning of Rule 13d-3
under the Exchange Act) of and is entitled to dispose of the Company Shares set forth on such Shareholder’s signature page of
this Agreement (collectively, such Shareholder’s “Owned Shares”; the Owned Shares and any additional Company
Shares (or any securities convertible into or exercisable or exchangeable for Company Shares) in which such Shareholder acquires record
or beneficial ownership after the date hereof, including by purchase, as a result of a stock dividend, stock split, recapitalization,
combination, reclassification, exchange or change of such shares, or upon exercise or conversion of any securities, such Shareholder’s
“Covered Shares”); and
WHEREAS,
as a condition and inducement to the willingness of PubCo, SPAC and the Company to enter into the Merger Agreement, the Shareholder is
entering into this Agreement.
AGREEMENT
NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be
legally bound hereby, PubCo, SPAC, the Company, and the Shareholder hereby agree as follows:
1. Agreement
to Vote. Subject to the earlier termination of this Agreement in accordance with Section 3, such Shareholder, solely in
his, her or its capacity as a Shareholder of the Company agrees, and agrees to cause any other holder of record of any of such Shareholder’s
Covered Shares, to validly execute and deliver to the Company in respect of all of such Shareholder’s Covered Shares, on (or effective
as of) the third Business Day following the date that the Registration Statement becomes effective, the written from such Shareholder
pursuant to the Merger Agreement. In addition, subject to the last paragraph of this Section 1, prior to the Termination Date
(as defined herein), such Shareholder, in his, her or its capacity as a Shareholder of the Company agrees that, at any meeting of the
Shareholders of the Company (whether annual or special and whether or not an adjourned or postponed meeting, however called and including
any adjournment or postponement thereof) and in connection with any written consent of Shareholders of the Company, such Shareholder shall,
and shall cause any other holder of record of any of such Shareholder’s Covered Shares to:
(a) when
such meeting is held, appear at such meeting or otherwise cause such Shareholder’s Covered Shares to be counted as present thereat
for the purpose of establishing a quorum;
(b) vote
(or execute and return an action by written consent), or cause to be voted at such meeting (or validly execute and return and cause such
consent to be granted with respect to), all of such Shareholder’s Covered Shares owned as of the record date for such meeting (or
the date that any written consent is executed by such Shareholder) in favor of the Mergers and the adoption of the Merger Agreement and
any other matters necessary or reasonably requested by the Company for consummation of the Mergers and the other transactions contemplated
by the Merger Agreement; and
(c) vote
(or execute and return an action by written consent), or cause to be voted at such meeting, or validly execute and return and cause such
consent to be granted with respect to, all of such Shareholder’s Covered Shares against any Acquisition Proposal and any other action
that would reasonably be expected to materially impede, interfere with, delay, postpone or adversely affect the Mergers or any of the
other transactions contemplated by the Merger Agreement or result in a breach of any covenant, representation or warranty or other obligation
or agreement of the Company under the Merger Agreement or result in a breach of any covenant, representation or warranty or other obligation
or agreement of such Shareholder contained in this Agreement.
The Shareholder obligations
specified in this Section 1 shall apply whether or not the Mergers or any action described above is recommended by the Company
Board or the Company Board has previously recommended the Mergers but changed such recommendation.
2. No
Inconsistent Agreements. The Shareholder hereby covenants and agrees that such Shareholder shall not, at any time prior to the Termination
Date, (i) enter into any voting agreement or voting trust with respect to any of such Shareholder’s Covered Shares that is
inconsistent with such Shareholder’s obligations pursuant to this Agreement, (ii) grant a proxy or power of attorney with respect
to any of such Shareholder’s Covered Shares that is inconsistent with such Shareholder’s obligations pursuant to this Agreement,
or (iii) enter into any agreement or undertaking that is otherwise inconsistent with, or would interfere with, or prohibit or prevent
it from satisfying, its obligations pursuant to this Agreement.
3. Termination.
This Agreement shall terminate upon the earliest of (i) the SPAC Merger Effective Time, (ii) the termination of the Merger Agreement
in accordance with its terms, and (iii) the time this Agreement is terminated upon the mutual written agreement of PubCo, SPAC, the
Company, and the Shareholder (the earliest such date under clause (i), (ii) and (iii) being referred to herein as the “Termination
Date”); provided, that the provisions set forth in Sections 10 through 21 shall survive the termination
of this Agreement.
4. Representations
and Warranties of the Shareholders. The Shareholder hereby represents and warrants to PubCo as to itself as follows:
(a) Such
Shareholder is the only record and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good, valid
and marketable title to, the Covered Shares, free and clear of Liens other than as created by this Agreement or the Company Governing
Documents (including, for the purposes hereof, any agreements between or among shareholders of the Company). As of the date hereof, other
than the Covered Shares, such Shareholder does not own beneficially or of record any shares of capital stock of the Company (or any securities
convertible into shares of capital stock of the Company) or any interest therein.
(b) Such
Shareholder (i) except as provided in this Agreement, has full voting power, full power of disposition and full power to issue instructions
with respect to the matters set forth herein, in each case, with respect to the Shareholder’s Covered Shares, (ii) has not
entered into any voting agreement or voting trust with respect to any of such Shareholder’s Covered Shares that is inconsistent
with such Shareholder’s obligations pursuant to this Agreement, (iii) has not granted a proxy or power of attorney with respect
to any of such Shareholder’s Covered Shares that is inconsistent with such Shareholder’s obligations pursuant to this Agreement
and (iv) has not entered into any agreement or undertaking that is otherwise inconsistent with, or would interfere with, or prohibit
or prevent it from satisfying, its obligations pursuant to this Agreement.
(c) Such
Shareholder affirms that (i) if such Shareholder is a natural person, he or she has all the requisite power and authority and has
taken all action necessary in order to execute and deliver this Agreement, to perform his or her obligations hereunder and to consummate
the transactions contemplated hereby, and (ii) if such Shareholder is not a natural person, (A) it is a legal entity duly organized,
validly existing and, to the extent such concept is applicable, in good standing under the Laws of the jurisdiction of its organization
and (B) has all requisite corporate or other power and authority and has taken all corporate or other action necessary in order to
execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby . This Agreement
has been duly executed and delivered by such Shareholder and constitutes a valid and binding agreement of such Shareholder enforceable
against such Shareholder in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and similar Laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity.
(d) Other
than the filings, notices and reports pursuant to, in compliance with or required to be made under the Exchange Act, no filings, notices,
reports, consents, registrations, approvals, permits, waivers, expirations of waiting periods or authorizations are required to be obtained
by such Shareholder from, or to be given by such Shareholder to, or be made by the Shareholder with, any Governmental Authority in connection
with the execution, delivery and performance by such Shareholder of this Agreement, the consummation of the transactions contemplated
hereby or the Mergers and the other transactions contemplated by the Merger Agreement.
(e) The
execution, delivery and performance of this Agreement by such Shareholder do not, and the consummation of the transactions contemplated
hereby or the Mergers and the other transactions contemplated by the Merger Agreement will not, constitute or result in (i) a breach
or violation of, or a default under, the limited liability company agreement or similar governing documents of such Shareholder (if such
Shareholder is not a natural person), (ii) with or without notice, lapse of time or both, a breach or violation of, a termination
(or right of termination) of or a default under, the loss of any benefit under, the creation, modification or acceleration of any obligations
under or the creation of a Lien on any of the properties, rights or assets of such Shareholder pursuant to any Contract binding upon such
Shareholder or, assuming (solely with respect to performance of this Agreement and the transactions contemplated hereby) compliance with
the matters referred to in Section 4(d), under any applicable Law to which such Shareholder is subject or (iii) any change
in the rights or obligations of any party under any Contract legally binding upon such Shareholder, except, in the case of clause (ii) or
(iii) directly above, for any such breach, violation, termination, default, creation, acceleration or change that would not, individually
or in the aggregate, reasonably be expected to prevent or materially delay or impair such Shareholder’s ability to perform its obligations
hereunder or to consummate the transactions contemplated hereby, the consummation of the Mergers or the other transactions contemplated
by the Merger Agreement.
(f) As
of the date of this Agreement, there is no action, proceeding or investigation pending against such Shareholder or, to the knowledge of
such Shareholder, threatened against such Shareholder that questions the beneficial or record ownership of such Shareholder’s Owned
Shares, the validity of this Agreement or the performance by such Shareholder of its obligations under this Agreement.
(g) Such
Shareholder understands and acknowledges that PubCo, SPAC and the Company are entering into the Merger Agreement in reliance upon such
Shareholder’s execution and delivery of this Agreement and the representations, warranties, covenants and other agreements of such
Shareholder contained herein.
(h) No
investment banker, broker, finder or other intermediary is entitled to any broker’s, finder’s, financial advisor’s or
other similar fee or commission for which PubCo, SPAC or the Company is or will be liable in connection with the transactions contemplated
hereby based upon arrangements made by such Shareholder in his, her or its capacity as a Shareholder or on behalf of such Shareholder
in his, her or its capacity as a Shareholder.
5. Certain
Covenants of the Shareholders. Except in accordance with the terms of this Agreement, the Shareholder hereby covenants and agrees
as follows:
(a) No
Solicitation. Prior to the Termination Date, such Shareholder agrees not to, directly or indirectly, (i) initiate, solicit or
knowingly encourage or knowingly facilitate any inquiries or requests for information with respect to, or the making of, any inquiry regarding,
or any proposal or offer that constitutes, or could reasonably be expected to result in or lead to, any Acquisition Proposal, (ii) engage
in, continue or otherwise participate in any negotiations or discussions concerning, or provide access to its properties, books and records
or any confidential information or data to, any Person relating to any proposal, offer, inquiry or request for information that constitutes,
or could reasonably be expected to result in or lead to, any Acquisition Proposal, (iii) approve, endorse or recommend, or propose
publicly to approve, endorse or recommend, any Acquisition Proposal, (iv) execute or enter into, any letter of intent, memorandum
of understanding, agreement in principle, confidentiality agreement, merger agreement, acquisition agreement, exchange agreement, joint
venture agreement, partnership agreement, option agreement or other similar agreement for or relating to any Acquisition Proposal or (v) resolve
or agree to do any of the foregoing. Such Shareholder also agrees that immediately following the execution of this Agreement, such Shareholder
shall, and shall use commercially reasonable efforts to cause its Representatives to, cease any solicitations, discussions or negotiations
with any Person (other than the Parties and their respective Representatives) conducted heretofore in connection with an Acquisition Proposal
or any inquiry or request for information that could reasonably be expected to lead to, or result in, an Acquisition Proposal. Such Shareholder
shall promptly (and in any event within one Business Day) notify, in writing, PubCo, SPAC and the Company of the receipt of any inquiry,
proposal, offer or request for information received after the date hereof that constitutes, or could reasonably be expected to result
in or lead to, any Acquisition Proposal.
Such Shareholder shall promptly
(and in any event within one Business Day) keep PubCo, SPAC and the Company reasonably informed of any material developments with respect
to any such inquiry, proposal, offer, request for information or Acquisition Proposal (including any material changes thereto).
Notwithstanding
anything in this Agreement to the contrary, (i) such Shareholder shall not be responsible for the actions of the Company or the Company’s
Board (or any committee thereof), any Affiliate or Subsidiary of the Company, or any officers, directors (in their capacity as such),
employees and professional advisors of any of the foregoing (the “Company Related Parties”), including with
respect to any of the matters contemplated by this Section 5(a), (ii) such Shareholder makes no representations or warranties
with respect to the actions of any of the Company Related Parties, and (iii) any breach by the Company of its obligations under Section 8.7
of the Merger Agreement shall not be considered a breach of this Section 5(a) (it being understood for the avoidance
of doubt that such Shareholder shall remain responsible for any breach by such Shareholder or his, her or its Representatives (other
than any such Representative that is a Company Related Party) of this Section 5(a)).
(b) Such
Shareholder hereby agrees not to, directly or indirectly, (i) sell, transfer, pledge, encumber, assign, hedge, swap, convert or otherwise
dispose of (including by merger (including by conversion into securities or other consideration), by tendering into any tender or exchange
offer, by testamentary disposition, by operation of Law or otherwise), either voluntarily or involuntarily (collectively, “Transfer”),
or enter into any Contract or option with respect to the Transfer of, any of such Shareholder’s Covered Shares, or (ii) take
any action that would make any representation or warranty of such Shareholder contained herein untrue or incorrect or have the effect
of preventing or disabling the Shareholder from performing its obligations under this Agreement; provided, however, that
nothing herein shall prohibit a Transfer to an Affiliate of such Shareholder or Transfers made in connection with the Restructuring (a
“Permitted Transfer”); provided, further, that any Permitted Transfer shall be permitted only
if, as a precondition to such Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to SPAC, to
assume all of the obligations of such Shareholder under, and be bound by all of the terms of, this Agreement; provided, further,
that any Transfer permitted under this Section 5(b) shall not relieve such Shareholder of its obligations under this
Agreement. Any Transfer in violation of this Section 5(b) with respect to such Shareholder’s Covered Shares shall
be null and void.
(c) Such
Shareholder hereby authorizes the Company to maintain a copy of this Agreement at either the executive office or the registered office
of the Company.
6. Further
Assurances. From time to time, at PubCo’s request and without further consideration, the Shareholder shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or reasonably requested to effect the actions
and consummate the transactions contemplated by this Agreement. Such Shareholder further agrees not to commence or participate in, and
to take all actions necessary to opt out of any class in any class action with respect to, any action or claim, derivative or otherwise,
against PubCo, PubCo’s Affiliates, SPAC, the Sponsor, the Company or any of their respective successors and assigns challenging
the transactions contemplated by the Merger Agreement or disputing the allocation of the consideration payable as part of the Mergers
pursuant to the terms of the Merger Agreement.
7. Disclosure.
The Shareholder hereby authorizes PubCo, SPAC and the Company to publish and disclose in any announcement or disclosure required by the
SEC such Shareholder’s identity and ownership of the Covered Shares and the nature of such Shareholder’s obligations under
this Agreement; provided, that prior to any such publication or disclosure PubCo, SPAC and the Company have provided such Shareholder
with an opportunity to review and comment upon such announcement or disclosure, which comments PubCo, SPAC and the Company will consider
in good faith.
8. Changes
in Capital Stock. In the event of a stock split, stock dividend or distribution, or any change in the Company’s capital stock
by reason of any split-up, reverse stock split, recapitalization, combination, reclassification, exchange of shares or the like, the terms
“Owned Shares” and “Covered Shares” shall be deemed to refer to and include such shares as well as all such stock
dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which
are received in such transaction.
9. Amendment
and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise,
except by an instrument in writing signed by PubCo, SPAC, the Company and the Shareholder.
10. Waiver.
No failure or delay by any party hereto exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall
any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.
The rights and remedies of the parties hereto hereunder are cumulative and are not exclusive of any rights or remedies which they would
otherwise have hereunder. Any agreement on the part of a party hereto to any such waiver shall be valid only if set forth in a written
instrument executed and delivered by such party.
11. Notices.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, by email (with confirmation
of receipt) or sent by a nationally recognized overnight courier service, such as Federal Express, to the parties hereto at the following
addresses (or at such other address for a party as shall be specified by like notice made pursuant to this Section 11):
if to the Shareholder, to it at:
the address (including email) set forth
in the Company’s books and records, or to such other address or to the attention of such other person as such Shareholder has specified
by prior written notice to the sending party
if to PubCo or the Company, to it at:
GCL Global Limited
29 Tai Seng Avenue
#02-01
Natural Cool Lifestyle
Hub
Singapore 534119
Email: jacky@gcl.asia
Attention: Choo See
Wee
With a copy to (which
shall not constitute notice):
Loeb & Loeb
LLP
901 New York Avenue
NW, Suite 300
Washington, DC 20001
Email:
jtam@loeb.com
Attention: Jane Tam
if to SPAC, to it at:
RF Acquisition Corp
111 Somerset, #05-06
Singapore 238164
Email:
tsemeng.ng@ruifengwealth.com
Attention: Tse Meng
Ng
with a copy to (which
shall not constitute notice):
Winston &
Strawn LLP
Bank of China Tower,
42nd Floor
1 Garden Road
Central, Hong Kong
Email:
sluk@winston.com
Attention: Simon Luk
12. No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in PubCo, SPAC or the Company any direct or indirect
ownership or incidence of ownership of or with respect to the Covered Shares of the Shareholder. All rights, ownership and economic benefits
of and relating to the Covered Shares of the Shareholder shall remain vested in and belong to the Shareholder, and none of PubCo, SPAC
or the Company shall have any authority to direct any Shareholder in the voting or disposition of any of such Shareholder’s Covered
Shares, except as otherwise provided herein.
13. Entire
Agreement. This Agreement and the Merger Agreement constitute the entire agreement and supersede all prior agreements and understandings,
both written and oral, between the parties hereto with respect to the subject matter hereof and thereof.
14. No
Third-Party Beneficiaries. The Shareholder hereby agrees that its representations, warranties and covenants set forth herein are solely
for the benefit of PubCo, SPAC and the Company in accordance with and subject to the terms of this Agreement, and this Agreement is not
intended to, and does not, confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right
to rely upon the representations and warranties set forth herein, and the parties hereto hereby further agree that this Agreement may
only be enforced against, and any Action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution
or performance of this Agreement may only be made against, the Persons expressly named as parties hereto; provided, that PubCo,
SPAC and the Company shall be express third party beneficiaries with respect to Section 4 and Section 5(b) hereof.
15. Governing
Law and Venue; Service of Process; Waiver of Jury Trial.
(a) This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York, without giving effect to conflicts
of laws principles or rules to the extent such principles or rules are not mandatorily applicable and would require or permit
the application of the Law of any jurisdiction other than the State of New York.
(b) In
addition, each of the parties (i) consents to submit itself, and hereby submits itself, to the personal jurisdiction of the state
and federal courts located in the State of New York having subject matter jurisdiction, in the event any dispute arises out of this Agreement
or any of the transactions contemplated by this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any such court, and agrees not to plead or claim any objection to the laying of venue in any
such court or that any judicial proceeding in any such court has been brought in an inconvenient forum, (iii) agrees that it will
not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than the
state or federal courts located in the State of New York having subject matter jurisdiction, and (iv) consents to service of process
being made through the notice procedures set forth in Section 11.
(c) EACH
OF THE PARTIES HEREBY KNOWINGLY, INTENTIONALLY AND VOLUNTARILY IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
16. Assignment;
Successors. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties
hereto in whole or in part (whether by operation of Law or otherwise) without the prior written consent of the other party, and any such
assignment without such consent shall be null and void. This Agreement shall be binding upon, inure to the benefit of and be enforceable
by the parties hereto and their respective successors and permitted assigns.
17. Enforcement.
The rights and remedies of the parties shall be cumulative with and not exclusive of any other remedy conferred hereby. The parties agree
that irreparable damage would occur and that the parties would not have any adequate remedy at law in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement, including the Shareholder’s obligations to vote its Covered Shares as provided
in this Agreement, in the state or federal courts located in the State of New York, without proof of actual damages or otherwise (and
each party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition
to any other remedy to which they are entitled at law or in equity.
18. Severability.
If any term or other provision of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void,
unenforceable or against its regulatory policy, the remainder of the terms and provisions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, so long as the economic and legal substance of the transactions contemplated
hereby, taken as a whole, are not affected in a manner materially adverse to any party hereto. Upon such a determination, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as
possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest
extent possible.
19. Counterparts.
This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, it being understood
that each party need not sign the same counterpart. This Agreement shall become effective when each party shall have received a counterpart
hereof signed by all of the other parties. Signatures delivered electronically or by facsimile shall be deemed to be original signatures.
20. Interpretation
and Construction. The words “hereof,” “herein” and “hereunder” and words of like import used in
this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The descriptive headings
used herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation
of this Agreement. References to Sections are to Sections of this Agreement unless otherwise specified. Any singular term in this Agreement
shall be deemed to include the plural, and any plural term the singular. The definitions contained in this Agreement are applicable to
the masculine as well as to the feminine and neuter genders of such term. Whenever the words “include,” “includes”
or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation,”
whether or not they are in fact followed by those words or words of like import. “Writing,” “written” and comparable
terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any
statute shall be deemed to refer to such statute and to any rules or regulations promulgated thereunder. References to any person
include the successors and permitted assigns of that person. References from or through any date mean, unless otherwise specified, from
and including such date or through and including such date, respectively. In the event an ambiguity or question of intent or interpretation
arises, this Agreement will be construed as if drafted jointly by the Parties, and no presumption or burden of proof will arise favoring
or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.
21. Capacity
as a Shareholder. Notwithstanding anything herein to the contrary, the Shareholder signs this Agreement solely in such Shareholder’s
capacity as a Shareholder of the Company, and not in any other capacity and this Agreement shall not limit or otherwise affect the actions
of such Shareholder or any Affiliate, employee or designee of such Shareholder or any of their respective Affiliates in his or her capacity,
if applicable, as an officer or director of the Company or any other Person.
[The remainder of this page is intentionally
left blank.]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be executed as of the date first written above.
|
SHAREHOLDER |
|
|
|
Epicsoft Ventures Pte Ltd |
|
|
|
/s/ Choo See Wee |
|
Name: Choo See Wee |
|
Title: Director |
|
|
|
Owned Shares: |
|
|
|
____________ Company Shares |
[Signature Page to Shareholder Support
Agreement]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be executed as of the date first written above.
|
GCL GLOBAL HOLDINGS LTD |
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
|
|
|
|
GRAND CENTREX LIMITED |
|
|
|
|
By: |
/s/ Choo See Wee |
|
|
Name: Choo See Wee |
|
|
Title: Director |
[Signature Page to Shareholder Support Agreement]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be executed as of the date first written above.
|
RF ACQUISITION CORP. |
|
|
|
|
By: |
/s/ Tse Meng Ng |
|
|
Name: Tse Meng Ng |
|
|
Title: Chief Executive Officer |
[Signature Page to Shareholder Support
Agreement]
RF Acquisition (NASDAQ:RFACU)
Historical Stock Chart
From Oct 2024 to Nov 2024
RF Acquisition (NASDAQ:RFACU)
Historical Stock Chart
From Nov 2023 to Nov 2024